{
 "PMC4890308": {
  "Sentences0": {
   "text": "Those with inflammation indicated by high C-reactive protein CRP had more depression and bipolar disorder and more than twice the suicide rate of those with low CRP 111\u2013 113 ",
   "entities": [
    [
     "T1",
     61,
     64,
     "gene",
     "CRP"
    ],
    [
     "T1",
     161,
     164,
     "gene",
     "CRP"
    ],
    [
     "T2",
     74,
     84,
     "phenotype",
     "depression"
    ],
    [
     "T3",
     97,
     105,
     "phenotype",
     "disorder"
    ]
   ]
  }
 },
 "PMC5397476": {
  "Sentences0": {
   "text": "M Male F Female PTGBA Percutaneous transhepatic gallbladder aspiration ERCP Endoscopic retrograde Cholangiopancreatography NA Not applicable TG13 Tokyo guidelines 2013 ESBL Extended-spectrum \u00df-lactamase CTRX Ceftriaxone SBT Sulbactam CPZ Cefoperazone ",
   "entities": [
    [
     "T1",
     234,
     237,
     "gene",
     "CPZ"
    ],
    [
     "T2",
     60,
     70,
     "phenotype",
     "aspiration"
    ]
   ]
  }
 },
 "PMC5398507": {
  "Sentences0": {
   "text": "In addition HbA1c is a very good predictor of cardiovascular disease even in nondiabetic populations 2 3  and recently the ADA recommended the adoption of the HbA1c test for the diagnosis of diabetes and prediabetes 1 ",
   "entities": [
    [
     "T1",
     123,
     126,
     "gene",
     "ADA"
    ],
    [
     "T2",
     46,
     68,
     "phenotype",
     "cardiovascular disease"
    ],
    [
     "T3",
     191,
     199,
     "phenotype",
     "diabetes"
    ],
    [
     "T4",
     61,
     68,
     "phenotype",
     "disease"
    ],
    [
     "T5",
     204,
     215,
     "phenotype",
     "prediabetes"
    ]
   ]
  }
 },
 "PMC5402056": {
  "Sentences0": {
   "text": "Once APCs verify the tumor antigen as foreign via their interaction with CD4 and CD8 T cells the APCs signal for the proliferation of various T cell subtypes that also recognize the tumor antigen ",
   "entities": [
    [
     "T1",
     73,
     76,
     "gene",
     "CD4"
    ],
    [
     "T2",
     21,
     26,
     "phenotype",
     "tumor"
    ],
    [
     "T2",
     182,
     187,
     "phenotype",
     "tumor"
    ]
   ]
  }
 },
 "PMC5402967": {
  "Sentences0": {
   "text": "In breast cancer KLF5 plays an important role in tumorigenesis and high expression level of KLF5 is positively correlated with poor survival rate of breast cancer patients 7 8 ",
   "entities": [
    [
     "T1",
     17,
     21,
     "gene",
     "KLF5"
    ],
    [
     "T1",
     92,
     96,
     "gene",
     "KLF5"
    ],
    [
     "T2",
     10,
     16,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     156,
     162,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences1": {
   "text": "We previously found that KLF5 promotes breast cancer cell proliferation migration and invasion by upregulating the expression of FGF-BP mPGES1 and TNFAIP2 and down-regulating the expression of p27 9\u201312 ",
   "entities": [
    [
     "T1",
     25,
     29,
     "gene",
     "KLF5"
    ],
    [
     "T2",
     147,
     154,
     "gene",
     "TNFAIP2"
    ],
    [
     "T3",
     46,
     52,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences2": {
   "text": "KLF5 depletion leads to breast cancer cell apoptosis and suppresses xenograft tumor growth in vivo 13 14 ",
   "entities": [
    [
     "T1",
     0,
     4,
     "gene",
     "KLF5"
    ],
    [
     "T2",
     78,
     83,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     31,
     37,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences3": {
   "text": "MiR-217 was first illustrated to function as a potential tumor suppressor by targeting KRAS in pancreatic ductal adenocarcinoma 20\u201322 ",
   "entities": [
    [
     "T1",
     87,
     91,
     "gene",
     "KRAS"
    ],
    [
     "T2",
     57,
     62,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences4": {
   "text": "MiR-217 inhibits clear cell renal cell carcinoma hepatocellular carcinoma gastric cancer and glioma by targeting E2F3 EZH2 and Runx2 respectively 24\u201327 ",
   "entities": [
    [
     "T1",
     113,
     117,
     "gene",
     "E2F3"
    ],
    [
     "T2",
     118,
     122,
     "gene",
     "EZH2"
    ],
    [
     "T3",
     82,
     88,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     49,
     73,
     "phenotype",
     "hepatocellular carcinoma"
    ],
    [
     "T5",
     39,
     48,
     "phenotype",
     "carcinoma"
    ],
    [
     "T5",
     64,
     73,
     "phenotype",
     "carcinoma"
    ],
    [
     "T6",
     74,
     88,
     "phenotype",
     "gastric cancer"
    ],
    [
     "T7",
     17,
     48,
     "phenotype",
     "clear cell renal cell carcinoma"
    ]
   ]
  },
  "Sentences5": {
   "text": "Discussion The expression of KLF5 is correlated with different hormone status in different breast cancer subtypes 8 ",
   "entities": [
    [
     "T1",
     29,
     33,
     "gene",
     "KLF5"
    ],
    [
     "T2",
     98,
     104,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences6": {
   "text": "We previously have reported KLF5 promotes TNBC cell proliferation survival migration and invasion via regulating a variety of target genes however how KLF5 is regulated in breast cancer needs to be further elucidated ",
   "entities": [
    [
     "T1",
     28,
     32,
     "gene",
     "KLF5"
    ],
    [
     "T1",
     151,
     155,
     "gene",
     "KLF5"
    ],
    [
     "T2",
     179,
     185,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences7": {
   "text": "In pancreatic ductal adenocarcinoma miR-217 inhibits tumor cell growth by targeting KRAS and SIRT1 22 37 ",
   "entities": [
    [
     "T1",
     84,
     88,
     "gene",
     "KRAS"
    ],
    [
     "T2",
     93,
     98,
     "gene",
     "SIRT1"
    ],
    [
     "T3",
     53,
     58,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences8": {
   "text": "Furthermore miR-217 was reported to inhibit invasion of hepatocellular carcinoma cells through targeting E2F3 26 ",
   "entities": [
    [
     "T1",
     105,
     109,
     "gene",
     "E2F3"
    ],
    [
     "T2",
     56,
     80,
     "phenotype",
     "hepatocellular carcinoma"
    ],
    [
     "T3",
     71,
     80,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences9": {
   "text": "In esophageal squamous cell carcinoma cells miR-217 inhibits proliferation migration and invasion by targeting long noncoding RNA MALAT1 and kallikrein 7 KLK7  39 ",
   "entities": [
    [
     "T1",
     154,
     158,
     "gene",
     "KLK7"
    ],
    [
     "T2",
     28,
     37,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences10": {
   "text": "Overexpression of miR-217 induces drug resistance and invasion of MCF-7 and SKBR-3 cells through activating AKT by downregulation of PTEN 35 ",
   "entities": [
    [
     "T1",
     133,
     137,
     "gene",
     "PTEN"
    ]
   ]
  },
  "Sentences11": {
   "text": "We recently reported that mifepristone inhibits KLF5 expression and cancer stem cells in basal TNBC 15 ",
   "entities": [
    [
     "T1",
     48,
     52,
     "gene",
     "KLF5"
    ],
    [
     "T2",
     68,
     74,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences12": {
   "text": "Additionally Curcumin inhibits KLF5 expression through YAP/TAZ in bladder cancer cell lines 43 ",
   "entities": [
    [
     "T1",
     31,
     35,
     "gene",
     "KLF5"
    ],
    [
     "T2",
     74,
     80,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences13": {
   "text": "ML264 inhibits KLF5 expression in colorectal cancer cell lines 44 45 ",
   "entities": [
    [
     "T1",
     15,
     19,
     "gene",
     "KLF5"
    ],
    [
     "T2",
     45,
     51,
     "phenotype",
     "cancer"
    ]
   ]
  }
 },
 "PMC5403892": {
  "Sentences0": {
   "text": "AP acute pancreatitis SAP severe acute pancreatitis ANP acute necrotizing pancreatitis SIRS systemic inflammatory response syndrome NaTc sodium taurocholate hydrate LPS lipopolysaccharide CCK8 cholecystokinin 8 pM\u03a6 peritoneal macrophages MDA malondialdehyde NF-\u03baB nuclear factor kappa-B TNF-\u03b1 tumor necrosis factor-\u03b1 IL interleukin SOD superoxide dismutase Bip ER chaperone immunoglobulin-binding protein IRE1 inositol requiring protein 1 TRAF2 TNF receptor-associated factor 2 ASK1 apoptosis signal-regulating kinase 1 JNK c-Jun N-terminal kinase p38 MAPK p38 mitogen-activated protein kinases TXB2 thromboxane-2 HTRA1 serine protease high-temperature requirement A1 TGF-\u03b21 transforming growth factor-\u03b21 EGF epidermal growth factor ICAM intercellular adhesion molecule mCD14 membrane-bound CD14 PLA2 phospholipase A2 NO nitric oxide PAF platelet-activating factor PGE2 prostaglandin E2 CAT catalase AP-1 activator protein-1 iNOS inducible nitric oxide synthase GSH-Px glutathione peroxidase MPO myeloperoxidase VCAM-1 vascular cell adhesion molecule 1 I\u03baB inhibitor protein kappa B PI3K phosphatidylinositol 3\u2032-kinase AKT threonine kinase TLR4 Toll-like receptor 4 HMGB1 high mobility group box 1 PPAR\u03b3 peroxisome proliferator-activated receptor gamma CHOP C/EBP homologous protein ",
   "entities": [
    [
     "T1",
     439,
     444,
     "gene",
     "TRAF2"
    ],
    [
     "T2",
     614,
     619,
     "gene",
     "HTRA1"
    ],
    [
     "T3",
     705,
     708,
     "gene",
     "EGF"
    ],
    [
     "T4",
     887,
     890,
     "gene",
     "CAT"
    ],
    [
     "T5",
     992,
     995,
     "gene",
     "MPO"
    ],
    [
     "T6",
     1140,
     1144,
     "gene",
     "TLR4"
    ],
    [
     "T7",
     1166,
     1171,
     "gene",
     "HMGB1"
    ],
    [
     "T8",
     1260,
     1263,
     "gene",
     "EBP"
    ],
    [
     "T9",
     123,
     131,
     "phenotype",
     "syndrome"
    ],
    [
     "T10",
     9,
     21,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T10",
     39,
     51,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T10",
     74,
     86,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T11",
     293,
     298,
     "phenotype",
     "tumor"
    ],
    [
     "T12",
     3,
     21,
     "phenotype",
     "acute pancreatitis"
    ],
    [
     "T12",
     33,
     51,
     "phenotype",
     "acute pancreatitis"
    ],
    [
     "T13",
     62,
     86,
     "phenotype",
     "necrotizing pancreatitis"
    ]
   ]
  },
  "Sentences1": {
   "text": "Emodin attenuates pulmonary edema and enhances alveolar epithelial barrier function by up-regulating the expression of claudin-4 claudin-5 occludin AQP1 and AQP5 in lung tissue samples from rats with SAP-induced ALI Xia et al  2010 Xu et al  2016 ",
   "entities": [
    [
     "T1",
     148,
     152,
     "gene",
     "AQP1"
    ],
    [
     "T2",
     157,
     161,
     "gene",
     "AQP5"
    ],
    [
     "T3",
     28,
     33,
     "phenotype",
     "edema"
    ],
    [
     "T4",
     18,
     33,
     "phenotype",
     "pulmonary edema"
    ]
   ]
  },
  "Sentences2": {
   "text": "For instance resveratrol has a potential regulatory effect on CAV1 that promotes the maintenance of intracellular calcium homeostasis emodin maybe benefit to regulate blood lipid levels in AP by regulating the expression and function of APOE that contributes to the lipoprotein biosynthetic catabolic and metabolic process ligustrazine may improve the state of hypercoagulability and microcirculation during AP via regulating VWF and SELP expression ",
   "entities": [
    [
     "T1",
     62,
     66,
     "gene",
     "CAV1"
    ],
    [
     "T2",
     237,
     241,
     "gene",
     "APOE"
    ],
    [
     "T3",
     426,
     429,
     "gene",
     "VWF"
    ],
    [
     "T4",
     434,
     438,
     "gene",
     "SELP"
    ],
    [
     "T5",
     361,
     379,
     "phenotype",
     "hypercoagulability"
    ]
   ]
  },
  "Sentences3": {
   "text": "AP acute pancreatitis SIRS systemic inflammatory response syndrome ER endoplasmic reticulum ATP adenosine triphosphate OFRs oxygen free radicals MDA malondialdehyde ROS reactive oxygen species iNOS inducible nitric oxide synthase SOD superoxide dismutase CAT catalase NF-\u03baB nuclear factor kappa-B AP-1 activator protein-1 HMGB1 high mobility group box 1 TNF-\u03b1 tumor necrosis factor-\u03b1 IL-6 interleukin-6 PAF platelet-activating factor PLA2 phospholipase A2 ICAM-1 intercellular adhesion molecule-1 SR sarcoplasmic reticulum MPTP mitochondrial permeability transition pore IP3R inositol 1 4 5-trisphosphate receptor PERK RNA-activated protein kinase-like ER kinase IRE1 inositol requiring protein 1 Apaf-1 apoptotic protease activating factor-1 ",
   "entities": [
    [
     "T1",
     255,
     258,
     "gene",
     "CAT"
    ],
    [
     "T2",
     322,
     327,
     "gene",
     "HMGB1"
    ],
    [
     "T3",
     58,
     66,
     "phenotype",
     "syndrome"
    ],
    [
     "T4",
     9,
     21,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T5",
     360,
     365,
     "phenotype",
     "tumor"
    ],
    [
     "T6",
     3,
     21,
     "phenotype",
     "acute pancreatitis"
    ]
   ]
  }
 },
 "PMC5404094": {
  "Sentences0": {
   "text": "With Digestive Disease Week\u00ae DDW just around the corner we have compiled the following section highlights and meeting guides prepared by the AGA Council Sections listed below ",
   "entities": [
    [
     "T1",
     141,
     144,
     "gene",
     "AGA"
    ],
    [
     "T2",
     15,
     22,
     "phenotype",
     "Disease"
    ]
   ]
  },
  "Sentences1": {
   "text": "Introduction The AGA Council section Cellular amp Molecular Gastroenterology  CMG has broad interests in the basic mechanisms underlying digestive diseases and gastrointestinal biology ",
   "entities": [
    [
     "T1",
     17,
     20,
     "gene",
     "AGA"
    ],
    [
     "T2",
     147,
     155,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences2": {
   "text": "Introduction The EGD section continues to heavily contribute to the educational and research mission of the AGA Institute and remains a highly visible section at Digestive Disease Week\u00ae DDW ",
   "entities": [
    [
     "T1",
     108,
     111,
     "gene",
     "AGA"
    ],
    [
     "T2",
     172,
     179,
     "phenotype",
     "Disease"
    ]
   ]
  },
  "Sentences3": {
   "text": "Introduction The Imaging and Advanced Technology section of the AGA Council identifies research submitted to Digestive Disease Week\u00ae DDW that incorporates novel applications or improvements to existing technology or new techniques that image or treat disorders of the gastrointestinal tract liver bile ducts gallbladder or pancreas ",
   "entities": [
    [
     "T1",
     64,
     67,
     "gene",
     "AGA"
    ],
    [
     "T2",
     251,
     260,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences4": {
   "text": "It is the second largest section in the AGA Council and collaborates with multiple AGA sections and the American Association for the Study of Liver Diseases AASLD in offering abstract-driven sessions at DDW ",
   "entities": [
    [
     "T1",
     40,
     43,
     "gene",
     "AGA"
    ],
    [
     "T1",
     83,
     86,
     "gene",
     "AGA"
    ],
    [
     "T2",
     142,
     156,
     "phenotype",
     "Liver Diseases"
    ],
    [
     "T3",
     148,
     156,
     "phenotype",
     "Diseases"
    ]
   ]
  },
  "Sentences5": {
   "text": "The best clinical and basic science research and symposia should be in the AGA Pancreatic Disorders section ",
   "entities": [
    [
     "T1",
     75,
     78,
     "gene",
     "AGA"
    ],
    [
     "T2",
     90,
     99,
     "phenotype",
     "Disorders"
    ]
   ]
  }
 },
 "PMC6593664": {
  "Sentences0": {
   "text": "Case Report A 35\u2010year\u2010old pregnant woman with Alagille\u2010like syndrome chronic cholestasis characteristic facial phenotype and NOTCH2 c 14A gt C mutation was referred to our hospital because of severe pruritus at 16 weeks of pregnancy 5 No mutations of the ATPase phospholipid transporting 8B1 gene benign recurrent intrahepatic cholestasis BRIC 1/progressive familial intrahepatic cholestasis PFIC 1  the ATP binding cassette subfamily B member 11 ABCB11 gene BRIC2/PFIC2  and the ABCB4 gene PFIC3 were found ",
   "entities": [
    [
     "T1",
     125,
     131,
     "gene",
     "NOTCH2"
    ],
    [
     "T2",
     480,
     485,
     "gene",
     "ABCB4"
    ],
    [
     "T3",
     60,
     68,
     "phenotype",
     "syndrome"
    ],
    [
     "T4",
     199,
     207,
     "phenotype",
     "pruritus"
    ],
    [
     "T5",
     314,
     338,
     "phenotype",
     "intrahepatic cholestasis"
    ],
    [
     "T5",
     367,
     391,
     "phenotype",
     "intrahepatic cholestasis"
    ],
    [
     "T6",
     297,
     338,
     "phenotype",
     "benign recurrent intrahepatic cholestasis"
    ]
   ]
  }
 },
 "PMC6594023": {
  "Sentences0": {
   "text": "The most important risk factors include previous thromboembolic events age gt 60\u00a0years and JAK2 V617F mutation Barbui et\u00a0al 2011 Prajs amp Kuliczkowski 2017 ",
   "entities": [
    [
     "T1",
     91,
     95,
     "gene",
     "JAK2"
    ],
    [
     "T2",
     49,
     70,
     "phenotype",
     "thromboembolic events"
    ]
   ]
  }
 },
 "PMC6594081": {
  "Sentences0": {
   "text": "For example the focally deleted genes BAP1 and PBRM1 on 3p21 1 were also commonly affected by an arm\u2010length deletion in our study population 38  Table 3 and by known inactivating mutations in CCA and renal cell carcinoma 6 23 As an example of a candidate gene residing in the amplified 12q15 region the MDM2 oncogene showed a significant positive correlation P  0 016 r  0 40 with its expression in the TCGA\u2010CHOL cohort ",
   "entities": [
    [
     "T1",
     38,
     42,
     "gene",
     "BAP1"
    ],
    [
     "T2",
     47,
     52,
     "gene",
     "PBRM1"
    ],
    [
     "T3",
     303,
     307,
     "gene",
     "MDM2"
    ],
    [
     "T4",
     211,
     220,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences1": {
   "text": "Further analyses of known cancer driver genes showed that RPL22 ROBO1 ROBO2 TGFBR1 and TGFBR2 were most frequently altered either by deletion or promoter hypermethylation in all groups Fig 3A 22 The IDH and H groups frequently showed deletions on chromosome arms 3p and 6q the former harboring the tumor\u2010suppressor genes BAP1 PBRM1 TGFBR2 ROBO1 and ROBO2 the latter ZNF292 and EEF1A1 ",
   "entities": [
    [
     "T1",
     58,
     63,
     "gene",
     "RPL22"
    ],
    [
     "T2",
     64,
     69,
     "gene",
     "ROBO1"
    ],
    [
     "T2",
     339,
     344,
     "gene",
     "ROBO1"
    ],
    [
     "T3",
     70,
     75,
     "gene",
     "ROBO2"
    ],
    [
     "T3",
     349,
     354,
     "gene",
     "ROBO2"
    ],
    [
     "T4",
     76,
     82,
     "gene",
     "TGFBR1"
    ],
    [
     "T5",
     87,
     93,
     "gene",
     "TGFBR2"
    ],
    [
     "T5",
     332,
     338,
     "gene",
     "TGFBR2"
    ],
    [
     "T6",
     321,
     325,
     "gene",
     "BAP1"
    ],
    [
     "T7",
     326,
     331,
     "gene",
     "PBRM1"
    ],
    [
     "T8",
     366,
     372,
     "gene",
     "ZNF292"
    ],
    [
     "T9",
     377,
     383,
     "gene",
     "EEF1A1"
    ],
    [
     "T10",
     298,
     303,
     "phenotype",
     "tumor"
    ],
    [
     "T11",
     26,
     32,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences2": {
   "text": "Among the genes amplified on 1q a strong correlation was observed for PI4KB r  0 71 FDR q  3 66 10\u22125 and PIP5K1A r  0 69 FDR q  5 91 10\u22125  which together with AKT3 r  0 28 FDR q  0 19  Supporting Fig S7A  belong to the cancer\u2010relevant phosphoinositide signaling pathway 24 Another candidate was YY1AP1 r  0 65 FDR q  2 36 10\u22124  known as an oncogenic driver in EpCAM  AFP  hepatocellular carcinoma 25 which shows features of hepatic stem/progenitor cells 26 By high correlation r  0 82 FDR q 1 09 10\u22126  SETDB1 encoding a histone lysine methyltransferase and known to be involved in breast cancer 27 proved a candidate driver gene on the focally amplified 1q21 3 Supporting Fig S7B ",
   "entities": [
    [
     "T1",
     105,
     112,
     "gene",
     "PIP5K1A"
    ],
    [
     "T2",
     159,
     163,
     "gene",
     "AKT3"
    ],
    [
     "T3",
     295,
     301,
     "gene",
     "YY1AP1"
    ],
    [
     "T4",
     367,
     370,
     "gene",
     "AFP"
    ],
    [
     "T5",
     502,
     508,
     "gene",
     "SETDB1"
    ],
    [
     "T6",
     219,
     225,
     "phenotype",
     "cancer"
    ],
    [
     "T6",
     588,
     594,
     "phenotype",
     "cancer"
    ],
    [
     "T7",
     372,
     396,
     "phenotype",
     "hepatocellular carcinoma"
    ],
    [
     "T8",
     387,
     396,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences3": {
   "text": "However potential candidates on 8q are CHRAC1 r  0 61 FDR q  0 010  RAD21 r  0 51 FDR q  0 023  and TRAPPC9 r  0 50 FDR q  0 030  Supporting Fig S7C  all known to be involved in breast cancer 28 29 These results suggest the importance of CNA\u2010driven gene\u2010expression changes ",
   "entities": [
    [
     "T1",
     39,
     45,
     "gene",
     "CHRAC1"
    ],
    [
     "T2",
     68,
     73,
     "gene",
     "RAD21"
    ],
    [
     "T3",
     185,
     191,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences4": {
   "text": "However the IDH group\u2010specific alterations did not show enrichment of cancer\u2010related pathways Supporting Fig S9 but were aggregated in CTCF and RAD21 binding sites and depleted in the binding sites of other transcription factors Fig 4D ",
   "entities": [
    [
     "T1",
     135,
     139,
     "gene",
     "CTCF"
    ],
    [
     "T2",
     144,
     149,
     "gene",
     "RAD21"
    ],
    [
     "T3",
     70,
     76,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences5": {
   "text": "Clustering analysis of the tumor\u2010specific LMC2\u20105 profiles showed that LMC2 co\u2010occurred with IDH1 and IDH2 gain\u2010of\u2010function mutation of HCC and CCA but did not include any PDAC cases Fig 4E and Supporting Fig S10 ",
   "entities": [
    [
     "T1",
     92,
     96,
     "gene",
     "IDH1"
    ],
    [
     "T2",
     101,
     105,
     "gene",
     "IDH2"
    ],
    [
     "T3",
     27,
     32,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences6": {
   "text": "The latter gene may initiate tumor onset and progression by negatively regulating tumor suppressor p5335 or by a p53\u2010independent mechanism 36 In addition ARID1A ROBO1 ROBO2 TGFBR2 CDKN2A and TP53 were found to be affected by recurrent deletions or amplifications ",
   "entities": [
    [
     "T1",
     154,
     160,
     "gene",
     "ARID1A"
    ],
    [
     "T2",
     161,
     166,
     "gene",
     "ROBO1"
    ],
    [
     "T3",
     167,
     172,
     "gene",
     "ROBO2"
    ],
    [
     "T4",
     173,
     179,
     "gene",
     "TGFBR2"
    ],
    [
     "T5",
     180,
     186,
     "gene",
     "CDKN2A"
    ],
    [
     "T6",
     191,
     195,
     "gene",
     "TP53"
    ],
    [
     "T7",
     29,
     34,
     "phenotype",
     "tumor"
    ],
    [
     "T7",
     82,
     87,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences7": {
   "text": "The most conspicuous subgroup is the IDH group characterized by gain\u2010of\u2010function IDH1 and IDH2 hotspot mutations in 9 of 10 tumor samples sequenced many CNAs DNA hypermethylation and high LMC2 values ",
   "entities": [
    [
     "T1",
     81,
     85,
     "gene",
     "IDH1"
    ],
    [
     "T2",
     90,
     94,
     "gene",
     "IDH2"
    ],
    [
     "T3",
     124,
     129,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences8": {
   "text": "The 3p deletions include tumor\u2010suppressor genes like BAP1 and PBRM1 found to be frequently inactivated in iCCA 6 Amplification of 1q which is seen in the M and H groups is common in many different cancers and often associated with bad prognosis 39 In HCC this amplification occurs in more than 70 of cases40 and has been described in iCCA as well 41 It harbors the stem cell\u2013related oncogene YY1AP1 and genes of the phosphoinositide signaling pathway known to be involved in breast cancer 24 25 A possible candidate gene of the 1q region PIP5K1A is a potential therapeutic target of kinase inhibitors of which some are already in clinical trials 22 SETDB1 which is amplified in almost 50 of the patients in the H and M groups is discussed as a therapeutic target showing sensitivity against mithramycin 42 Gain\u2010of\u2010function mutations of IDH1 and IDH2 are known to lead to DNA hypermethylation by the enrichment of the oncometabolite 2\u2010hydroxyglutarate which inhibits TET enzymes involved in active demethylation 20 IDH mutations alone were shown to be sufficient to induce a hypermethylator phenotype 43 and they tend to appear more frequently in recurrent tumors with gene\u2010expression traits of epithelial\u2010mesenchymal transition 44 Targeted therapies for IDH\u2010mutant tumors are already in clinical trials 45 46 Our pathway analyses consistent with the general hypermethylation of IDH\u2010mutant tumors showed no strong enrichment in any pathways Supporting Fig S9  but the transcription factor binding site\u2010enrichment analysis revealed enrichment of hypermethylation at CTCF and RAD21 binding sites ",
   "entities": [
    [
     "T1",
     53,
     57,
     "gene",
     "BAP1"
    ],
    [
     "T2",
     62,
     67,
     "gene",
     "PBRM1"
    ],
    [
     "T3",
     392,
     398,
     "gene",
     "YY1AP1"
    ],
    [
     "T4",
     538,
     545,
     "gene",
     "PIP5K1A"
    ],
    [
     "T5",
     649,
     655,
     "gene",
     "SETDB1"
    ],
    [
     "T6",
     836,
     840,
     "gene",
     "IDH1"
    ],
    [
     "T7",
     845,
     849,
     "gene",
     "IDH2"
    ],
    [
     "T8",
     1564,
     1568,
     "gene",
     "CTCF"
    ],
    [
     "T9",
     1573,
     1578,
     "gene",
     "RAD21"
    ],
    [
     "T10",
     25,
     30,
     "phenotype",
     "tumor"
    ],
    [
     "T11",
     197,
     204,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences9": {
   "text": "This is largely in line with the recent finding of Flavahan et al 47 showing that hypermethylation led to disruption of the insulator function of the CTCF protein in IDH\u2010mutant gliomas and subsequent overexpression of the PDGFRA candidate oncogene ",
   "entities": [
    [
     "T1",
     150,
     154,
     "gene",
     "CTCF"
    ]
   ]
  }
 },
 "PMC6594799": {
  "Sentences0": {
   "text": "The results show that 9 laminin subunit genes LAMA2 LAMA3 LAMA4 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 were highly expressed in tumor tissues of PAAD with differences that were statistically significant Figure 1A ",
   "entities": [
    [
     "T1",
     46,
     51,
     "gene",
     "LAMA2"
    ],
    [
     "T2",
     52,
     57,
     "gene",
     "LAMA3"
    ],
    [
     "T3",
     58,
     63,
     "gene",
     "LAMA4"
    ],
    [
     "T4",
     64,
     69,
     "gene",
     "LAMA5"
    ],
    [
     "T5",
     70,
     75,
     "gene",
     "LAMB1"
    ],
    [
     "T6",
     76,
     81,
     "gene",
     "LAMB2"
    ],
    [
     "T7",
     82,
     87,
     "gene",
     "LAMB3"
    ],
    [
     "T8",
     88,
     93,
     "gene",
     "LAMC1"
    ],
    [
     "T9",
     94,
     99,
     "gene",
     "LAMC2"
    ],
    [
     "T10",
     125,
     130,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences1": {
   "text": "Profiling of the expression in TCGA of various cancers and survival analysis using the gene expression omnibus GEO database for further selection For the laminin subunits LAMA3 LAMA4 LAMB3 and LAMC2 that were found to be associated with the prognosis of pancreatic cancer we further analyzed their TCGA tumor tissue expression profiles Figure 2C\u20132F ",
   "entities": [
    [
     "T1",
     171,
     176,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     177,
     182,
     "gene",
     "LAMA4"
    ],
    [
     "T3",
     183,
     188,
     "gene",
     "LAMB3"
    ],
    [
     "T4",
     193,
     198,
     "gene",
     "LAMC2"
    ],
    [
     "T5",
     303,
     308,
     "phenotype",
     "tumor"
    ],
    [
     "T6",
     47,
     54,
     "phenotype",
     "cancers"
    ],
    [
     "T7",
     254,
     271,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences2": {
   "text": "The results show that LAMA3 and LAMC2 expression is significantly upregulated in PDAC tumor tissues in most studies Figure 4A\u20134I ",
   "entities": [
    [
     "T1",
     22,
     27,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     32,
     37,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     86,
     91,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences3": {
   "text": "The ROC analysis of LAMA3 LAMC2 and their combined expression in PDAC sets indicate that both genes display high accuracy in distinguishing between tumor and non-tumor tissues the AUCs of the ROC curves were gt 0 70 Figure 4J\u20134R ",
   "entities": [
    [
     "T1",
     20,
     25,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     26,
     31,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     148,
     153,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     162,
     167,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences4": {
   "text": " A\u2013I Comparison of LAMA3 and LAMC2 gene expression in tumor and non-tumor tissues ",
   "entities": [
    [
     "T1",
     19,
     24,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     29,
     34,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     54,
     59,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     68,
     73,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences5": {
   "text": "Furthermore serum LAMC2 levels can be used to significantly improve the diagnostic accuracy of using CA19-9 for PDAC patients since the AUC for distinguishing between tumor and non-tumor tissues for the combined analysis of LAMC2 and CA19-9 AUC 0 922 0 792 and 0 888 respectively in two of three cohorts were higher than the AUC values obtained for CA19-9 alone AUC 0 863 0 847 and 0 827 respectively Figure 6J\u20136L ",
   "entities": [
    [
     "T1",
     18,
     23,
     "gene",
     "LAMC2"
    ],
    [
     "T1",
     224,
     229,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     167,
     172,
     "phenotype",
     "tumor"
    ],
    [
     "T2",
     181,
     186,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences6": {
   "text": "Figure 8 Expression levels of A LAMA3 and B LAMC2 in heathy donor and PDAC Circulating tumor cells CTCs and the relationship between C\u2013D LAMA3 and E\u2013F LAMC2 expression and CTC number in PDAC patients as processed using EpCAM and IgG CTC\u2013Chip ",
   "entities": [
    [
     "T1",
     32,
     37,
     "gene",
     "LAMA3"
    ],
    [
     "T1",
     137,
     142,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     44,
     49,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     151,
     156,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     87,
     92,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences7": {
   "text": "DISCUSSION In the present study we initially screened out four differentially expressed subunits LAMA3 LAMA4 LAMB3 and LAMC2 of the laminin gene family that were found to be associated with the clinical outcome of pancreas cancer patients in TCGA ",
   "entities": [
    [
     "T1",
     97,
     102,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     103,
     108,
     "gene",
     "LAMA4"
    ],
    [
     "T3",
     109,
     114,
     "gene",
     "LAMB3"
    ],
    [
     "T4",
     119,
     124,
     "gene",
     "LAMC2"
    ],
    [
     "T5",
     223,
     229,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences8": {
   "text": "The expression of LAMA3 and LAMC2 was found to be upregulated in PDAC tumor tissues in the 9 datasets with a favorable diagnostic ability for distinguishing between PDAC and non-tumor tissues ",
   "entities": [
    [
     "T1",
     18,
     23,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     28,
     33,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     70,
     75,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     178,
     183,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences9": {
   "text": "LAMA3 and LAMC2 encode for products that are essential parts of laminin-322 formerly known as laminin-5  which is known to stimulate cell migration in cancers 18 19 and is related with the prognosis of diseases 20 ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     10,
     15,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     151,
     158,
     "phenotype",
     "cancers"
    ],
    [
     "T4",
     202,
     210,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences10": {
   "text": "In addition a study on gastric cancer 25 has suggested LAMB3 and LAMC2 chains accumulate intracellularly and are related with cancer progression while epigenetic silencing of the LAMA3 chain may lead to an inability of synthesizing the basement membrane which may affect cancer cell invasion ",
   "entities": [
    [
     "T1",
     55,
     60,
     "gene",
     "LAMB3"
    ],
    [
     "T2",
     65,
     70,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     179,
     184,
     "gene",
     "LAMA3"
    ],
    [
     "T4",
     31,
     37,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     126,
     132,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     271,
     277,
     "phenotype",
     "cancer"
    ],
    [
     "T5",
     23,
     37,
     "phenotype",
     "gastric cancer"
    ]
   ]
  },
  "Sentences11": {
   "text": "These results suggest that there may be some differences in the biological function of LAMA3 and LAMC2 regarding tumor progression ",
   "entities": [
    [
     "T1",
     87,
     92,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     97,
     102,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     113,
     118,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences12": {
   "text": "In the expression level difference analysis LAMA3 mRNA expression in PDAC non-tumor tissues in GSE102238 was lower when compared with tumor tissues from paired patients whose histopathology confirmed various extents of neurological invasion ",
   "entities": [
    [
     "T1",
     44,
     49,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     78,
     83,
     "phenotype",
     "tumor"
    ],
    [
     "T2",
     134,
     139,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences13": {
   "text": "However LAMC2 expression was still elevated in PDAC tumor tissues ",
   "entities": [
    [
     "T1",
     8,
     13,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     52,
     57,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences14": {
   "text": "found that LAMC2 plays an important role in nerve invasion with high LAMC2 mRNA and protein expression being associated with long nerve invasion 26 ",
   "entities": [
    [
     "T1",
     11,
     16,
     "gene",
     "LAMC2"
    ],
    [
     "T1",
     69,
     74,
     "gene",
     "LAMC2"
    ]
   ]
  },
  "Sentences15": {
   "text": "Further they studied the knockdown of LAMC2 in cancer cells which was found to significantly shorten nerve invasion in an animal model ",
   "entities": [
    [
     "T1",
     38,
     43,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     47,
     53,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences16": {
   "text": "Our results indicate that LAMC2 expression in GSE102238 tumor tissues is higher than that of paracancer tissues of PDAC and patients who harbored high levels of LAMC2 expression had a poor prognosis ",
   "entities": [
    [
     "T1",
     26,
     31,
     "gene",
     "LAMC2"
    ],
    [
     "T1",
     161,
     166,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     56,
     61,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences17": {
   "text": "We hypothesize that high expression of LAMC2 promotes PDAC cell invasion of the nerve and leads to an increased risk of tumor recurrence ",
   "entities": [
    [
     "T1",
     39,
     44,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     120,
     125,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences18": {
   "text": "Another study identified signaling events coordinated by EGF and a specific ITG that regulates the invasive behavior of carcinoma cells ",
   "entities": [
    [
     "T1",
     57,
     60,
     "gene",
     "EGF"
    ],
    [
     "T2",
     120,
     129,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences19": {
   "text": "EGF stimulation of pancreatic carcinoma cells led to invasion and metastasis that was blocked by antagonists of ITG 28 ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "EGF"
    ],
    [
     "T2",
     30,
     39,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences20": {
   "text": "Additionally the elevated expression of LAMC2 in cancer cells appears to drive tumorigenesis through its interactions with several cell-surface receptors including ITGs and EGFRs 29 ",
   "entities": [
    [
     "T1",
     40,
     45,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     49,
     55,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences21": {
   "text": "These results suggest that the interaction between laminins and ITGs may play a role in tumor invasion and metastasis of the EGF pathway but the specific mechanism needs further verification ",
   "entities": [
    [
     "T1",
     125,
     128,
     "gene",
     "EGF"
    ],
    [
     "T2",
     88,
     93,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences22": {
   "text": "The cytoplasmic expression of LAMC2 represents the high invasive potential of the tumor and is correlated with distant metastasis especially hepatic metastasis and with a poorer prognosis in patients with PDAC 31 ",
   "entities": [
    [
     "T1",
     30,
     35,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     82,
     87,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences23": {
   "text": "The above results indicate that the expression patterns of LAMC2 have different biological behaviors in tumor cells ",
   "entities": [
    [
     "T1",
     59,
     64,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     104,
     109,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences24": {
   "text": "In PDAC tumor tissues the expression of LAMA3 and LAMC2 are upregulated with a favorable ability of distinguishing between PDAC and non-tumor tissues which is of a prognostic value for PDAC patients ",
   "entities": [
    [
     "T1",
     40,
     45,
     "gene",
     "LAMA3"
    ],
    [
     "T2",
     50,
     55,
     "gene",
     "LAMC2"
    ],
    [
     "T3",
     8,
     13,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     136,
     141,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences25": {
   "text": "Further the researchers identified a biomarker panel consisting of CA19-9 CA125 and LAMC2 which was found to be better at detecting PDAC patients than CA19-9 alone most notably during the early stages of the disease 35 ",
   "entities": [
    [
     "T1",
     84,
     89,
     "gene",
     "LAMC2"
    ],
    [
     "T2",
     208,
     215,
     "phenotype",
     "disease"
    ]
   ]
  }
 },
 "PMC6595533": {
  "Sentences0": {
   "text": "Although some danger signals are only released during times of necrotic cell death others such as high-mobility group box 1 HMGB1  heat-shock protein 72 Hsp72  and ATP are actively released during times of psychological stress and initiate an inflammatory response 14\u201316 ",
   "entities": [
    [
     "T1",
     124,
     129,
     "gene",
     "HMGB1"
    ]
   ]
  }
 },
 "PMC6595551": {
  "Sentences0": {
   "text": "In trials that studied statin vs placebo therapy residual CVD risk was shown to be 25\u201340 in the statin-treated groups 8\u201313 Interestingly though intensive statin therapy resulted only in a slight decrease in incidence of major CVD events 14\u201316 In 2005 Libby stipulated that the post-statin era suffers from a residual burden of cardiovascular mortality in about two-thirds of the patients with CAD indicating the need for better understanding of factors contributing to this unexplained residual risk 2 Superko similarly concluded that a therapy that focusses on LDL-C reduction alone neglects other important aspects of lipoprotein metabolism 17 In the Multi-Ethnic Study of Atherosclerosis the overall residual risk in statin-treated individuals was gt 17 in a 10 year period ",
   "entities": [
    [
     "T1",
     393,
     396,
     "gene",
     "CAD"
    ]
   ]
  },
  "Sentences1": {
   "text": "In recent years several novel lipid lowering pharmacological therapies other than statins have been developed and results from clinical trials are now emerging 23 These include ezetimibe a cholesterol absorption inhibitor and the very potent PCSK9 inhibitors that have already been licenced in Europe and the US 24 More recently initial studies with anti-sense oligonucleotides ASOs blocking apoCIII and apo a have shown promising results 25 With these new therapies emerging there is a need for specific guidance in selection of the most appropriate therapy and selection of the patients for this therapy ",
   "entities": [
    [
     "T1",
     242,
     247,
     "gene",
     "PCSK9"
    ],
    [
     "T2",
     383,
     391,
     "phenotype",
     "blocking"
    ]
   ]
  },
  "Sentences2": {
   "text": "evaluated the role of LDL-C and HDL-C in CVD through common SNPs in nine genes 117 APOB SNP rs693 was shown to be individually associated with LDL-C concentrations in 5287 subjects of the cardiovascular cohort of the Malmo\u00a8 Diet and Cancer Study ",
   "entities": [
    [
     "T1",
     83,
     87,
     "gene",
     "APOB"
    ],
    [
     "T2",
     233,
     239,
     "phenotype",
     "Cancer"
    ]
   ]
  },
  "Sentences3": {
   "text": "Individuals with a loss-of-function mutation in the apoB gene typically have familial hypercholesterolemia FH  which is characterized by substantially elevated concentrations of LDL-C and early-onset CVD specifically CAD e g ",
   "entities": [
    [
     "T1",
     217,
     220,
     "gene",
     "CAD"
    ]
   ]
  },
  "Sentences4": {
   "text": "ApoCII The second most frequently reported cause of chylomicronaemia often resulting in severe pancreatitis is the presence of homogeneous APOC2 loss-of-function mutations 120 Indeed several case reports indicate chylomicronaemia and decreased concentrations of apoCII in individuals with APOC2 loss-of-function mutations 121\u2013125 However so far these numbers are too small for full observational studies and MRTs have not yet been conducted ",
   "entities": [
    [
     "T1",
     139,
     144,
     "gene",
     "APOC2"
    ],
    [
     "T1",
     289,
     294,
     "gene",
     "APOC2"
    ],
    [
     "T2",
     95,
     107,
     "phenotype",
     "pancreatitis"
    ]
   ]
  },
  "Sentences5": {
   "text": "Thus compared with treatment with a statin later in life prolonged exposure to lower LDL-C beginning early in life was associated with a two- to three-fold greater reduction in the risk of CHD for each unit lower LDL-C Figure 3 129 141 This was further corroborated by Kathiresan et\u00a0al  who monitored the same APOE rs4420638 SNP to study the relation between LDL-C and CVD risk in the Malmo\u00a8 Diet and Cancer Study 117 Figure 3 ",
   "entities": [
    [
     "T1",
     310,
     314,
     "gene",
     "APOE"
    ],
    [
     "T2",
     401,
     407,
     "phenotype",
     "Cancer"
    ]
   ]
  },
  "Sentences6": {
   "text": "reported that the achieved concentrations of on-treatment non-HDL-C and TG concentrations were closely associated with coronary atheroma progression and regression irrespective of achieved concentrations of LDL-C CRP and DM status 172 While the current clinical care pathway does indeed improve cardiovascular risk considerable residual risk remains particularly in women and individuals with remnant lipoprotein particles ",
   "entities": [
    [
     "T1",
     213,
     216,
     "gene",
     "CRP"
    ],
    [
     "T2",
     119,
     136,
     "phenotype",
     "coronary atheroma"
    ]
   ]
  }
 },
 "PMC6596321": {
  "Sentences0": {
   "text": " B In melanoma associated TLO CD20 B cells form a follicle with CD4 and CD8 T cells in the parafollicular cortex or marginal zones ",
   "entities": [
    [
     "T1",
     64,
     67,
     "gene",
     "CD4"
    ],
    [
     "T2",
     6,
     14,
     "phenotype",
     "melanoma"
    ]
   ]
  },
  "Sentences1": {
   "text": "The density of mature DCs DC-LAMP  is highly correlated with the density of infiltrating CD4 and T-bet T-cell into tumor which also is associated with a favorable long-time survival of patients 38 ",
   "entities": [
    [
     "T1",
     89,
     92,
     "gene",
     "CD4"
    ],
    [
     "T2",
     115,
     120,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences2": {
   "text": "Recruitment of CCR7 lymphoid tissue inducer LTi cells by CCL21-expressing melanomas leads to TLO formation which also recruit immune suppressive cells like CD4 Treg cells and MDSCs to suppress anti-tumor immune response 56 ",
   "entities": [
    [
     "T1",
     156,
     159,
     "gene",
     "CD4"
    ],
    [
     "T2",
     74,
     83,
     "phenotype",
     "melanomas"
    ]
   ]
  },
  "Sentences3": {
   "text": "In the virus-induced TLO formation model IL-22 signaling is necessary for CXCL12 and CXCL13 expression in epithelial and fibroblastic stromal cells which leads to B-cell recruitment and TLO formation 67 ",
   "entities": [
    [
     "T1",
     85,
     91,
     "gene",
     "CXCL13"
    ]
   ]
  },
  "Sentences4": {
   "text": "LT\u03b11\u03b22-induced non-canonical NF-\u03baB p52/RelB pathway is essential for chemokine CXCL13 CCL21 and CCL19 and adhesion molecules MAdCAM-1 expression by LTo which mediates the recruitment of immune cells as well as LTi for the growth and development of lymph nodes 73\u201375 ",
   "entities": [
    [
     "T1",
     79,
     85,
     "gene",
     "CXCL13"
    ]
   ]
  },
  "Sentences5": {
   "text": "In the aged NOD non-obase diabetic and ApoE\u2212/\u2212 mice LT\u03b2R mediated non-canonical NF-\u03baB pathway induces CXCL13 CCL21 and MAdCAM-1 expression to recruit and activate immune cells forming TLOs in metabolic diseases condition 77 ",
   "entities": [
    [
     "T1",
     102,
     108,
     "gene",
     "CXCL13"
    ],
    [
     "T2",
     192,
     210,
     "phenotype",
     "metabolic diseases"
    ],
    [
     "T3",
     202,
     210,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences6": {
   "text": "Additionally IL-7 or together with RANKL induces LTi to secrete LT\u03b11\u03b22 which further interact with LT\u03b2R of stromal cell to promote the maturation of LTo and chemokine production CXCL13 CCL19 and CCL21 for lymphocyte recruitment 83 ",
   "entities": [
    [
     "T1",
     178,
     184,
     "gene",
     "CXCL13"
    ]
   ]
  },
  "Sentences7": {
   "text": "Similar strategy has been used in the study using a fusion protein containing LIGHT and anti-EGRF antibody which could specifically target EGFR tumor cell 90 ",
   "entities": [
    [
     "T1",
     139,
     143,
     "gene",
     "EGFR"
    ],
    [
     "T2",
     144,
     149,
     "phenotype",
     "tumor"
    ]
   ]
  }
 },
 "PMC6597539": {
  "Sentences0": {
   "text": "Patients harbouring the GSTP1 IleVal or ValVal genotypes showed 4 28-fold higher likelihood of presenting grade 2 or 3 vomiting and lower GFR with treatment than those harbouring the IleIle genotype ",
   "entities": [
    [
     "T1",
     24,
     29,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     119,
     127,
     "phenotype",
     "vomiting"
    ]
   ]
  },
  "Sentences1": {
   "text": "In multivariate Cox analysis patients with the GSTP1 105ValVal genotype had 3 87 more chance of presenting disease progression than those with the IleIle or IleVal genotype p\u2009 lt \u20090 01 ",
   "entities": [
    [
     "T1",
     47,
     52,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     107,
     114,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences2": {
   "text": "In a previous study tumour response to CDDP chemoradiation was observed in a HNSCC patient with distinct genotypes of GSTT1 and GSTP1 Ile105Val polymorphisms12 however another study indicated that the GSTM1 GSTT1 and GSTP1 genes did not alter response to CDDP9 ",
   "entities": [
    [
     "T1",
     128,
     133,
     "gene",
     "GSTP1"
    ],
    [
     "T1",
     217,
     222,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     20,
     26,
     "phenotype",
     "tumour"
    ]
   ]
  },
  "Sentences3": {
   "text": "Multivariate analysis was adjusted by tumour stage and GSTP1 Ile105Val genotypes ",
   "entities": [
    [
     "T1",
     55,
     60,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     38,
     44,
     "phenotype",
     "tumour"
    ]
   ]
  },
  "Sentences4": {
   "text": "The presence of GSTT1 and the GSTP1 IleVal or ValVal genotype were found to be associated with a higher likelihood of presenting vomiting with chemoradiation as previously suggested20 ",
   "entities": [
    [
     "T1",
     30,
     35,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     129,
     137,
     "phenotype",
     "vomiting"
    ]
   ]
  },
  "Sentences5": {
   "text": "In a previous publication we analysed almost the same patients enrolled in the current study n\u2009 \u200988 and focused on the roles of GSTM1 GSTT1 GSTP1 and other genetic polymorphisms in genes involved in the repair of DNA damage induced by CDDP and apoptosis of cells with CDDP-induced lesions only in severity of vomiting presented by HNSCC patients treated with CDDP chemoradiation14 ",
   "entities": [
    [
     "T1",
     140,
     145,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     309,
     317,
     "phenotype",
     "vomiting"
    ]
   ]
  },
  "Sentences6": {
   "text": "Our previous findings indicated that the GSTP1 IleVal or ValVal genotype but not the presence of GSTT1 was associated with vomiting in the current study vomiting was strongly associated with the presence of both GSTT1 and the GSTP1 IleVal or ValVal genotype ",
   "entities": [
    [
     "T1",
     41,
     46,
     "gene",
     "GSTP1"
    ],
    [
     "T1",
     226,
     231,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     123,
     131,
     "phenotype",
     "vomiting"
    ],
    [
     "T2",
     153,
     161,
     "phenotype",
     "vomiting"
    ]
   ]
  },
  "Sentences7": {
   "text": "Thus increased apoptosis of CDDP-damaged enterochromaffin cells of the intestines which is associated with the less active Val allele of the GSTP1 Ile105Val polymorphism may have influenced the severity of vomiting in the HNSCC patients ",
   "entities": [
    [
     "T1",
     141,
     146,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     206,
     214,
     "phenotype",
     "vomiting"
    ]
   ]
  },
  "Sentences8": {
   "text": "The GSTP1 Val allele was associated with ototoxicity in patients with medulloblastoma who were treated with CDDP-based therapy25 ",
   "entities": [
    [
     "T1",
     4,
     9,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     70,
     85,
     "phenotype",
     "medulloblastoma"
    ]
   ]
  },
  "Sentences9": {
   "text": "We observed pronounced myelotoxicity and a durable complete response in one HNSCC patient treated with both CDDP 100\u2009mg/m\u00b2 and RT which was attributed to inherited deficiency in CDDP detoxification GSTT1 null genotype  deficiency in repair of CDDP cellular damage MSH3 1045ThrThr  and increased apoptosis induction during CDDP cellular damage GSTP1 105IleIle 12 ",
   "entities": [
    [
     "T1",
     264,
     268,
     "gene",
     "MSH3"
    ],
    [
     "T2",
     343,
     348,
     "gene",
     "GSTP1"
    ],
    [
     "T3",
     164,
     174,
     "phenotype",
     "deficiency"
    ],
    [
     "T3",
     219,
     229,
     "phenotype",
     "deficiency"
    ]
   ]
  },
  "Sentences10": {
   "text": "Furthermore patients harbouring the GSTP1 IleVal or ValVal genotype showed more pronounced renal dysfunction ",
   "entities": [
    [
     "T1",
     36,
     41,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     91,
     108,
     "phenotype",
     "renal dysfunction"
    ]
   ]
  },
  "Sentences11": {
   "text": "Results of a unique study conducted by Joerger et al 31 showed no associations between GSTM1 and GSTP1 A313G Ile105Val genotypes with CDDP pharmacokinetics in advanced non-small-cell lung cancer patients ",
   "entities": [
    [
     "T1",
     97,
     102,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     188,
     194,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     183,
     194,
     "phenotype",
     "lung cancer"
    ]
   ]
  },
  "Sentences12": {
   "text": "The GSTP1 105IleIle genotype was previously associated with higher PFS in epithelial ovarian cancer patients treated with CDDP 100\u2009mg/m\u00b2 and cyclophosphamide27 and oesophageal cancer patients treated with CDDP and 5-FU/paclitaxel33 ",
   "entities": [
    [
     "T1",
     4,
     9,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     93,
     99,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     176,
     182,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences13": {
   "text": "Free radicals produced by CDDP that are not detoxified due to the lack of GSTP1 are likely to induce new mutations in residual tumour cells thereby facilitating survival and proliferation of the tumour cells34 ",
   "entities": [
    [
     "T1",
     74,
     79,
     "gene",
     "GSTP1"
    ],
    [
     "T2",
     127,
     133,
     "phenotype",
     "tumour"
    ],
    [
     "T2",
     195,
     201,
     "phenotype",
     "tumour"
    ]
   ]
  },
  "Sentences14": {
   "text": "EFS and OS were calculated for each participant from the date of diagnosis until the date of tumour progression tumour relapse death attributed to tumour effects or last follow-up and from the date of diagnosis until the date of death by any cause or last follow-up contact respectively ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "EFS"
    ],
    [
     "T2",
     93,
     99,
     "phenotype",
     "tumour"
    ],
    [
     "T2",
     112,
     118,
     "phenotype",
     "tumour"
    ],
    [
     "T2",
     147,
     153,
     "phenotype",
     "tumour"
    ]
   ]
  }
 },
 "PMC6598400": {
  "Sentences0": {
   "text": "Our results show ponatinib reduces phosphorylation of STAT1 and production of IP-10 induced by influenza virus infection Figure S2 ",
   "entities": [
    [
     "T1",
     54,
     59,
     "gene",
     "STAT1"
    ],
    [
     "T2",
     105,
     120,
     "phenotype",
     "virus infection"
    ],
    [
     "T3",
     111,
     120,
     "phenotype",
     "infection"
    ]
   ]
  },
  "Sentences1": {
   "text": "For example eritoran a TLR4 antagonist is protective when administered starting on 2 days post-infection but only has limited effects when given 3 h prior to infection 44 45 ",
   "entities": [
    [
     "T1",
     23,
     27,
     "gene",
     "TLR4"
    ],
    [
     "T2",
     95,
     104,
     "phenotype",
     "infection"
    ],
    [
     "T2",
     158,
     167,
     "phenotype",
     "infection"
    ]
   ]
  }
 },
 "PMC6598598": {
  "Sentences0": {
   "text": "Both polymyalgia-like syndrome and giant cell arteritis GCA have been reported following treatment with ICI ",
   "entities": [
    [
     "T1",
     56,
     59,
     "gene",
     "GCA"
    ],
    [
     "T2",
     22,
     30,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     35,
     55,
     "phenotype",
     "giant cell arteritis"
    ]
   ]
  },
  "Sentences1": {
   "text": "ICI-induced GCA symptoms mirror those of traditional GCA including temporal headache jaw claudication monocular vision loss unexplained fever and fatigue ",
   "entities": [
    [
     "T1",
     12,
     15,
     "gene",
     "GCA"
    ],
    [
     "T1",
     53,
     56,
     "gene",
     "GCA"
    ],
    [
     "T2",
     16,
     24,
     "phenotype",
     "symptoms"
    ],
    [
     "T3",
     136,
     141,
     "phenotype",
     "fever"
    ],
    [
     "T4",
     67,
     84,
     "phenotype",
     "temporal headache"
    ],
    [
     "T5",
     124,
     141,
     "phenotype",
     "unexplained fever"
    ]
   ]
  },
  "Sentences2": {
   "text": "Visual impairment has been reported in 28 of patients with ICI-induced GCA 24 ",
   "entities": [
    [
     "T1",
     71,
     74,
     "gene",
     "GCA"
    ]
   ]
  },
  "Sentences3": {
   "text": "The diagnosis of GCA should not be made based upon symptoms alone and investigations including complete blood count CBC  ESR and CRP ",
   "entities": [
    [
     "T1",
     17,
     20,
     "gene",
     "GCA"
    ],
    [
     "T2",
     129,
     132,
     "gene",
     "CRP"
    ],
    [
     "T3",
     51,
     59,
     "phenotype",
     "symptoms"
    ]
   ]
  },
  "Sentences4": {
   "text": "Initial investigations were notable for markedly elevated ESR and CRP ",
   "entities": [
    [
     "T1",
     66,
     69,
     "gene",
     "CRP"
    ],
    [
     "T2",
     49,
     61,
     "phenotype",
     "elevated ESR"
    ]
   ]
  },
  "Sentences5": {
   "text": "In the case of relapsed GCA symptoms despite high-dose corticosteroids abatacept has demonstrated efficacy 26  while methotrexate and tocilizumab are alternate therapeutic options ",
   "entities": [
    [
     "T1",
     24,
     27,
     "gene",
     "GCA"
    ],
    [
     "T2",
     28,
     36,
     "phenotype",
     "symptoms"
    ]
   ]
  },
  "Sentences6": {
   "text": "Other investigations including creatinine kinase aldolase ESR and CRP should be sent to assess for concurrent myositis ",
   "entities": [
    [
     "T1",
     66,
     69,
     "gene",
     "CRP"
    ],
    [
     "T2",
     110,
     118,
     "phenotype",
     "myositis"
    ]
   ]
  },
  "Sentences7": {
   "text": "Diagnostic Evaluation Diagnostic work-up for colitis includes standard laboratory testing to assess for infectious vs non-infectious etiologies including CBC CMP ESR and CRP ",
   "entities": [
    [
     "T1",
     170,
     173,
     "gene",
     "CRP"
    ],
    [
     "T2",
     45,
     52,
     "phenotype",
     "colitis"
    ]
   ]
  },
  "Sentences8": {
   "text": "Anderson and Rapport recently suggested a biomarker profile incorporating IL-17/IFN-\u03b3/IL-10/TGF-\u03b21/CRP based on findings from ipilimumab-associated colitis 106 ",
   "entities": [
    [
     "T1",
     99,
     102,
     "gene",
     "CRP"
    ],
    [
     "T2",
     148,
     155,
     "phenotype",
     "colitis"
    ]
   ]
  }
 },
 "PMC6599049": {
  "Sentences0": {
   "text": "Additionally oral administration of manassantin B in mice attenuated CVB3 infection-associated symptoms by reducing systemic production of inflammatory cytokines and chemokines including TNF-\u03b1 IL-6 IFN-\u03b3 CCL2 and CXCL-1 ",
   "entities": [
    [
     "T1",
     204,
     208,
     "gene",
     "CCL2"
    ],
    [
     "T2",
     95,
     103,
     "phenotype",
     "symptoms"
    ]
   ]
  },
  "Sentences1": {
   "text": "Likewise the level of serum cytokines and chemokines including TNF-\u03b1 IL-6 IFN-\u03b3 CCL2 and CXCL-1 which increased after 5 days post CVB3 infection was significantly reduced by treatment with Man B or ribavirin Fig ",
   "entities": [
    [
     "T1",
     80,
     84,
     "gene",
     "CCL2"
    ],
    [
     "T2",
     135,
     144,
     "phenotype",
     "infection"
    ]
   ]
  }
 },
 "PMC6599198": {
  "Sentences0": {
   "text": "Although commonly they occur sporadically some of them 25-30  are hereditary and part of multiple endocrine neoplasia type 2 MEN2  caused by germline mutations of the RET proto-oncogene 14 ",
   "entities": [
    [
     "T1",
     167,
     170,
     "gene",
     "RET"
    ],
    [
     "T2",
     108,
     117,
     "phenotype",
     "neoplasia"
    ],
    [
     "T3",
     98,
     117,
     "phenotype",
     "endocrine neoplasia"
    ]
   ]
  },
  "Sentences1": {
   "text": "Interestingly low DICER1 expression was also associated with poor clinical outcome in adrenocortical carcinoma 30\u201332 ",
   "entities": [
    [
     "T1",
     18,
     24,
     "gene",
     "DICER1"
    ],
    [
     "T2",
     101,
     110,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences2": {
   "text": "More than 30 of the cases are attributed to germline mutation leading to autosomal dominant genetic syndromes such as multiple endocrine neoplasia type 2A and 2B caused by RET mutations von Hippel Lindau syndrome due to VHL mutations neurofibromatosis type 1 with NF1 mutations or hereditary PG syndromes caused by mutations of succinate dehydrogenase SDH genes ",
   "entities": [
    [
     "T1",
     172,
     175,
     "gene",
     "RET"
    ],
    [
     "T2",
     220,
     223,
     "gene",
     "VHL"
    ],
    [
     "T3",
     264,
     267,
     "gene",
     "NF1"
    ],
    [
     "T4",
     100,
     109,
     "phenotype",
     "syndromes"
    ],
    [
     "T4",
     295,
     304,
     "phenotype",
     "syndromes"
    ],
    [
     "T5",
     137,
     146,
     "phenotype",
     "neoplasia"
    ],
    [
     "T6",
     92,
     109,
     "phenotype",
     "genetic syndromes"
    ],
    [
     "T7",
     127,
     146,
     "phenotype",
     "endocrine neoplasia"
    ]
   ]
  },
  "Sentences3": {
   "text": "Upregulation of miR-139-3p miR-541 miR-765 and miR-133b was described in VHL associated tumors while miR-96 and miR-183 were found to be overexpressed in neoplasms with SDHB mutations 30 44 45 ",
   "entities": [
    [
     "T1",
     73,
     76,
     "gene",
     "VHL"
    ],
    [
     "T2",
     169,
     173,
     "gene",
     "SDHB"
    ],
    [
     "T3",
     88,
     94,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences4": {
   "text": "NGF nerve growth factor treatment in vitro in PCC cell line significantly decreased the level of miR-139-3p and miR-210 and led to differentiation raising the role of these two miRNAs in tumor development 46 ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "NGF"
    ],
    [
     "T2",
     187,
     192,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences5": {
   "text": "Interestingly miR-137 and miR-382 can be considered as general PCC/PGL markers as they were found overexpressed in most cases except for MAX mutation associated tumors 30 ",
   "entities": [
    [
     "T1",
     137,
     140,
     "gene",
     "MAX"
    ],
    [
     "T2",
     161,
     167,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences6": {
   "text": "These miRNAs were downregulated in several neoplasms and they are considered tumor suppressors by targeting BCL2 and CCND1 30 47 ",
   "entities": [
    [
     "T1",
     108,
     112,
     "gene",
     "BCL2"
    ],
    [
     "T2",
     117,
     122,
     "gene",
     "CCND1"
    ],
    [
     "T3",
     77,
     82,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences7": {
   "text": "Compared with benign PCCs miR-101 level was higher in patients with malignant PCCs and the level of miR-101 was higher in SDHD mutation associated tumors 48 ",
   "entities": [
    [
     "T1",
     122,
     126,
     "gene",
     "SDHD"
    ],
    [
     "T2",
     147,
     153,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences8": {
   "text": "Of these 95 are sporadic only the remaining 5 are associated with genetic syndromes such as MEN1 MEN4 Carney complex or McCune-Albright syndrome ",
   "entities": [
    [
     "T1",
     92,
     96,
     "gene",
     "MEN1"
    ],
    [
     "T2",
     74,
     83,
     "phenotype",
     "syndromes"
    ],
    [
     "T3",
     66,
     83,
     "phenotype",
     "genetic syndromes"
    ]
   ]
  },
  "Sentences9": {
   "text": "The overexpression of Pituitary Tumor-Transforming Gene 1 PTTG1 was demonstrated in 90 of pituitary adenoma independently of adenoma type ",
   "entities": [
    [
     "T1",
     58,
     63,
     "gene",
     "PTTG1"
    ]
   ]
  },
  "Sentences10": {
   "text": "In sporadic GH-producing adenomas miR-34a and miR-107 were found to regulate AIP a well-known tumor suppressor frequently mutated in familial pituitary adenomas ",
   "entities": [
    [
     "T1",
     77,
     80,
     "gene",
     "AIP"
    ],
    [
     "T2",
     94,
     99,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences11": {
   "text": "Additionally miR-106b influenced migration and invasion of pituitary adenoma cells via regulating PTEN and further activity of the PI3K/AKT signaling pathway and MMP-9 expression 51 ",
   "entities": [
    [
     "T1",
     98,
     102,
     "gene",
     "PTEN"
    ]
   ]
  },
  "Sentences12": {
   "text": "In pituitary carcinoma metastasis expression of miR-20a miR-106b and miR-17-5p were increased compared to the primary neoplasm and these miRNAs were proved to be involved in pituitary carcinoma metastasis by attenuating PTEN and TIMP2 TIMP metallopeptidase inhibitor 2  55 ",
   "entities": [
    [
     "T1",
     220,
     224,
     "gene",
     "PTEN"
    ],
    [
     "T2",
     229,
     234,
     "gene",
     "TIMP2"
    ],
    [
     "T3",
     118,
     126,
     "phenotype",
     "neoplasm"
    ],
    [
     "T4",
     13,
     22,
     "phenotype",
     "carcinoma"
    ],
    [
     "T4",
     184,
     193,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences13": {
   "text": "LGALS3 and RUNX2 are both predicted targets of miR-493 and these genes have been shown to have roles in pituitary tumor cell growth 56 ",
   "entities": [
    [
     "T1",
     0,
     6,
     "gene",
     "LGALS3"
    ],
    [
     "T2",
     11,
     16,
     "gene",
     "RUNX2"
    ],
    [
     "T3",
     114,
     119,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences14": {
   "text": "In corticotroph adenomas miR-93-3p miR-93-5p miR-25-3p and miR-106b-5p were detected to be overexpressed in invasive tumors compared to non-invasive ones through targeting MCM7 the overexpression of these miRNAs led to increased invasiveness and unfavorable outcomes after resection 51 59 ",
   "entities": [
    [
     "T1",
     172,
     176,
     "gene",
     "MCM7"
    ],
    [
     "T2",
     117,
     123,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences15": {
   "text": "In NFPAs several miRNAs showed correlation with tumor size some of the miR-450b-5p miR-424 miR-503 miR-542-3p miR-629 and miR-214 were underexpressed and target SMAD3 54 ",
   "entities": [
    [
     "T1",
     161,
     166,
     "gene",
     "SMAD3"
    ],
    [
     "T2",
     48,
     53,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences16": {
   "text": "In GH3 cells Caveolin-1 CAV1 was reported to promote invasion while silencing CAV1 indirectly induced miR-145 miR-124 and miR-183 that suppressed the migration and invasion of pituitary adenoma cells through targeting FSCN1 PTTG1IP and EZR respectively 57 ",
   "entities": [
    [
     "T1",
     24,
     28,
     "gene",
     "CAV1"
    ],
    [
     "T1",
     78,
     82,
     "gene",
     "CAV1"
    ]
   ]
  },
  "Sentences17": {
   "text": "In addition the lost expression of general tumor suppressor miRNAs targeting BCL2 and CCND1 have been described in other non-endocrine tumors as well 30 47 ",
   "entities": [
    [
     "T1",
     77,
     81,
     "gene",
     "BCL2"
    ],
    [
     "T2",
     86,
     91,
     "gene",
     "CCND1"
    ],
    [
     "T3",
     43,
     48,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences18": {
   "text": "Additionally Pituitary Tumor-Transforming Gene 1 PTTG1 is another target gene that is regulated by miRNAs in endocrine tumors ",
   "entities": [
    [
     "T1",
     49,
     54,
     "gene",
     "PTTG1"
    ],
    [
     "T2",
     119,
     125,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences19": {
   "text": "Several miRNAs miR-126 miR-381 miR-665 miR-300 miR-381 miR-329 are suggested to contribute to PTTG1 overexpression in pituitary adenomas 51  that is also upregulated in colorectal NET by the loss of miR-186 70 ",
   "entities": [
    [
     "T1",
     94,
     99,
     "gene",
     "PTTG1"
    ]
   ]
  },
  "Sentences20": {
   "text": "However PTTG1 overexpression is not unique for endocrine tumors as it was described in several other malignancies with prognostic potential ",
   "entities": [
    [
     "T1",
     8,
     13,
     "gene",
     "PTTG1"
    ],
    [
     "T2",
     57,
     63,
     "phenotype",
     "tumors"
    ]
   ]
  }
 },
 "PMC6599265": {
  "Sentences0": {
   "text": "Background Necroptosis a form of programmed cell death mediated by receptor interacting serine/threonine-protein kinase-3 RIPK3  is implicated in murine models of acute respiratory distress syndrome ARDS ",
   "entities": [
    [
     "T1",
     122,
     127,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     190,
     198,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     169,
     198,
     "phenotype",
     "respiratory distress syndrome"
    ],
    [
     "T4",
     163,
     198,
     "phenotype",
     "acute respiratory distress syndrome"
    ]
   ]
  },
  "Sentences1": {
   "text": "Methods We utilized prospective cohort studies of critically ill sepsis n\u2009 \u2009120 and trauma n\u2009 \u2009180 patients and measured plasma RIPK3 at presentation and 48\u2009h Patients were followed for 6\u2009days for ARDS by the Berlin definition ",
   "entities": [
    [
     "T1",
     128,
     133,
     "gene",
     "RIPK3"
    ]
   ]
  },
  "Sentences2": {
   "text": "Secondary analyses showed similar findings for the association of \u0394RIPK3 with acute kidney injury and 30-day mortality ",
   "entities": [
    [
     "T1",
     67,
     72,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     78,
     97,
     "phenotype",
     "acute kidney injury"
    ]
   ]
  },
  "Sentences3": {
   "text": "We subsequently showed that plasma RIPK3 measured 48\u2009h after presentation was associated with RBC transfusions and acute kidney injury AKI in 80 trauma patients 19 ",
   "entities": [
    [
     "T1",
     35,
     40,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     115,
     134,
     "phenotype",
     "acute kidney injury"
    ]
   ]
  },
  "Sentences4": {
   "text": "Because our prior studies showed low RIPK3 levels at presentation in most trauma patients 19  and in order to account for RIPK3 release in the early stages of critical illness we used the change in plasma RIPK3 from presentation to 48\u2009h \u0394RIPK3 for primary analyses ",
   "entities": [
    [
     "T1",
     37,
     42,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     122,
     127,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     205,
     210,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     238,
     243,
     "gene",
     "RIPK3"
    ]
   ]
  },
  "Sentences5": {
   "text": "Definition of abbreviations ARDS acute respiratory distress syndrome AKI acute kidney injury RIPK3 receptor interacting protein kinase-3 The association of \u0394RIPK3 with ARDS remained significant in both cohorts in multivariable regression models adjusting for potential confounders Table\u00a03 ",
   "entities": [
    [
     "T1",
     93,
     98,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     157,
     162,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     60,
     68,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     73,
     92,
     "phenotype",
     "acute kidney injury"
    ],
    [
     "T4",
     39,
     68,
     "phenotype",
     "respiratory distress syndrome"
    ],
    [
     "T5",
     33,
     68,
     "phenotype",
     "acute respiratory distress syndrome"
    ]
   ]
  },
  "Sentences6": {
   "text": "Definition of abbreviations ARDS acute respiratory distress syndrome RIPK3 receptor interacting protein kinase-3 SD standard deviation RBCs red blood cellsFig 1Adjusted probability of acute respiratory distress syndrome ARDS across the range of \u0394RIPK3 change from presentation to 48\u2009h in each cohort ",
   "entities": [
    [
     "T1",
     69,
     74,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     246,
     251,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     60,
     68,
     "phenotype",
     "syndrome"
    ],
    [
     "T2",
     211,
     219,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     39,
     68,
     "phenotype",
     "respiratory distress syndrome"
    ],
    [
     "T3",
     190,
     219,
     "phenotype",
     "respiratory distress syndrome"
    ],
    [
     "T4",
     33,
     68,
     "phenotype",
     "acute respiratory distress syndrome"
    ],
    [
     "T4",
     184,
     219,
     "phenotype",
     "acute respiratory distress syndrome"
    ]
   ]
  },
  "Sentences7": {
   "text": "b PETROS cohort probabilities adjusted for red blood cell transfusions in the first 6\u2009h trauma mechanism and injury severity score In MESSI the association of \u0394RIPK3 with ARDS was similar when patients were stratified by infection source adjusted OR 1 31 95 CI 0 88\u20131 97 for pulmonary n\u2009 \u200951  1 30 0 98\u20131 72 for non-pulmonary n\u2009 \u200969  interaction p\u2009 \u20090 844 and did not differ significantly by shock adjusted OR 1 23 0 97\u20131 56 if present n\u2009 \u200993  2 79 1 00\u20137 81 if absent n\u2009 \u200927  interaction p\u2009 \u20090 287 ",
   "entities": [
    [
     "T1",
     160,
     165,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     221,
     230,
     "phenotype",
     "infection"
    ]
   ]
  },
  "Sentences8": {
   "text": "Underweight and obese MESSI patients had higher \u0394RIPK3 than normal and overweight patients though these findings were not statistically significant p\u2009 \u20090 073 ",
   "entities": [
    [
     "T1",
     49,
     54,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     16,
     21,
     "phenotype",
     "obese"
    ],
    [
     "T3",
     71,
     81,
     "phenotype",
     "overweight"
    ]
   ]
  },
  "Sentences9": {
   "text": "As noted the majority of PETROS patients had presentation RIPK3 levels below the limit of detection only congestive heart failure and blunt trauma mechanism were associated with higher RIPK3 levels at this time point Additional\u00a0file\u00a01 Table S5 ",
   "entities": [
    [
     "T1",
     58,
     63,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     185,
     190,
     "gene",
     "RIPK3"
    ]
   ]
  },
  "Sentences10": {
   "text": "In MESSI however younger age chronic alcohol abuse higher APACHE II score and higher volume of crystalloid resuscitation were associated with presentation RIPK3 concentrations ",
   "entities": [
    [
     "T1",
     155,
     160,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     37,
     50,
     "phenotype",
     "alcohol abuse"
    ]
   ]
  },
  "Sentences11": {
   "text": "While we showed in trauma patients that \u0394RIPK3 was associated with ARDS developing after 48\u2009h future studies with serial RIPK3 measurements may provide more granular detail of the time-varying relationship of RIPK3 and ARDS during early critical illness to allow for more robust causal inference ",
   "entities": [
    [
     "T1",
     41,
     46,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     121,
     126,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     209,
     214,
     "gene",
     "RIPK3"
    ]
   ]
  },
  "Sentences12": {
   "text": "Conclusions We demonstrated a significant association of plasma \u0394RIPK3 with ARDS in critically ill sepsis and trauma patients and showed that both lung and plasma RIPK3 increased rapidly in mice injected with LPS-ZVAD ",
   "entities": [
    [
     "T1",
     65,
     70,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     163,
     168,
     "gene",
     "RIPK3"
    ]
   ]
  },
  "Sentences13": {
   "text": "Change in plasma RIPK3 concentration from presentation to 48\u2009h by Acute Respiratory Distress Syndrome ARDS status excluding patients who met ARDS criteria \u2264\u200948\u2009h after presentation among patients in the PETROS trauma cohort No ARDS n\u2009 \u2009143 ARDS n\u2009 \u200918 meeting criteria 55\u2013140\u2009h after presentation ",
   "entities": [
    [
     "T1",
     17,
     22,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     93,
     101,
     "phenotype",
     "Syndrome"
    ],
    [
     "T3",
     72,
     101,
     "phenotype",
     "Respiratory Distress Syndrome"
    ],
    [
     "T4",
     66,
     101,
     "phenotype",
     "Acute Respiratory Distress Syndrome"
    ]
   ]
  },
  "Sentences14": {
   "text": "Adjusted probability of acute kidney injury AKI across range of \u0394 receptor interacting protein kinase-3 RIPK3 levels RIPK3 change from presentation to 48\u2009h in each cohort ",
   "entities": [
    [
     "T1",
     104,
     109,
     "gene",
     "RIPK3"
    ],
    [
     "T1",
     117,
     122,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     24,
     43,
     "phenotype",
     "acute kidney injury"
    ]
   ]
  },
  "Sentences15": {
   "text": "Plasma levels of \u0394 receptor interacting protein kinase-3 \u0394RIPK3 change from presentation to 48\u2009h by acute kidney injury AKI and acute respiratory distress syndrome ARDS category in human cohorts ",
   "entities": [
    [
     "T1",
     58,
     63,
     "gene",
     "RIPK3"
    ],
    [
     "T2",
     155,
     163,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     100,
     119,
     "phenotype",
     "acute kidney injury"
    ],
    [
     "T4",
     134,
     163,
     "phenotype",
     "respiratory distress syndrome"
    ],
    [
     "T5",
     128,
     163,
     "phenotype",
     "acute respiratory distress syndrome"
    ]
   ]
  }
 },
 "PMC6599277": {
  "Sentences0": {
   "text": "Here we used NQO1-knockout KO mice to investigate the role of NQO1 in both the aging process and tumor susceptibility specifically in the context of CR ",
   "entities": [
    [
     "T1",
     13,
     17,
     "gene",
     "NQO1"
    ],
    [
     "T1",
     62,
     66,
     "gene",
     "NQO1"
    ],
    [
     "T2",
     97,
     102,
     "phenotype",
     "tumor"
    ]
   ]
  }
 },
 "PMC6599917": {
  "Sentences0": {
   "text": "Autoimmune pancreatitis AIP is now considered a pancreatic manifestation of a newly proposed disease condition IgG4-related disease IgG4-RD ",
   "entities": [
    [
     "T1",
     24,
     27,
     "gene",
     "AIP"
    ],
    [
     "T2",
     11,
     23,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     132,
     139,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T4",
     111,
     131,
     "phenotype",
     "IgG4-related disease"
    ],
    [
     "T5",
     0,
     23,
     "phenotype",
     "Autoimmune pancreatitis"
    ]
   ]
  },
  "Sentences1": {
   "text": "Recent epidemiological studies have addressed the incidence of cancer in patients with AIP and/or IgG4-RD ",
   "entities": [
    [
     "T1",
     87,
     90,
     "gene",
     "AIP"
    ],
    [
     "T2",
     98,
     105,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     63,
     69,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences2": {
   "text": "Surprisingly a significant number of AIP patients were detected with cancer at or within one year of the diagnosis of AIP ",
   "entities": [
    [
     "T1",
     37,
     40,
     "gene",
     "AIP"
    ],
    [
     "T1",
     118,
     121,
     "gene",
     "AIP"
    ],
    [
     "T2",
     69,
     75,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences3": {
   "text": "Furthermore around 50 of all cancers detected in AIP patients comprised mainly 3 types gastric lung and prostate cancer ",
   "entities": [
    [
     "T1",
     49,
     52,
     "gene",
     "AIP"
    ],
    [
     "T2",
     29,
     36,
     "phenotype",
     "cancers"
    ],
    [
     "T3",
     104,
     119,
     "phenotype",
     "prostate cancer"
    ]
   ]
  },
  "Sentences4": {
   "text": "Thus AIP appears to be associated with cancer of other organs rather than the pancreas itself which suggests that AIP is not a pre-cancerous condition of the pancreas ",
   "entities": [
    [
     "T1",
     5,
     8,
     "gene",
     "AIP"
    ],
    [
     "T1",
     114,
     117,
     "gene",
     "AIP"
    ],
    [
     "T2",
     39,
     45,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences5": {
   "text": "Moreover the simultaneous occurrence of cancer and AIP in many patients has led to the establishment of an attractive concept that AIP might sometimes arise from co-existing cancers as a paraneoplastic syndrome ",
   "entities": [
    [
     "T1",
     51,
     54,
     "gene",
     "AIP"
    ],
    [
     "T1",
     131,
     134,
     "gene",
     "AIP"
    ],
    [
     "T2",
     202,
     210,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     40,
     46,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences6": {
   "text": "Introduction Autoimmune pancreatitis AIP is a unique form of chronic pancreatitis in which autoimmunity against as-yet-unidentified auto antigens Ags underlie the chronic fibro-inflammatory responses in the pancreas 1 ",
   "entities": [
    [
     "T1",
     37,
     40,
     "gene",
     "AIP"
    ],
    [
     "T2",
     24,
     36,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T2",
     69,
     81,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     13,
     36,
     "phenotype",
     "Autoimmune pancreatitis"
    ],
    [
     "T4",
     61,
     81,
     "phenotype",
     "chronic pancreatitis"
    ]
   ]
  },
  "Sentences7": {
   "text": "AIP is now classified into type 1 AIP and type 2 AIP based on clinical features pathological findings and IgG4 antibody Ab responses 2 ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "AIP"
    ],
    [
     "T1",
     34,
     37,
     "gene",
     "AIP"
    ],
    [
     "T1",
     49,
     52,
     "gene",
     "AIP"
    ],
    [
     "T2",
     27,
     37,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T3",
     42,
     52,
     "phenotype",
     "type 2 AIP"
    ]
   ]
  },
  "Sentences8": {
   "text": "It is generally accepted that type 1 AIP also called lymphoplasmacytic sclerosing pancreatitis is a pancreatic manifestation of the systemic IgG4-related disease IgG4-RD ",
   "entities": [
    [
     "T1",
     37,
     40,
     "gene",
     "AIP"
    ],
    [
     "T2",
     82,
     94,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     162,
     169,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T4",
     141,
     161,
     "phenotype",
     "IgG4-related disease"
    ],
    [
     "T5",
     30,
     40,
     "phenotype",
     "type 1 AIP"
    ]
   ]
  },
  "Sentences9": {
   "text": "Massive infiltration of IgG4-expressing plasmacytes into the affected organs accompanied by storiform fibrosis is a prominent pathological feature of type 1 AIP 3-5 ",
   "entities": [
    [
     "T1",
     157,
     160,
     "gene",
     "AIP"
    ],
    [
     "T2",
     150,
     160,
     "phenotype",
     "type 1 AIP"
    ]
   ]
  },
  "Sentences10": {
   "text": "A wide variety of single-organ diseases such as AIP sialoadenitis and retroperitoneal fibrosis are now regarded as organ-specific manifestations of this systemic autoimmune disorder 3-5 ",
   "entities": [
    [
     "T1",
     48,
     51,
     "gene",
     "AIP"
    ],
    [
     "T2",
     173,
     181,
     "phenotype",
     "disorder"
    ],
    [
     "T3",
     70,
     94,
     "phenotype",
     "retroperitoneal fibrosis"
    ]
   ]
  },
  "Sentences11": {
   "text": "As the number of patients with IgG4-RD and type 1 AIP increases gastroenterologists and clinical immunologists promote further their investigations of type 1 AIP and our knowledge regarding the clinicopathological findings is rapidly expanding ",
   "entities": [
    [
     "T1",
     50,
     53,
     "gene",
     "AIP"
    ],
    [
     "T1",
     158,
     161,
     "gene",
     "AIP"
    ],
    [
     "T2",
     31,
     38,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     43,
     53,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T3",
     151,
     161,
     "phenotype",
     "type 1 AIP"
    ]
   ]
  },
  "Sentences12": {
   "text": "At present however our knowledge of the clinicopathological findings of type 2 AIP also called idiopathic duct centric chronic pancreatitis is limited ",
   "entities": [
    [
     "T1",
     79,
     82,
     "gene",
     "AIP"
    ],
    [
     "T2",
     127,
     139,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     119,
     139,
     "phenotype",
     "chronic pancreatitis"
    ],
    [
     "T4",
     72,
     82,
     "phenotype",
     "type 2 AIP"
    ]
   ]
  },
  "Sentences13": {
   "text": "Infiltration of neutrophils but not IgG4-expressing plasmacytes is a pathological hallmark of type 2 AIP 5 6 ",
   "entities": [
    [
     "T1",
     101,
     104,
     "gene",
     "AIP"
    ],
    [
     "T2",
     94,
     104,
     "phenotype",
     "type 2 AIP"
    ]
   ]
  },
  "Sentences14": {
   "text": "In addition the co-occurrence of inflammatory bowel diseases is sometimes seen in patients with type 2 AIP ",
   "entities": [
    [
     "T1",
     103,
     106,
     "gene",
     "AIP"
    ],
    [
     "T2",
     96,
     106,
     "phenotype",
     "type 2 AIP"
    ],
    [
     "T3",
     33,
     60,
     "phenotype",
     "inflammatory bowel diseases"
    ],
    [
     "T4",
     52,
     60,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences15": {
   "text": "These differences in clinicopathological features between type 1 and type 2 AIP support the idea that two different types of immune responses are involved in the development of AIP although both diseases are sensitive to corticosteroid treatment ",
   "entities": [
    [
     "T1",
     76,
     79,
     "gene",
     "AIP"
    ],
    [
     "T1",
     177,
     180,
     "gene",
     "AIP"
    ],
    [
     "T2",
     69,
     79,
     "phenotype",
     "type 2 AIP"
    ],
    [
     "T3",
     195,
     203,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences16": {
   "text": "Given that AIP is a unique form of chronic fibroinflammatory disorder of the pancreas it is possible that AIP is a pre-cancerous condition ",
   "entities": [
    [
     "T1",
     11,
     14,
     "gene",
     "AIP"
    ],
    [
     "T1",
     106,
     109,
     "gene",
     "AIP"
    ],
    [
     "T2",
     61,
     69,
     "phenotype",
     "disorder"
    ]
   ]
  },
  "Sentences17": {
   "text": "Indeed recent studies have addressed the relationship between AIP and malignant diseases 10-14 ",
   "entities": [
    [
     "T1",
     62,
     65,
     "gene",
     "AIP"
    ],
    [
     "T2",
     80,
     88,
     "phenotype",
     "diseases"
    ],
    [
     "T3",
     70,
     88,
     "phenotype",
     "malignant diseases"
    ]
   ]
  },
  "Sentences18": {
   "text": "Interestingly it has been suggested that the presence of AIP is associated with cancers of other organs rather than the pancreas ",
   "entities": [
    [
     "T1",
     57,
     60,
     "gene",
     "AIP"
    ],
    [
     "T2",
     80,
     87,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences19": {
   "text": "In this review we discuss the risk of cancer in type 1 AIP and IgG4-RD ",
   "entities": [
    [
     "T1",
     55,
     58,
     "gene",
     "AIP"
    ],
    [
     "T2",
     63,
     70,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     48,
     58,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T4",
     38,
     44,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences20": {
   "text": "Incidence of Cancer in IgG4-RD and AIP Shiokawa et al ",
   "entities": [
    [
     "T1",
     35,
     38,
     "gene",
     "AIP"
    ],
    [
     "T2",
     23,
     30,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     13,
     19,
     "phenotype",
     "Cancer"
    ]
   ]
  },
  "Sentences21": {
   "text": "were the first to show that the incidence of cancer after the diagnosis of AIP is significantly higher in patients with AIP than in a sex- age- and observation period-matched standard population in a multicenter retrospective cohort study 10  Table 1 ",
   "entities": [
    [
     "T1",
     75,
     78,
     "gene",
     "AIP"
    ],
    [
     "T1",
     120,
     123,
     "gene",
     "AIP"
    ],
    [
     "T2",
     45,
     51,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences22": {
   "text": "They investigated the incidence of cancer at or after the diagnosis of AIP in 108 patients ",
   "entities": [
    [
     "T1",
     71,
     74,
     "gene",
     "AIP"
    ],
    [
     "T2",
     35,
     41,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences23": {
   "text": "During the follow-up period 15 AIP patients 13 9  were diagnosed with cancer ",
   "entities": [
    [
     "T1",
     31,
     34,
     "gene",
     "AIP"
    ],
    [
     "T2",
     70,
     76,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences24": {
   "text": "Thus these data support the idea that the presence of AIP is a strong risk factor for cancer ",
   "entities": [
    [
     "T1",
     54,
     57,
     "gene",
     "AIP"
    ],
    [
     "T2",
     86,
     92,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences25": {
   "text": "Their study included 109 patients with AIP and 28 patients with AIP developed cancer at or after the diagnosis of AIP Table 3 ",
   "entities": [
    [
     "T1",
     39,
     42,
     "gene",
     "AIP"
    ],
    [
     "T1",
     64,
     67,
     "gene",
     "AIP"
    ],
    [
     "T1",
     114,
     117,
     "gene",
     "AIP"
    ],
    [
     "T2",
     78,
     84,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences26": {
   "text": "Furthermore a high incidence of cancer in AIP patients with a high level of SIR 17 3 was also reported in a single-center study in Germany 15  Table 1 ",
   "entities": [
    [
     "T1",
     42,
     45,
     "gene",
     "AIP"
    ],
    [
     "T2",
     32,
     38,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences27": {
   "text": "They investigated 106 patients with IgG4-RD including 10 patients with type 1 AIP and performed a retrospective observational study to determine the occurrence rate of cancer following the diagnosis of IgG4-RD ",
   "entities": [
    [
     "T1",
     78,
     81,
     "gene",
     "AIP"
    ],
    [
     "T2",
     36,
     43,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T2",
     202,
     209,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     71,
     81,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T4",
     168,
     174,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences28": {
   "text": "In addition 2 of the 10 AIP patients were diagnosed with renal cell cancer and prostate cancer during the follow-up period Table 3 ",
   "entities": [
    [
     "T1",
     24,
     27,
     "gene",
     "AIP"
    ],
    [
     "T2",
     68,
     74,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     88,
     94,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     79,
     94,
     "phenotype",
     "prostate cancer"
    ]
   ]
  },
  "Sentences29": {
   "text": "In addition to the these reports providing evidence that the presence of AIP and/or IgG4-RD increase the risk of cancer after the diagnosis one report showed an association between IgG4-RD and a history of malignancy 16  Table 2 3 ",
   "entities": [
    [
     "T1",
     73,
     76,
     "gene",
     "AIP"
    ],
    [
     "T2",
     84,
     91,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T2",
     181,
     188,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     113,
     119,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences30": {
   "text": "Therefore it may be possible that not only does the presence of IgG4-RD and/or AIP increase the risk of cancer but also that the pre-existing malignant disorders are associated with the subsequent development of IgG4-RD and/or AIP 16 ",
   "entities": [
    [
     "T1",
     79,
     82,
     "gene",
     "AIP"
    ],
    [
     "T1",
     227,
     230,
     "gene",
     "AIP"
    ],
    [
     "T2",
     64,
     71,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T2",
     212,
     219,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     104,
     110,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     152,
     161,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences31": {
   "text": "In contrast to the aforementioned studies two recent studies failed to confirm the association between AIP and cancer Table 1 ",
   "entities": [
    [
     "T1",
     103,
     106,
     "gene",
     "AIP"
    ],
    [
     "T2",
     111,
     117,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences32": {
   "text": "analyzed 113 patients with IgG4-RD including 95 AIP cases to determine the occurrence rate of cancer during the follow-up period 11 ",
   "entities": [
    [
     "T1",
     48,
     51,
     "gene",
     "AIP"
    ],
    [
     "T2",
     27,
     34,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     94,
     100,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences33": {
   "text": "Thus the presence of AIP was not identified as a risk factor for cancer in their study ",
   "entities": [
    [
     "T1",
     21,
     24,
     "gene",
     "AIP"
    ],
    [
     "T2",
     65,
     71,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences34": {
   "text": "reported that the cancer risk before and after the diagnosis of AIP was similar to that in the control subjects 12  Table 1 ",
   "entities": [
    [
     "T1",
     64,
     67,
     "gene",
     "AIP"
    ],
    [
     "T2",
     18,
     24,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences35": {
   "text": "One possibility is related to dealing with patients in whom cancer and AIP occur concurrently ",
   "entities": [
    [
     "T1",
     71,
     74,
     "gene",
     "AIP"
    ],
    [
     "T2",
     60,
     66,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences36": {
   "text": "This simultaneous occurrence of cancer and AIP is one of the most striking findings in their study ",
   "entities": [
    [
     "T1",
     43,
     46,
     "gene",
     "AIP"
    ],
    [
     "T2",
     32,
     38,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences37": {
   "text": "Since the aim of Hirano s study was to clarify the oncogenic effects in the presence of established IgG4-RD they tried to address whether preceding IgG4-RD and/or type 1 AIP could cause malignant disorders ",
   "entities": [
    [
     "T1",
     170,
     173,
     "gene",
     "AIP"
    ],
    [
     "T2",
     100,
     107,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T2",
     148,
     155,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     163,
     173,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T4",
     196,
     205,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences38": {
   "text": "Therefore the discrepancy between Shiokawa s and Hirano s studies can be partially explained by the fact that significant numbers of cases with concurrent cancer and AIP were included in the former study 10 whereas such cases were excluded in the latter study 12 17 ",
   "entities": [
    [
     "T1",
     166,
     169,
     "gene",
     "AIP"
    ],
    [
     "T2",
     155,
     161,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences39": {
   "text": "Consistent with this idea the SIR for cancer was much lower in cancer cases detected at more than one year after the diagnosis of AIP than in those detected within one year 10 ",
   "entities": [
    [
     "T1",
     130,
     133,
     "gene",
     "AIP"
    ],
    [
     "T2",
     38,
     44,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     63,
     69,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences40": {
   "text": "showed that the cancer risk before and after the diagnosis of AIP was similar to that of control subjects 12 ",
   "entities": [
    [
     "T1",
     62,
     65,
     "gene",
     "AIP"
    ],
    [
     "T2",
     16,
     22,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences41": {
   "text": "In Japan PET is widely used for the detection and evaluation of multiple organ involvement in IgG4-RD and AIP ",
   "entities": [
    [
     "T1",
     106,
     109,
     "gene",
     "AIP"
    ],
    [
     "T2",
     94,
     101,
     "phenotype",
     "IgG4-RD"
    ]
   ]
  },
  "Sentences42": {
   "text": "point out 12  the routine use of several kinds of screening tests might increase the detection rate of malignancy at the diagnosis of IgG4-RD and/or AIP in Japan ",
   "entities": [
    [
     "T1",
     149,
     152,
     "gene",
     "AIP"
    ],
    [
     "T2",
     134,
     141,
     "phenotype",
     "IgG4-RD"
    ]
   ]
  },
  "Sentences43": {
   "text": "Taken together these findings support the association between cancer and AIP if cases with simultaneous occurrence of type 1 AIP and cancer are included in the analysis ",
   "entities": [
    [
     "T1",
     73,
     76,
     "gene",
     "AIP"
    ],
    [
     "T1",
     125,
     128,
     "gene",
     "AIP"
    ],
    [
     "T2",
     118,
     128,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T3",
     62,
     68,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     133,
     139,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences44": {
   "text": "Is Type 1 AIP a Pre-cancerous Condition ",
   "entities": [
    [
     "T1",
     10,
     13,
     "gene",
     "AIP"
    ],
    [
     "T2",
     3,
     13,
     "phenotype",
     "Type 1 AIP"
    ]
   ]
  },
  "Sentences45": {
   "text": "If AIP enhances the risk of cancer then the next question is whether proceeding AIP promotes the development of malignancy through inflammation-associated carcinogenesis ",
   "entities": [
    [
     "T1",
     3,
     6,
     "gene",
     "AIP"
    ],
    [
     "T1",
     80,
     83,
     "gene",
     "AIP"
    ],
    [
     "T2",
     28,
     34,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences46": {
   "text": "Several case reports regarding the co-existence of AIP and pancreatic cancer are available 18 19 ",
   "entities": [
    [
     "T1",
     51,
     54,
     "gene",
     "AIP"
    ],
    [
     "T2",
     70,
     76,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     59,
     76,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences47": {
   "text": "One single-center study showed that the incident rate of pancreatic cancer after the diagnosis of AIP or CP was comparable between the two groups 4 8 vs 2 4  20 ",
   "entities": [
    [
     "T1",
     98,
     101,
     "gene",
     "AIP"
    ],
    [
     "T2",
     68,
     74,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     57,
     74,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences48": {
   "text": "Given that CP is one of the strongest risk factors for the development of pancreatic cancer 21  surveillance for the development of pancreatic cancer might also be required for patients with AIP ",
   "entities": [
    [
     "T1",
     191,
     194,
     "gene",
     "AIP"
    ],
    [
     "T2",
     85,
     91,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     143,
     149,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     74,
     91,
     "phenotype",
     "pancreatic cancer"
    ],
    [
     "T3",
     132,
     149,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences49": {
   "text": "However in contrast to these previous findings the incidence of pancreatic cancer at or after the diagnosis of AIP is not very high ranging from 0 0 to 17 among all of the detected cancers Table 1 2 ",
   "entities": [
    [
     "T1",
     111,
     114,
     "gene",
     "AIP"
    ],
    [
     "T2",
     75,
     81,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     64,
     81,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences50": {
   "text": "It therefore seems less likely that AIP increases the risk of pancreatic cancer through inflammation-associated carcinogenesis ",
   "entities": [
    [
     "T1",
     36,
     39,
     "gene",
     "AIP"
    ],
    [
     "T2",
     73,
     79,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     62,
     79,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences51": {
   "text": "To clarify the relationship between AIP and pancreatic cancer we investigated the types of cancer in patients with AIP at or after the diagnosis of AIP in five reports 10 11 13-15  in which types of cancers at or after the diagnosis of AIP were fully described ",
   "entities": [
    [
     "T1",
     36,
     39,
     "gene",
     "AIP"
    ],
    [
     "T1",
     115,
     118,
     "gene",
     "AIP"
    ],
    [
     "T1",
     148,
     151,
     "gene",
     "AIP"
    ],
    [
     "T1",
     236,
     239,
     "gene",
     "AIP"
    ],
    [
     "T2",
     55,
     61,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     91,
     97,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     44,
     61,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences52": {
   "text": "As shown in Figure gastric lung and prostate cancer are frequently detected cancers in patients with AIP and account for around 50 of all cancers detected at or after the diagnosis of AIP ",
   "entities": [
    [
     "T1",
     101,
     104,
     "gene",
     "AIP"
    ],
    [
     "T1",
     184,
     187,
     "gene",
     "AIP"
    ],
    [
     "T2",
     45,
     51,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     36,
     51,
     "phenotype",
     "prostate cancer"
    ]
   ]
  },
  "Sentences53": {
   "text": "These data regarding cancer distribution strongly suggest that the presence of AIP might be more closely associated with extra-pancreatic gastric lung and prostate cancers rather than pancreatic cancer ",
   "entities": [
    [
     "T1",
     79,
     82,
     "gene",
     "AIP"
    ],
    [
     "T2",
     21,
     27,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     195,
     201,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     184,
     201,
     "phenotype",
     "pancreatic cancer"
    ],
    [
     "T4",
     155,
     171,
     "phenotype",
     "prostate cancers"
    ]
   ]
  },
  "Sentences54": {
   "text": "Thus it is unlikely that the presence of AIP promotes the development of pancreatic cancer through inflammation-associated carcinogenesis ",
   "entities": [
    [
     "T1",
     41,
     44,
     "gene",
     "AIP"
    ],
    [
     "T2",
     84,
     90,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     73,
     90,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences55": {
   "text": "The numbers of malignant diseases were obtained from five reports that addressed the incidence of cancers at or after the diagnosis of AIP 10 11 13-15 ",
   "entities": [
    [
     "T1",
     135,
     138,
     "gene",
     "AIP"
    ],
    [
     "T2",
     98,
     105,
     "phenotype",
     "cancers"
    ],
    [
     "T3",
     25,
     33,
     "phenotype",
     "diseases"
    ],
    [
     "T4",
     15,
     33,
     "phenotype",
     "malignant diseases"
    ]
   ]
  },
  "Sentences56": {
   "text": "analyzed the expression of IgG4 in cancer tissues in AIP patients with cancer 10 ",
   "entities": [
    [
     "T1",
     53,
     56,
     "gene",
     "AIP"
    ],
    [
     "T2",
     35,
     41,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     71,
     77,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences57": {
   "text": "Thus the cancer and pancreatic tissues of AIP patients with cancer might share key immune responses leading to the enhancement of IgG4 Ab production ",
   "entities": [
    [
     "T1",
     42,
     45,
     "gene",
     "AIP"
    ],
    [
     "T2",
     9,
     15,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     60,
     66,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences58": {
   "text": "provides new insights into the pathogenesis of the co-occurrence of AIP and cancer 10 ",
   "entities": [
    [
     "T1",
     68,
     71,
     "gene",
     "AIP"
    ],
    [
     "T2",
     76,
     82,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences59": {
   "text": "Another possibility is that the enhancement of IgG4 Ab responses arises from the cancer tissues and then IgG4-expressing plasma cells cause AIP by migrating to the pancreatic tissue ",
   "entities": [
    [
     "T1",
     140,
     143,
     "gene",
     "AIP"
    ],
    [
     "T2",
     81,
     87,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences60": {
   "text": "The identification of the primary sites for enhanced IgG4 Ab responses might provide new insights into the pathogenesis of cancer in AIP patients ",
   "entities": [
    [
     "T1",
     133,
     136,
     "gene",
     "AIP"
    ],
    [
     "T2",
     123,
     129,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences61": {
   "text": "One question that needs to be addressed in Shiokawa s study is whether or not the extra-pancreatic occurrence of cancer in patients with AIP is associated with long-standing inflammation related to IgG4-RD ",
   "entities": [
    [
     "T1",
     137,
     140,
     "gene",
     "AIP"
    ],
    [
     "T2",
     198,
     205,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     113,
     119,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences62": {
   "text": "have demonstrated the presence of IgG4-expressing plasmacytes in cancer tissues of AIP patients they have not described the chronic inflammation characteristics of IgG4-RD in cancer tissue ",
   "entities": [
    [
     "T1",
     83,
     86,
     "gene",
     "AIP"
    ],
    [
     "T2",
     164,
     171,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     65,
     71,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     175,
     181,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences63": {
   "text": "In addition to IgG4 Ab responses K-ras gene mutations might be involved in the development of gastrointestinal tract cancer in AIP patients ",
   "entities": [
    [
     "T1",
     127,
     130,
     "gene",
     "AIP"
    ],
    [
     "T2",
     117,
     123,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences64": {
   "text": "Conversely a mutational K-ras analysis in endoscopic ultrasound-guided fine needle aspiration samples of pancreatic tissue revealed that none of the AIP cases exhibited significant K-ras mutations whereas most cases of pancreatic cancer bear K-ras mutations 23 ",
   "entities": [
    [
     "T1",
     149,
     152,
     "gene",
     "AIP"
    ],
    [
     "T2",
     83,
     93,
     "phenotype",
     "aspiration"
    ],
    [
     "T3",
     230,
     236,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     219,
     236,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences65": {
   "text": "Thus the status of K-ras mutations also supports the idea that the presence of AIP may be associated with cancer of the gastrointestinal tract rather than the pancreas ",
   "entities": [
    [
     "T1",
     79,
     82,
     "gene",
     "AIP"
    ],
    [
     "T2",
     106,
     112,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences66": {
   "text": "Gastric lung and prostate cancer are frequently detected malignancies in patients with AIP and account for around 50 of all cancers detected at or after the diagnosis of AIP ",
   "entities": [
    [
     "T1",
     87,
     90,
     "gene",
     "AIP"
    ],
    [
     "T1",
     170,
     173,
     "gene",
     "AIP"
    ],
    [
     "T2",
     26,
     32,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     17,
     32,
     "phenotype",
     "prostate cancer"
    ]
   ]
  },
  "Sentences67": {
   "text": "In addition patients with AIP and IgG4-RD are typically men and elderly as in the case of prostate cancer 3-5 26 ",
   "entities": [
    [
     "T1",
     26,
     29,
     "gene",
     "AIP"
    ],
    [
     "T2",
     34,
     41,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     99,
     105,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     90,
     105,
     "phenotype",
     "prostate cancer"
    ]
   ]
  },
  "Sentences68": {
   "text": "At present there are no studies that directly compare the incidence of gastric lung and prostate cancers between patients with AIP/IgG4-RD and risk factor-matched controls ",
   "entities": [
    [
     "T1",
     127,
     130,
     "gene",
     "AIP"
    ],
    [
     "T2",
     131,
     138,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     97,
     104,
     "phenotype",
     "cancers"
    ],
    [
     "T4",
     88,
     104,
     "phenotype",
     "prostate cancers"
    ]
   ]
  },
  "Sentences69": {
   "text": "Thus the limitations of the recent epidemiological studies are the lack of analyses of cancer risk factors in both AIP/IgG4-RD patients and control subjects ",
   "entities": [
    [
     "T1",
     115,
     118,
     "gene",
     "AIP"
    ],
    [
     "T2",
     119,
     126,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     87,
     93,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences70": {
   "text": "Future prospective studies addressing the incidence of pancreatic cancer in AIP patients are absolutely required to confirm this idea ",
   "entities": [
    [
     "T1",
     76,
     79,
     "gene",
     "AIP"
    ],
    [
     "T2",
     66,
     72,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     55,
     72,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences71": {
   "text": "Is Type 1 AIP a Paraneoplastic Syndrome ",
   "entities": [
    [
     "T1",
     10,
     13,
     "gene",
     "AIP"
    ],
    [
     "T2",
     31,
     39,
     "phenotype",
     "Syndrome"
    ],
    [
     "T3",
     3,
     13,
     "phenotype",
     "Type 1 AIP"
    ]
   ]
  },
  "Sentences72": {
   "text": "Two Japanese studies reported that a significant population of patients with type 1 AIP already had cancer at the time of the AIP diagnosis 10 11 ",
   "entities": [
    [
     "T1",
     84,
     87,
     "gene",
     "AIP"
    ],
    [
     "T1",
     126,
     129,
     "gene",
     "AIP"
    ],
    [
     "T2",
     77,
     87,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T3",
     100,
     106,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences73": {
   "text": "We must therefore consider the possibility of co-existing cancer upon the diagnosis of AIP ",
   "entities": [
    [
     "T1",
     87,
     90,
     "gene",
     "AIP"
    ],
    [
     "T2",
     58,
     64,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences74": {
   "text": "According to the studies by Shiokawa et al  10 cancer cases were diagnosed at or within 1 year of the AIP diagnosis 10 ",
   "entities": [
    [
     "T1",
     102,
     105,
     "gene",
     "AIP"
    ],
    [
     "T2",
     47,
     53,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences75": {
   "text": "Strikingly eight cancer cases were detected at the diagnosis of AIP ",
   "entities": [
    [
     "T1",
     64,
     67,
     "gene",
     "AIP"
    ],
    [
     "T2",
     17,
     23,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences76": {
   "text": "A high incidence of cancer early after the diagnosis of AIP was also reported in Asano s study 14 ",
   "entities": [
    [
     "T1",
     56,
     59,
     "gene",
     "AIP"
    ],
    [
     "T2",
     20,
     26,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences77": {
   "text": "proposed that pre-existing cancer might evoke IgG4-related type 1 AIP and that type 1 AIP can occur as an autoimmune paraneoplastic disease ",
   "entities": [
    [
     "T1",
     66,
     69,
     "gene",
     "AIP"
    ],
    [
     "T1",
     86,
     89,
     "gene",
     "AIP"
    ],
    [
     "T2",
     59,
     69,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T2",
     79,
     89,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T3",
     27,
     33,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     132,
     139,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences78": {
   "text": "They therefore speculate that as-yet-undisclosed immune responses caused by the malignant tumors might underlie the immuno-pathogenesis of simultaneous occurrence of type 1 AIP and cancer ",
   "entities": [
    [
     "T1",
     173,
     176,
     "gene",
     "AIP"
    ],
    [
     "T2",
     166,
     176,
     "phenotype",
     "type 1 AIP"
    ],
    [
     "T3",
     90,
     96,
     "phenotype",
     "tumors"
    ],
    [
     "T4",
     181,
     187,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences79": {
   "text": "A high incidence of cancer in AIP patients early after the diagnosis can be fully explained by this novel concept ",
   "entities": [
    [
     "T1",
     30,
     33,
     "gene",
     "AIP"
    ],
    [
     "T2",
     20,
     26,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences80": {
   "text": "As in the case of other autoimmune paraneoplastic disorders such as polymyositis and dermatomyositis 27 28  remission of AIP has been achieved after the successful treatment of co-existing cancer 10 ",
   "entities": [
    [
     "T1",
     121,
     124,
     "gene",
     "AIP"
    ],
    [
     "T2",
     189,
     195,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     68,
     80,
     "phenotype",
     "polymyositis"
    ],
    [
     "T4",
     50,
     59,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences81": {
   "text": "propose a very attractive concept that type 1 AIP and IgG4-RD can occur as a paraneoplastic syndrome ",
   "entities": [
    [
     "T1",
     46,
     49,
     "gene",
     "AIP"
    ],
    [
     "T2",
     92,
     100,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     54,
     61,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T4",
     39,
     49,
     "phenotype",
     "type 1 AIP"
    ]
   ]
  },
  "Sentences82": {
   "text": "Confirmation of this new concept awaits future prospective studies that address the time window of cancer occurrence in a large number of patients with AIP and IgG4-RD ",
   "entities": [
    [
     "T1",
     152,
     155,
     "gene",
     "AIP"
    ],
    [
     "T2",
     160,
     167,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     99,
     105,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences83": {
   "text": "In addition elucidation of the molecular mechanisms underlying how co-existing cancer induces AIP and/or IgG4-RD as a paraneoplastic syndrome will help strengthen this concept ",
   "entities": [
    [
     "T1",
     94,
     97,
     "gene",
     "AIP"
    ],
    [
     "T2",
     133,
     141,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     105,
     112,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T4",
     79,
     85,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences84": {
   "text": "Conclusion The presence of AIP may be associated with the risk of cancers of extra-pancreatic organs such as the stomach lung and prostate ",
   "entities": [
    [
     "T1",
     27,
     30,
     "gene",
     "AIP"
    ],
    [
     "T2",
     66,
     73,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences85": {
   "text": "However the presence of AIP and/or IgG4-RD may not promote the development of pancreatic cancer ",
   "entities": [
    [
     "T1",
     24,
     27,
     "gene",
     "AIP"
    ],
    [
     "T2",
     35,
     42,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     89,
     95,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     78,
     95,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences86": {
   "text": "The large number of AIP patients in whom cancers are detected at or within one year of the AIP diagnosis strongly suggests that AIP and/or IgG4-RD sometimes arise as a paraneoplastic syndrome ",
   "entities": [
    [
     "T1",
     20,
     23,
     "gene",
     "AIP"
    ],
    [
     "T1",
     91,
     94,
     "gene",
     "AIP"
    ],
    [
     "T1",
     128,
     131,
     "gene",
     "AIP"
    ],
    [
     "T2",
     183,
     191,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     139,
     146,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T4",
     41,
     48,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences87": {
   "text": "Confirmation of these findings awaits future-prospective studies in which the incidences of cancer in patients with AIP and/or IgG4-RD are directly compared with those in age- sex- and risk factor-matched control subjects ",
   "entities": [
    [
     "T1",
     116,
     119,
     "gene",
     "AIP"
    ],
    [
     "T2",
     127,
     134,
     "phenotype",
     "IgG4-RD"
    ],
    [
     "T3",
     92,
     98,
     "phenotype",
     "cancer"
    ]
   ]
  }
 },
 "PMC6600032": {
  "Sentences0": {
   "text": "Positivity for CD34 was found only on vessels Fig 2e  excluding a solitary fibrous tumor ",
   "entities": [
    [
     "T1",
     15,
     19,
     "gene",
     "CD34"
    ],
    [
     "T2",
     83,
     88,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences1": {
   "text": "The expression for DOG-1 and CD34 was negative also anaplastic lymphoma kinase gene ALK marking was absent excluding a myofibroblastic tumor Fig 2f ",
   "entities": [
    [
     "T1",
     29,
     33,
     "gene",
     "CD34"
    ],
    [
     "T2",
     84,
     87,
     "gene",
     "ALK"
    ],
    [
     "T3",
     135,
     140,
     "phenotype",
     "tumor"
    ],
    [
     "T4",
     63,
     71,
     "phenotype",
     "lymphoma"
    ]
   ]
  }
 },
 "PMC6600038": {
  "Sentences0": {
   "text": "Diagnosis is mainly based on tumor cytology and architecture and is completed by immunostaining with specific neuroendocrine markers such as chromogranin synaptophysin and CD56 for the neuroendocrine component  combined with markers of non-endocrine differentiation such as keratin 7 for gastric tumors and keratin 20 CDX2 and carcinoembryonic antigen CEA  2 ",
   "entities": [
    [
     "T1",
     318,
     322,
     "gene",
     "CDX2"
    ],
    [
     "T2",
     29,
     34,
     "phenotype",
     "tumor"
    ]
   ]
  }
 },
 "PMC6600238": {
  "Sentences0": {
   "text": "SmLy6B Uniprot B8Y6H3 from Schistosoma mansoni represents the class Trematoda 11  Bucandin Uniprot P81782 from Bungarus candidus and Denmotoxin Uniprot Q06ZW0 from Boiga dendrophilae both represent the class Reptilia CD59 Uniprot P13987 and LYNX1 Uniprot P0DP58 from Homo sapiens both represent the class Mammalia ",
   "entities": [
    [
     "T1",
     217,
     221,
     "gene",
     "CD59"
    ],
    [
     "T2",
     27,
     46,
     "phenotype",
     "Schistosoma mansoni"
    ]
   ]
  },
  "Sentences1": {
   "text": "The ability of rodents to withstand CD59 deficiency could be due to the protective activity of another complement regulatory component Crry in those species 58 ",
   "entities": [
    [
     "T1",
     36,
     40,
     "gene",
     "CD59"
    ],
    [
     "T2",
     41,
     51,
     "phenotype",
     "deficiency"
    ]
   ]
  },
  "Sentences2": {
   "text": "This mutation destabilizes CD59 folding and interferes with transport of the protein to cell surface 57  thus providing the molecular basis for its association with disease development ",
   "entities": [
    [
     "T1",
     27,
     31,
     "gene",
     "CD59"
    ],
    [
     "T2",
     165,
     172,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences3": {
   "text": "Third GPIHBP1\u2032s intrinsically disordered extension has a chaperon-like function blocking the tendency of LPL to unfold 70 ",
   "entities": [
    [
     "T1",
     105,
     108,
     "gene",
     "LPL"
    ],
    [
     "T2",
     80,
     88,
     "phenotype",
     "blocking"
    ]
   ]
  },
  "Sentences4": {
   "text": "Any defect in the assembly of the LPL\u2022GPIHBP1 complex causes severe hypertriglyceridemia chylomicronemia \u2014a condition associated with life-threatening bouts of acute pancreatitis ",
   "entities": [
    [
     "T1",
     34,
     37,
     "gene",
     "LPL"
    ],
    [
     "T2",
     166,
     178,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     160,
     178,
     "phenotype",
     "acute pancreatitis"
    ],
    [
     "T4",
     68,
     88,
     "phenotype",
     "hypertriglyceridemia"
    ]
   ]
  },
  "Sentences5": {
   "text": "LY6E Two interferon inducible LU genes LY6E and PSCA have adverse pathogenic effects as they enhance the susceptibility of certain cell types to a subset of viral infections ",
   "entities": [
    [
     "T1",
     0,
     4,
     "gene",
     "LY6E"
    ],
    [
     "T1",
     39,
     43,
     "gene",
     "LY6E"
    ],
    [
     "T2",
     48,
     52,
     "gene",
     "PSCA"
    ],
    [
     "T3",
     163,
     173,
     "phenotype",
     "infections"
    ],
    [
     "T4",
     157,
     173,
     "phenotype",
     "viral infections"
    ]
   ]
  },
  "Sentences6": {
   "text": "Host entry of Flaviviridae such as Zika virus dengue virus and yellow fever virus occurs via clathrin-mediated endocytosis but the size of these virion particles requires the active engagement of a non-canonical endocytosis pathway which includes the GPI-anchored LU domain protein LY6E 80 ",
   "entities": [
    [
     "T1",
     282,
     286,
     "gene",
     "LY6E"
    ],
    [
     "T2",
     46,
     52,
     "phenotype",
     "dengue"
    ],
    [
     "T3",
     70,
     75,
     "phenotype",
     "fever"
    ]
   ]
  },
  "Sentences7": {
   "text": "A different mechanism for enhanced viral infection revealed that influenza A rely on LY6E for promoting disassembly of the viral capsid uncoating after endosomal escape of the internalized virus ",
   "entities": [
    [
     "T1",
     85,
     89,
     "gene",
     "LY6E"
    ],
    [
     "T2",
     41,
     50,
     "phenotype",
     "infection"
    ],
    [
     "T3",
     35,
     50,
     "phenotype",
     "viral infection"
    ]
   ]
  }
 },
 "PMC6600250": {
  "Sentences0": {
   "text": "For example H2 has been demonstrated to reduce the expression of several pro-inflammatory mediators and markers of oxidative stress and apoptosis including TNF-\u03b1 IL-6 IL-1\u03b2 IL-10 IL-12 chemokine ligand 2 CCL2  intercellular adhesion molecule 1 NF-\u03baB nuclear factor of activated T-cells NFAT  high mobility group box 1 protein prostaglandin E2 cyclooxygenase-2 COX2  serum diamine oxidase tissue MDA protein carbonyl TBARs myeloperoxidase activity JNK and caspase-3 bringing there levels within or preventing their levels from diverging away from normal the homeostatic range 161 162 163 ",
   "entities": [
    [
     "T1",
     204,
     208,
     "gene",
     "CCL2"
    ],
    [
     "T2",
     115,
     131,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences1": {
   "text": "Studies demonstrate that these hydrogen-rich solutions have the ability to inhibit oxidative stress suppress immune and inflammatory responses inhibit release of high mobility group box 1 HMGB1  improve mitochondrial function and energy metabolism enhance graft survival and attenuate cardiac injury during preservation or reperfusion in heart transplantation 190 192 193 194 195 ",
   "entities": [
    [
     "T1",
     188,
     193,
     "gene",
     "HMGB1"
    ],
    [
     "T2",
     83,
     99,
     "phenotype",
     "oxidative stress"
    ]
   ]
  }
 },
 "PMC6600289": {
  "Sentences0": {
   "text": "SCFAs GLP-1 and PYY influence energy intake and energy metabolism to affect the occurrence of obesity by activating various pathways through calcium signaling pathways including neuronal excitability islet cell proliferation and apoptosis insulin and glucagon secretion adipose tissue metabolism and gastrointestinal tract activity ",
   "entities": [
    [
     "T1",
     16,
     19,
     "gene",
     "PYY"
    ],
    [
     "T2",
     94,
     101,
     "phenotype",
     "obesity"
    ],
    [
     "T3",
     187,
     199,
     "phenotype",
     "excitability"
    ]
   ]
  },
  "Sentences1": {
   "text": "Many studies have shown that SCFAs PYY and GLP-1 have regulatory effects on the absorption of nutrients in the intestinal tract thus affecting the occurrence of obesity ",
   "entities": [
    [
     "T1",
     35,
     38,
     "gene",
     "PYY"
    ],
    [
     "T2",
     161,
     168,
     "phenotype",
     "obesity"
    ]
   ]
  }
 },
 "PMC6600324": {
  "Sentences0": {
   "text": "They concluded that CTRB1 protects against secretagogue-induced pancreatitis by reducing trypsin activity ",
   "entities": [
    [
     "T1",
     20,
     25,
     "gene",
     "CTRB1"
    ],
    [
     "T2",
     64,
     76,
     "phenotype",
     "pancreatitis"
    ]
   ]
  }
 },
 "PMC6600640": {
  "Sentences0": {
   "text": "Experimental evidences indicated a role of TRPM8 in cold thermal transduction different life-threatening tumors and other pathologies including migraine urinary tract dysfunction dry eye disease and obesity ",
   "entities": [
    [
     "T1",
     43,
     48,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     199,
     206,
     "phenotype",
     "obesity"
    ],
    [
     "T3",
     105,
     111,
     "phenotype",
     "tumors"
    ],
    [
     "T4",
     52,
     56,
     "phenotype",
     "cold"
    ],
    [
     "T5",
     187,
     194,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences1": {
   "text": "This short review will cover recent progress on the TRPM8 agonists and antagonists describing newly reported chemotypes and their application in the pharmacological characterization of TRPM8 in health and disease ",
   "entities": [
    [
     "T1",
     52,
     57,
     "gene",
     "TRPM8"
    ],
    [
     "T1",
     185,
     190,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     205,
     212,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences2": {
   "text": "It is known that TRPM8 receptors are implicated in cold allodynia after inflammation or nerve injury and different modulators have been studied as potential treatments for different pain conditions 9 ",
   "entities": [
    [
     "T1",
     17,
     22,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     56,
     65,
     "phenotype",
     "allodynia"
    ],
    [
     "T3",
     51,
     55,
     "phenotype",
     "cold"
    ]
   ]
  },
  "Sentences3": {
   "text": "In addition some studies strongly suggested a correlation between specific Single Nucleotide Polymorphisms SNPs in the TRPM8 encoding gene and migraine processes thus positioning TRPM8 as a potential novel target for this disabling condition 9 10 ",
   "entities": [
    [
     "T1",
     119,
     124,
     "gene",
     "TRPM8"
    ],
    [
     "T1",
     179,
     184,
     "gene",
     "TRPM8"
    ]
   ]
  },
  "Sentences4": {
   "text": "Numerous experimental results link the expression of the TRPM8 channel with cell migration and tumor progression 13 14 ",
   "entities": [
    [
     "T1",
     57,
     62,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     95,
     100,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences5": {
   "text": "To solve these discrepancies there is a need of efficient TRPM8 modulators both agonists and antagonists and of TRPM8 diagnostic probes to shed light on the real role of these channels in cancer malignancies ",
   "entities": [
    [
     "T1",
     58,
     63,
     "gene",
     "TRPM8"
    ],
    [
     "T1",
     112,
     117,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     188,
     194,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences6": {
   "text": "In addition to the above mentioned pathologic processes TRPM8 channels have also been implicated in irritable bowel syndrome SNP increased risks  16  oropharyngeal dysphagia OD  17  and chronic cough 18  while the downregulation of TRPM8 by angiotensin II may be involved in hypertension 19 ",
   "entities": [
    [
     "T1",
     56,
     61,
     "gene",
     "TRPM8"
    ],
    [
     "T1",
     232,
     237,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     116,
     124,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     275,
     287,
     "phenotype",
     "hypertension"
    ]
   ]
  },
  "Sentences7": {
   "text": "established the relationship between thermoregulation and TRPM8 expression in the afferent vagal nerve 28 ",
   "entities": [
    [
     "T1",
     58,
     63,
     "gene",
     "TRPM8"
    ]
   ]
  },
  "Sentences8": {
   "text": "On the other hand a second study demonstrated the involvement of TRPM8 channels in the anti-inflammatory effects induced by eucalyptol both in lungs of mice exposed to lipopolysaccharide LPS and in a Complete Freund s Adjuvant CFA -induced model of inflammatory pain 29 ",
   "entities": [
    [
     "T1",
     65,
     70,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     249,
     266,
     "phenotype",
     "inflammatory pain"
    ]
   ]
  },
  "Sentences9": {
   "text": "The inventors rationalized that the activation of TRPM8 the inactivation of transient receptor potential cation channel subfamily A member 1 TRPA1 without activating the transient receptor potential cation channel subfamily V member 1 TRPV1 ion channels and the inhibition of the enzyme cyclooxygenase 2 COX-2 effectively blocked pain signaling to the brain from the skin muscles and joints ",
   "entities": [
    [
     "T1",
     50,
     55,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     141,
     146,
     "gene",
     "TRPA1"
    ]
   ]
  },
  "Sentences10": {
   "text": "developed a series of triazole-based menthol derivatives as potent TRPM8 agonists and they claimed that they could be particularly useful in the prevention and treatment of dry eye syndrome DES  vaginal dryness and burning mouth syndrome 34 ",
   "entities": [
    [
     "T1",
     67,
     72,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     190,
     193,
     "gene",
     "DES"
    ],
    [
     "T3",
     181,
     189,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     229,
     237,
     "phenotype",
     "syndrome"
    ],
    [
     "T4",
     195,
     210,
     "phenotype",
     "vaginal dryness"
    ]
   ]
  },
  "Sentences11": {
   "text": "Thus the effects of a lotion that includes two menthol-based TRPM8 agonists  1R 2S 5R -N- 2- 2-pyridinyl ethyl -2-isopropyl-5-methylcyclohexancarbox-amide 12 Figure 1 and menthoxypropanediol MPO  13 Figure 1  prepared a few years ago 37  has been evaluated in patients suffering from chronic pruritus due to dry skin ClinicalTrials gov NCT00669708  38 ",
   "entities": [
    [
     "T1",
     61,
     66,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     191,
     194,
     "gene",
     "MPO"
    ],
    [
     "T3",
     292,
     300,
     "phenotype",
     "pruritus"
    ],
    [
     "T4",
     269,
     278,
     "phenotype",
     "suffering"
    ]
   ]
  },
  "Sentences12": {
   "text": "This lotion showed stronger activation of the TRPM8 channels than menthol and ameliorates severe pruritus whereby representing a potential treatment for this burdensome symptom ",
   "entities": [
    [
     "T1",
     46,
     51,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     97,
     105,
     "phenotype",
     "pruritus"
    ],
    [
     "T3",
     169,
     176,
     "phenotype",
     "symptom"
    ]
   ]
  },
  "Sentences13": {
   "text": "evaluated the anti-itching effects of a cream containing only MPO 13 Figure 1 in patients with atopic dermatitis AD in real-life settings ",
   "entities": [
    [
     "T1",
     62,
     65,
     "gene",
     "MPO"
    ]
   ]
  },
  "Sentences14": {
   "text": "Compound 13 Figure 1 inhibited neuritis outgrowth in dermal fibroblast treated with histamine as well as the germination of nerve fibers in innervated skin models including atopic fibroblasts and normal keratinocytes by reducing neuronal growth factor NGF expression ",
   "entities": [
    [
     "T1",
     252,
     255,
     "gene",
     "NGF"
    ],
    [
     "T2",
     31,
     39,
     "phenotype",
     "neuritis"
    ]
   ]
  },
  "Sentences15": {
   "text": "Given that elevated NGF levels and increased cutaneous nerve fiber density are associated with itch 41  these results point to the conclusion that MPO-induced anti-inflammatory effect is based not only on the activation of TRPM8 cold-sensing nerve fibers 42  but also on modified crosstalk between nerve endings and skin cells ",
   "entities": [
    [
     "T1",
     20,
     23,
     "gene",
     "NGF"
    ],
    [
     "T2",
     223,
     228,
     "gene",
     "TRPM8"
    ]
   ]
  },
  "Sentences16": {
   "text": "BASF extended its previous patents 45 46  and therefore increased the TRPM8 agonist chemotypes useful for application in the pharmaceutical field tumor treatment and bladder weakness among others  47 ",
   "entities": [
    [
     "T1",
     70,
     75,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     174,
     182,
     "phenotype",
     "weakness"
    ],
    [
     "T3",
     146,
     151,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences17": {
   "text": "In addition PZQ evoked calcium transients in a subpopulation of dorsal root ganglion DRG neurons which were also sensitive to the selective TRPM8 agonist WS-12 ",
   "entities": [
    [
     "T1",
     140,
     145,
     "gene",
     "TRPM8"
    ]
   ]
  },
  "Sentences18": {
   "text": "On the other hand an inhibition of TRPV1-induced Ca2 influxes by 3-T1AM-based TRPM8 activation through a negative feedback was observed in human corneal epithelial cells 62  and cancer cells such as TRPM8 transfected U2osB2 osteosarcoma 63  WERI-Rb1 retinoblastoma and human uveal melanoma UM 92-1  64 ",
   "entities": [
    [
     "T1",
     78,
     83,
     "gene",
     "TRPM8"
    ],
    [
     "T1",
     199,
     204,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     178,
     184,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     281,
     289,
     "phenotype",
     "melanoma"
    ]
   ]
  },
  "Sentences19": {
   "text": "TRPM8 Antagonists In the recent decade numerous TRPM8 antagonists have been reported by academic groups as well as pharmaceutical and biotech companies as potential drugs for neuropathic pain inflammation migraine and cancer 24 ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "TRPM8"
    ],
    [
     "T1",
     48,
     53,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     175,
     191,
     "phenotype",
     "neuropathic pain"
    ],
    [
     "T3",
     218,
     224,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences20": {
   "text": "Compound 33 Figure 4 showed good TRPM8/TRPx selectivities 1000 1  antiproliferative activity in a LNCap cell line of prostate cancer 64 3 cellular growth inhibition after three days and apoptotic activity enhancement of caspase 3/7  71 ",
   "entities": [
    [
     "T1",
     33,
     38,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     126,
     132,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     117,
     132,
     "phenotype",
     "prostate cancer"
    ]
   ]
  },
  "Sentences21": {
   "text": "A related tetrahydronaphthyridine-derived asymmetric urea  34 Figure 4 described by Amgen is a potent TRPM8 antagonist and demonstrated good efficacy in inhibiting wet-dog shaking and cold-induced arterial blood pressure in the corresponding in vivo rat models 72 ",
   "entities": [
    [
     "T1",
     102,
     107,
     "gene",
     "TRPM8"
    ]
   ]
  },
  "Sentences22": {
   "text": "A library of highly substituted azetidin-2-ones prepared from amino acid conjugates behave as the TRPM8 antagonists by blocking all modalities of channel activation voltage menthol and temperature 77 ",
   "entities": [
    [
     "T1",
     98,
     103,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     119,
     127,
     "phenotype",
     "blocking"
    ]
   ]
  },
  "Sentences23": {
   "text": "Currently there are some reports indicating the interest of the TRPM8 antagonists in urological disorders ",
   "entities": [
    [
     "T1",
     64,
     69,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     96,
     105,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences24": {
   "text": "For example Kissei Pharmaceutical Co described novel \u03b1-arylglycinamides as the TRPM8 antagonists playing important roles in bladder diseases ",
   "entities": [
    [
     "T1",
     79,
     84,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     132,
     140,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences25": {
   "text": "Thus the structure-activity relationships of a number of phenylglycine derivatives led to compounds KPR-2579 40 IC50  0 080 \u00b1 0 005 \u00b5M  a TRPM8 selective antagonist which do not show cardiovascular effect at the effective dose and decrease the number of icilin-induced wet-dog shakes and rhythmic bladder contraction in rats 78 ",
   "entities": [
    [
     "T1",
     138,
     143,
     "gene",
     "TRPM8"
    ]
   ]
  },
  "Sentences26": {
   "text": "Kissei Pharmaceutical has also described pyrazole and 2- phenylthiazolyl benzamide derivatives as TRPM8 antagonists useful for the treatment of conditions related to the hiperexcitability of afferent nerves particularly in OAB and LUTS ",
   "entities": [
    [
     "T1",
     98,
     103,
     "gene",
     "TRPM8"
    ]
   ]
  },
  "Sentences27": {
   "text": "From the family of active naphtyl derivatives they selected compound 43 Figure 4 displaying nanomolar potency IC50  7 23 nM  selectivity towards TRPA1 TRPV1 and TRPV3 good pK properties and in vivo efficacy in an overactive bladder rat model 83 ",
   "entities": [
    [
     "T1",
     145,
     150,
     "gene",
     "TRPA1"
    ]
   ]
  },
  "Sentences28": {
   "text": "Thus Mitsubishi Tanabe Pharma Corporation described 361 aromatic carboxamides exemplified by compound 44 IC50  4nM Figure 4  with TRPM8 IC50 values from 0 2 to 2760 nM in their biological assays which were used for the treatment of different types of chronic pain 84 ",
   "entities": [
    [
     "T1",
     130,
     135,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     251,
     263,
     "phenotype",
     "chronic pain"
    ]
   ]
  },
  "Sentences29": {
   "text": "They claimed to have interest in these compounds for pain neurodegeneration ischemia and psychiatric disorders among other pathologies associated with TRPM8 85 ",
   "entities": [
    [
     "T1",
     151,
     156,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     101,
     110,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences30": {
   "text": "Recent studies suggested that RQ-00434739 is a potent and selective antagonist of the d channel IC50  14 nM \u02c3100-TRPM8 versus TRPA1 TRPV1 TRPM2 Nav1 3 Nav1 5 Nav1 7 Cav2 2 Cav3 2  and a promising drug for bladder disorders without affecting body temperature ",
   "entities": [
    [
     "T1",
     126,
     131,
     "gene",
     "TRPA1"
    ],
    [
     "T2",
     138,
     143,
     "gene",
     "TRPM2"
    ],
    [
     "T3",
     213,
     222,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences31": {
   "text": "In a 2017 patent the commercially available TRPM8 antagonist SML0893 48 Figure 4  was administered alone or in combination with other substances to treat or prevent ocular pain or discomfort 91 ",
   "entities": [
    [
     "T1",
     44,
     49,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     180,
     190,
     "phenotype",
     "discomfort"
    ]
   ]
  },
  "Sentences32": {
   "text": "It is interesting to note that a recent study assessed that the reduced proliferation and migration induced by the well-known AMTB antagonist 50 Figure 4 on breast cancer cell lines was due to the inhibition of NaV isoforms NaV1 1\u20131 9 rather than TRPM8 93 ",
   "entities": [
    [
     "T1",
     247,
     252,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     164,
     170,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences33": {
   "text": "Similarly the alkaloid riparin II 52 Figure 5 has important anti-inflammatory activity and produces pain relief in classical models of nociception effects that seem mediated by a plethora of targets i e  TRPV1 TRPA1 TRPM8 and ASIC channels and bradykinin and histidine receptors among other 95 ",
   "entities": [
    [
     "T1",
     210,
     215,
     "gene",
     "TRPA1"
    ],
    [
     "T2",
     216,
     221,
     "gene",
     "TRPM8"
    ]
   ]
  },
  "Sentences34": {
   "text": "The commercial drug Riluzole 53 Figure 5  used in the treatment of amyotrophic lateral sclerosis was able to block cold allodynia alterations and mitigate mechanical allodynia produced by the antitumoral oxaliplatin via inhibition of TRPM8 overexpression in DRG neurons Figure 5  96  thus constituting a new example of drug repurposing ",
   "entities": [
    [
     "T1",
     234,
     239,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     155,
     175,
     "phenotype",
     "mechanical allodynia"
    ],
    [
     "T3",
     120,
     129,
     "phenotype",
     "allodynia"
    ],
    [
     "T3",
     166,
     175,
     "phenotype",
     "allodynia"
    ],
    [
     "T4",
     115,
     119,
     "phenotype",
     "cold"
    ]
   ]
  },
  "Sentences35": {
   "text": "This residue was also necessary for cold and voltage activation of the TRPM8 currents and for blockade with SKF96365 but not by other anatgonists such as BCTC capsazepine clotrimazole and econazole 99 ",
   "entities": [
    [
     "T1",
     71,
     76,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     36,
     40,
     "phenotype",
     "cold"
    ]
   ]
  },
  "Sentences36": {
   "text": "Molecular biology will also contribute with the identification of novel structural domains important for TRPM8 functions such as the prominent role of pore loop in cool-induced responses and therefore reinforcing the idea that the cold activation process is unique 108 ",
   "entities": [
    [
     "T1",
     105,
     110,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     231,
     235,
     "phenotype",
     "cold"
    ]
   ]
  },
  "Sentences37": {
   "text": "A better knowledge on the interrelation of TRPM8 and other ion channels could also assist in envisaging new approaches for the treatment of TRPM8-mediated diseases ",
   "entities": [
    [
     "T1",
     43,
     48,
     "gene",
     "TRPM8"
    ],
    [
     "T1",
     140,
     145,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     155,
     163,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences38": {
   "text": "For instance the activation of TRPM8 channels with menthol 109  and more importantly the coordinated activation of TRPM8 and \u03b13\u03b24-nAChRs could constitute attractive strategies for the treatment of obesity type 2 diabetes and related metabolic diseases 110 ",
   "entities": [
    [
     "T1",
     31,
     36,
     "gene",
     "TRPM8"
    ],
    [
     "T1",
     115,
     120,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     233,
     251,
     "phenotype",
     "metabolic diseases"
    ],
    [
     "T3",
     197,
     204,
     "phenotype",
     "obesity"
    ],
    [
     "T4",
     212,
     220,
     "phenotype",
     "diabetes"
    ],
    [
     "T5",
     243,
     251,
     "phenotype",
     "diseases"
    ],
    [
     "T6",
     205,
     220,
     "phenotype",
     "type 2 diabetes"
    ]
   ]
  },
  "Sentences39": {
   "text": "The location expression or morphological changes of the TRPM8 channels in different tissues such as eyes 111  salivary glands 112  the brain 113  or the oropharyngeal system 17  among others open new opportunities for the treatment of diseases related to these systems ",
   "entities": [
    [
     "T1",
     56,
     61,
     "gene",
     "TRPM8"
    ],
    [
     "T2",
     235,
     243,
     "phenotype",
     "diseases"
    ]
   ]
  }
 },
 "PMC6601579": {
  "Sentences0": {
   "text": "This hypothesis is supported by a previous genome\u2010wide association study GWAS in Japanese individuals which identified three pancreatic cancer susceptibility loci that were not observed to be associated with risk in prior GWAS studies of individuals of European ancestry 34 35 36 A recent GWAS meta\u2010analysis of three Japanese studies further found a genetic risk marker in GP2 that is also distinct to this population 37 In addition non\u2010O blood alleles which are associated with pancreatic cancer 38 appear to be more prevalent in Japanese\u00a0individuals compared to Europeans 39 Our analysis did not detect any difference in pancreatic cancer incidence and risk between Latino Americans and European Americans ",
   "entities": [
    [
     "T1",
     373,
     376,
     "gene",
     "GP2"
    ],
    [
     "T2",
     136,
     142,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     490,
     496,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     634,
     640,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     125,
     142,
     "phenotype",
     "pancreatic cancer"
    ],
    [
     "T3",
     479,
     496,
     "phenotype",
     "pancreatic cancer"
    ],
    [
     "T3",
     623,
     640,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  }
 },
 "PMC6601583": {
  "Sentences0": {
   "text": "Among them CO4 B2MG and A1AG enable early detection of cancer according to Wu et al 10 LG3BP is overexpressed in the serum or tissue of patients with various types of and plays roles in cancer cell aggregation and metastasis 23 24 25 CSF1 has been reported to be expressed in brain metastases of lung cancer and breast cancer 26 NKG2\u2010D type II integral membrane protein NKG2D acts as an activating receptor for killer cells providing therapeutic targets for the treatment of infectious diseases cancer and autoimmune diseases 27 On day 8 the tumor rats lost weight and tumors were detectable on MRI ",
   "entities": [
    [
     "T1",
     234,
     238,
     "gene",
     "CSF1"
    ],
    [
     "T2",
     475,
     494,
     "phenotype",
     "infectious diseases"
    ],
    [
     "T3",
     542,
     547,
     "phenotype",
     "tumor"
    ],
    [
     "T4",
     55,
     61,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     186,
     192,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     301,
     307,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     319,
     325,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     495,
     501,
     "phenotype",
     "cancer"
    ],
    [
     "T5",
     486,
     494,
     "phenotype",
     "diseases"
    ],
    [
     "T5",
     517,
     525,
     "phenotype",
     "diseases"
    ],
    [
     "T6",
     296,
     307,
     "phenotype",
     "lung cancer"
    ]
   ]
  },
  "Sentences1": {
   "text": "In addition to NKG2D LG3BP B2MG CSF1 and A1AG several proteins had been reported to be differentially expressed in the serum urine or brain tissue of brain metastasis or primary tumors ",
   "entities": [
    [
     "T1",
     32,
     36,
     "gene",
     "CSF1"
    ],
    [
     "T2",
     178,
     184,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences2": {
   "text": "Nine proteins including LG3BP CSF1 and NKG2D known to play important roles in the proliferation and metastasis of cancer were changed significantly ",
   "entities": [
    [
     "T1",
     30,
     34,
     "gene",
     "CSF1"
    ],
    [
     "T2",
     114,
     120,
     "phenotype",
     "cancer"
    ]
   ]
  }
 },
 "PMC6601705": {
  "Sentences0": {
   "text": "2 7 KRAS mutation analysis by polymerase chain reaction KRAS mutations key mutations in pancreatic cancer were analyzed using polymerase chain reaction PCR ",
   "entities": [
    [
     "T1",
     4,
     8,
     "gene",
     "KRAS"
    ],
    [
     "T1",
     56,
     60,
     "gene",
     "KRAS"
    ],
    [
     "T2",
     99,
     105,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     88,
     105,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences1": {
   "text": "In the data KRAS mutation signature of the CRCs p G12D correlated with the KRAS mutation found in the patient s primary tumor p G12D ",
   "entities": [
    [
     "T1",
     12,
     16,
     "gene",
     "KRAS"
    ],
    [
     "T1",
     75,
     79,
     "gene",
     "KRAS"
    ],
    [
     "T2",
     120,
     125,
     "phenotype",
     "tumor"
    ]
   ]
  }
 },
 "PMC6602843": {
  "Sentences0": {
   "text": "Subsequent expression quantitative trait loci eQTL analysis further revealed that these SNPs were associated with significantly altered mRNA expression levels either in 373 normal lymphoblastoid cell lines TP53 SNP rs9895829 P lt 0 05 or in whole blood cells of 369 normal donors from the genotype-tissue expression project GTEx database RPTOR SNP rs60268947 and rs28434589 both in high linkage disequilibrium r2 gt 0 9 with RPTOR rs62068300 P lt 0 001 ",
   "entities": [
    [
     "T1",
     206,
     210,
     "gene",
     "TP53"
    ]
   ]
  }
 },
 "PMC6603045": {
  "Sentences0": {
   "text": "The possible role of the expression of METTL3 YTHDF1 WTAP FTO and HNRNPA2/B1 transcripts in human breast tumors on overall survival was examined using the online tool Kaplan-Meier Plotter35 ",
   "entities": [
    [
     "T1",
     39,
     45,
     "gene",
     "METTL3"
    ],
    [
     "T2",
     46,
     52,
     "gene",
     "YTHDF1"
    ],
    [
     "T3",
     53,
     57,
     "gene",
     "WTAP"
    ],
    [
     "T4",
     58,
     61,
     "gene",
     "FTO"
    ],
    [
     "T5",
     105,
     111,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences1": {
   "text": "There was no association of overall survival OS for breast cancer patients based on primary tumor expression of METTL3 YTHDF1 or WTAP Supplementary Fig ",
   "entities": [
    [
     "T1",
     112,
     118,
     "gene",
     "METTL3"
    ],
    [
     "T2",
     119,
     125,
     "gene",
     "YTHDF1"
    ],
    [
     "T3",
     129,
     133,
     "gene",
     "WTAP"
    ],
    [
     "T4",
     92,
     97,
     "phenotype",
     "tumor"
    ],
    [
     "T5",
     59,
     65,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences2": {
   "text": "More data are needed to better understand whether low HNRNPA2B1 in the primary tumor predicts reduced OS after 220 months ",
   "entities": [
    [
     "T1",
     54,
     63,
     "gene",
     "HNRNPA2B1"
    ],
    [
     "T2",
     79,
     84,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences3": {
   "text": " C Summary of relative HNRNPA2B1 protein expression in MCF-7 cells transfected for 48\u2009h vs control n\u2009 \u2009mean\u2009\u00b1\u2009std of 7 biological replicates ",
   "entities": [
    [
     "T1",
     23,
     32,
     "gene",
     "HNRNPA2B1"
    ]
   ]
  },
  "Sentences4": {
   "text": "Thus the increase in miR-671-5p with HNRNPA2B1 overexpression in MCF-7 cells might not have the same tumor suppressor properties ",
   "entities": [
    [
     "T1",
     37,
     46,
     "gene",
     "HNRNPA2B1"
    ],
    [
     "T2",
     101,
     106,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences5": {
   "text": "These data support a role for increased HNRNPA2B1 in processes contributing to endocrine-resistance in breast cancer ",
   "entities": [
    [
     "T1",
     40,
     49,
     "gene",
     "HNRNPA2B1"
    ],
    [
     "T2",
     110,
     116,
     "phenotype",
     "cancer"
    ]
   ]
  }
 },
 "PMC6603181": {
  "Sentences0": {
   "text": "Pemphigus can be divided into three major forms pemphigus vulgaris PV  pemphigus foliaceus PF  and paraneoplastic pemphigus PNP ",
   "entities": [
    [
     "T1",
     124,
     127,
     "gene",
     "PNP"
    ],
    [
     "T2",
     0,
     9,
     "phenotype",
     "Pemphigus"
    ],
    [
     "T2",
     48,
     57,
     "phenotype",
     "Pemphigus"
    ],
    [
     "T2",
     71,
     80,
     "phenotype",
     "Pemphigus"
    ],
    [
     "T2",
     114,
     123,
     "phenotype",
     "Pemphigus"
    ]
   ]
  },
  "Sentences1": {
   "text": "Alike PV PF and PNP IgA pemphigus is an extremely rare variant of pemphigus in which IgA but not IgG autoantibodies against epidermal antigens can be identified 3 7 8 ",
   "entities": [
    [
     "T1",
     16,
     19,
     "gene",
     "PNP"
    ],
    [
     "T2",
     24,
     33,
     "phenotype",
     "pemphigus"
    ],
    [
     "T2",
     66,
     75,
     "phenotype",
     "pemphigus"
    ]
   ]
  },
  "Sentences2": {
   "text": "Epidemiology of Paraneoplastic Pemphigus PNP is considered a rare disease with about 500 cases reported in the literature 6 23 ",
   "entities": [
    [
     "T1",
     41,
     44,
     "gene",
     "PNP"
    ],
    [
     "T2",
     61,
     73,
     "phenotype",
     "rare disease"
    ],
    [
     "T3",
     31,
     40,
     "phenotype",
     "Pemphigus"
    ],
    [
     "T4",
     66,
     73,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences3": {
   "text": "PNP accounts for 3\u20135 of all pemphigus cases 6 23 ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "PNP"
    ],
    [
     "T2",
     28,
     37,
     "phenotype",
     "pemphigus"
    ]
   ]
  },
  "Sentences4": {
   "text": "Furthermore PNP can affect also children and adolescents particularly in association with Castleman s disease 6 23 ",
   "entities": [
    [
     "T1",
     12,
     15,
     "gene",
     "PNP"
    ],
    [
     "T2",
     102,
     109,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences5": {
   "text": "Paraneoplastic Pemphigus PNP is a rare pemphigus variant which is always associated with underlying neoplasms both malignant and benign ",
   "entities": [
    [
     "T1",
     25,
     28,
     "gene",
     "PNP"
    ],
    [
     "T2",
     100,
     109,
     "phenotype",
     "neoplasms"
    ],
    [
     "T3",
     15,
     24,
     "phenotype",
     "Pemphigus"
    ],
    [
     "T3",
     39,
     48,
     "phenotype",
     "Pemphigus"
    ]
   ]
  },
  "Sentences6": {
   "text": "Up to 84 of all PNP cases are secondary to hematologic malignancies 33  including non-Hodgkin lymphomas 38 6  chronic lymphocytic leukemia 18 4  Castleman s disease 18 4  thymoma 5 5  Waldenstrom s macroglobulinemia 1 2  Hodgkin lymphoma 0 6  and monoclonal gammopathy 0 6  6 33 ",
   "entities": [
    [
     "T1",
     16,
     19,
     "gene",
     "PNP"
    ],
    [
     "T2",
     82,
     103,
     "phenotype",
     "non-Hodgkin lymphomas"
    ],
    [
     "T3",
     157,
     164,
     "phenotype",
     "disease"
    ],
    [
     "T4",
     94,
     103,
     "phenotype",
     "lymphomas"
    ]
   ]
  },
  "Sentences7": {
   "text": "Less frequently epithelial carcinomas 8 6  sarcomas 6 2  and gastric cancers have been described in association with PNP 6 33\u201335 ",
   "entities": [
    [
     "T1",
     117,
     120,
     "gene",
     "PNP"
    ],
    [
     "T2",
     69,
     76,
     "phenotype",
     "cancers"
    ],
    [
     "T3",
     27,
     37,
     "phenotype",
     "carcinomas"
    ],
    [
     "T4",
     43,
     51,
     "phenotype",
     "sarcomas"
    ],
    [
     "T5",
     61,
     76,
     "phenotype",
     "gastric cancers"
    ]
   ]
  },
  "Sentences8": {
   "text": "PNP typically presents with a painful stomatitis and with extensive erosions of the oral cavity and oropharynx Figure 1C ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "PNP"
    ]
   ]
  },
  "Sentences9": {
   "text": "More than 90 of PNP cases show an involvement of the respiratory epithelium with dyspnea obstructive lung disease and bronchiolitis obliterans which is one of the main causes of death in PNP 6 42 43 ",
   "entities": [
    [
     "T1",
     16,
     19,
     "gene",
     "PNP"
    ],
    [
     "T1",
     187,
     190,
     "gene",
     "PNP"
    ],
    [
     "T2",
     106,
     113,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences10": {
   "text": "Recently a correlation between bronchiolitis obliterans and anti-epiplakin Ig Abs was found in Japanese PNP patients 42 ",
   "entities": [
    [
     "T1",
     104,
     107,
     "gene",
     "PNP"
    ]
   ]
  },
  "Sentences11": {
   "text": "Furthermore several other signaling molecules and pathways have been reported as altered by anti-Dsg autoantibodies in pemphigus acantholysis such as EGFR caspases 64  and MYC 65 ",
   "entities": [
    [
     "T1",
     150,
     154,
     "gene",
     "EGFR"
    ],
    [
     "T2",
     172,
     175,
     "gene",
     "MYC"
    ],
    [
     "T3",
     119,
     128,
     "phenotype",
     "pemphigus"
    ]
   ]
  },
  "Sentences12": {
   "text": "Bruton kinase BTK inhibitors are also a promising B-cell targeting therapy in pemphigus ",
   "entities": [
    [
     "T1",
     14,
     17,
     "gene",
     "BTK"
    ],
    [
     "T2",
     78,
     87,
     "phenotype",
     "pemphigus"
    ]
   ]
  },
  "Sentences13": {
   "text": "BTK inhibitors such as ibrutinib have shown impressive clinical responses in patients with B-cell malignancies but also hold promise for the treatment of autoimmune disorders ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "BTK"
    ],
    [
     "T2",
     165,
     174,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences14": {
   "text": "In particular over-activation of BTK have been shown to drive autoimmunity by enhancing autoantibody production and class switching promoting B-T cell cross talk and peripheral B-cell loss of tolerance 244 ",
   "entities": [
    [
     "T1",
     33,
     36,
     "gene",
     "BTK"
    ]
   ]
  },
  "Sentences15": {
   "text": "Furthermore enhanced expression of BTK in B-cells induces differentiation of T follicular helper cells which have been shown to be involved in the pathogenesis of pemphigus 67 246 ",
   "entities": [
    [
     "T1",
     35,
     38,
     "gene",
     "BTK"
    ],
    [
     "T2",
     163,
     172,
     "phenotype",
     "pemphigus"
    ]
   ]
  },
  "Sentences16": {
   "text": "Monoclonal antibodies targeting CD19  a B-cell surface molecule which is also expressed on antibody producing plasma cells such as inebilizumab would be an effective strategy in pemphigus since persistence of long-lived plasmablasts producing anti-Dsg IgG autoantibodies is presumably amongst the mechanisms of disease resistance to RTX treatment 125 ",
   "entities": [
    [
     "T1",
     32,
     36,
     "gene",
     "CD19"
    ],
    [
     "T2",
     178,
     187,
     "phenotype",
     "pemphigus"
    ],
    [
     "T3",
     311,
     318,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences17": {
   "text": "involving a murine model of autoimmune encephalitis in which mouse CD4 T cells were modified to express a CAR targeting myelin oligodendrocyte glycoprotein MOG in trans with the murine FoxP3 gene promoting Treg differentiation ",
   "entities": [
    [
     "T1",
     67,
     70,
     "gene",
     "CD4"
    ],
    [
     "T2",
     156,
     159,
     "gene",
     "MOG"
    ],
    [
     "T3",
     28,
     51,
     "phenotype",
     "autoimmune encephalitis"
    ]
   ]
  },
  "Sentences18": {
   "text": "Additionally they showed that the skin in pemphigus serves as a tertiary lymphoid organ in which a close interaction between IL-21- and IL17A-producing CD4 T cells leads to in loco production of anti-Dsg autoantibodies by auto-reactive B-cells ",
   "entities": [
    [
     "T1",
     152,
     155,
     "gene",
     "CD4"
    ],
    [
     "T2",
     42,
     51,
     "phenotype",
     "pemphigus"
    ]
   ]
  },
  "Sentences19": {
   "text": "Tofacinib an inhibitor of both JAK1 and JAK3 was suggested as a possible therapeutic in pemphigus 302 ",
   "entities": [
    [
     "T1",
     31,
     35,
     "gene",
     "JAK1"
    ],
    [
     "T2",
     40,
     44,
     "gene",
     "JAK3"
    ],
    [
     "T3",
     88,
     97,
     "phenotype",
     "pemphigus"
    ]
   ]
  },
  "Sentences20": {
   "text": " 308  inhibition of STAT3 by hydrocortisone rapamicin an inhibitor of mTOR or Stat3 inhibitor XVIII prevented blister formation in a passive transfer PV mouse model by up-regulating the expression of Dsg3 ",
   "entities": [
    [
     "T1",
     20,
     25,
     "gene",
     "STAT3"
    ],
    [
     "T1",
     78,
     83,
     "gene",
     "STAT3"
    ]
   ]
  }
 },
 "PMC6603279": {
  "Sentences0": {
   "text": "Genetic polymorphisms analysis showed that the C allele at the loci of PRSS1 and PRSS2 were significantly correlated to acute pancreatitis in male patients with alcohol abuse and smoking 7 ",
   "entities": [
    [
     "T1",
     71,
     76,
     "gene",
     "PRSS1"
    ],
    [
     "T2",
     126,
     138,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     120,
     138,
     "phenotype",
     "acute pancreatitis"
    ],
    [
     "T4",
     161,
     174,
     "phenotype",
     "alcohol abuse"
    ]
   ]
  },
  "Sentences1": {
   "text": "Besides mutations of SPINK1 and CTRC were directly associated with acute pancreatitis 8 9 ",
   "entities": [
    [
     "T1",
     32,
     36,
     "gene",
     "CTRC"
    ],
    [
     "T2",
     73,
     85,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     67,
     85,
     "phenotype",
     "acute pancreatitis"
    ]
   ]
  }
 },
 "PMC6603813": {
  "Sentences0": {
   "text": "NOD-like receptor NLR family caspase activation and recruitment domain CARD domain containing 5/NOD27/CLR16 1 NLRC5 is a highly conserved member of the NLR family and is involved in inflammation and immune responses by regulating various signaling pathways such as nuclear factor-\u03baB NF-\u03baB signaling ",
   "entities": [
    [
     "T1",
     110,
     115,
     "gene",
     "NLRC5"
    ]
   ]
  },
  "Sentences1": {
   "text": "It has been found that NLRC5 plays an important role in liver fibrosis but its specific effect and possible mechanism remain to be fully elucidated ",
   "entities": [
    [
     "T1",
     23,
     28,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     56,
     70,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences2": {
   "text": "AIM To investigate the role of NLRC5 in the activation and reversion of HSCs induced with transforming growth factor-\u03b2 TGF-\u03b2 and MDI and to explore its relationship with liver fibrosis ",
   "entities": [
    [
     "T1",
     31,
     36,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     170,
     184,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences3": {
   "text": "CONCLUSION NLRC5 may play a key role in the development and reversal of hepatic fibrosis through the NF-\u03baB signaling pathway and it is expected to be one of the clinical therapeutic targets ",
   "entities": [
    [
     "T1",
     11,
     16,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     72,
     88,
     "phenotype",
     "hepatic fibrosis"
    ]
   ]
  },
  "Sentences4": {
   "text": "NOD-like receptor NLR family caspase activation and recruitment domain CARD domain containing 5/NOD27/CLR16 1 NLRC5 is the largest member of the NLR family and is highly expressed in immune tissues or organs such as the spleen lung thymus and liver mediating inflammation inhibition and antiviral response ",
   "entities": [
    [
     "T1",
     110,
     115,
     "gene",
     "NLRC5"
    ]
   ]
  },
  "Sentences5": {
   "text": "The results demonstrate that NLRC5 may be involved in the development and reversal of liver fibrosis by negative regulation of nuclear factor-\u03baB ",
   "entities": [
    [
     "T1",
     29,
     34,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     86,
     100,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences6": {
   "text": "Our previous study found that NLRC5 protein levels fluctuated abnormally during progression and reversal of liver fibrosis ",
   "entities": [
    [
     "T1",
     30,
     35,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     108,
     122,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences7": {
   "text": "These results suggest that NLRC5 is involved in the development of liver fibrosis however there are few reports on the role of NLRC5 in liver fibrosis ",
   "entities": [
    [
     "T1",
     27,
     32,
     "gene",
     "NLRC5"
    ],
    [
     "T1",
     127,
     132,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     67,
     81,
     "phenotype",
     "liver fibrosis"
    ],
    [
     "T2",
     136,
     150,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences8": {
   "text": "Therefore this study aimed to investigate the role and mechanism of NLRC5 in HSC activation and reversal and to explore its relationship with liver fibrosis to evaluate its clinical application value ",
   "entities": [
    [
     "T1",
     68,
     73,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     142,
     156,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences9": {
   "text": "Following blocking with 5 skim milk for 1 h at room temperature the membranes were incubated with primary antibodies against NLRC5 Shanghai Youningwei Biotechnology Co  Ltd  at 1 3000 dilution \u03b1-SMA Shanghai Gefan Biotechnology Co  Ltd  at 1 3000 dilution Col1a1 Shanghai Gefan Biotechnology Co  Ltd  at 1 3000 dilution \u03b2-actin Santa Cruz at 1 1000 dilution I\u03baB\u03b1 Cell Signal at 1 2000 dilution p-I\u03baB\u03b1 Cell Signal at 1 2000 dilution and p65 Cell Signal at 1 2000 dilution overnight at 41 \u00b0C ",
   "entities": [
    [
     "T1",
     125,
     130,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     10,
     18,
     "phenotype",
     "blocking"
    ]
   ]
  },
  "Sentences10": {
   "text": "Effect of NLRC5 on NF-\u03baB activity in hepatic fibrosis Western blot analysis showed that the expression of p65 and p-I\u03baB\u03b1 increased in the liver of mice in the fibrosis group P lt 0 01  but decreased in the recovery group P lt 0 05 ",
   "entities": [
    [
     "T1",
     10,
     15,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     37,
     53,
     "phenotype",
     "hepatic fibrosis"
    ]
   ]
  },
  "Sentences11": {
   "text": "It is worth mentioning that NLRC5 is related to immune responses besides that it may be a key regulator during development and reversal of hepatic fibrosis 43  but little is known about the role of NLRC5 in hepatic fibrosis ",
   "entities": [
    [
     "T1",
     28,
     33,
     "gene",
     "NLRC5"
    ],
    [
     "T1",
     198,
     203,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     139,
     155,
     "phenotype",
     "hepatic fibrosis"
    ],
    [
     "T2",
     207,
     223,
     "phenotype",
     "hepatic fibrosis"
    ]
   ]
  },
  "Sentences12": {
   "text": "Therefore this article analyzed the relationship between NLRC5 and hepatic fibrosis and its related mechanism in order to evaluate its clinical application value ",
   "entities": [
    [
     "T1",
     57,
     62,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     67,
     83,
     "phenotype",
     "hepatic fibrosis"
    ]
   ]
  },
  "Sentences13": {
   "text": "In this study the expression levels of NLRC5 in liver tissue and LX-2 cells were analyzed to explore the role of NLRC5 in liver fibrosis and the results showed that the expression of NLRC5 in the fibrosis group was significantly higher than that in the normal and recovery groups ",
   "entities": [
    [
     "T1",
     39,
     44,
     "gene",
     "NLRC5"
    ],
    [
     "T1",
     113,
     118,
     "gene",
     "NLRC5"
    ],
    [
     "T1",
     183,
     188,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     122,
     136,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences14": {
   "text": "Based on these results it was suggested that NLRC5 may play an important role during the occurrence and reversal of liver fibrosis ",
   "entities": [
    [
     "T1",
     45,
     50,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     116,
     130,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences15": {
   "text": "The results of this study showed that the expression levels of p65 and p-I\u03baB\u03b1 in the nucleus were significantly increased after NLRC5-siRNA treatment suggesting that NLRC5 may be involved in liver fibrosis by negative regulation of NF-\u03baB ",
   "entities": [
    [
     "T1",
     128,
     133,
     "gene",
     "NLRC5"
    ],
    [
     "T1",
     166,
     171,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     191,
     205,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences16": {
   "text": "In the study by Chang G et al 47  the high expression of NLRC5 protein in mouse hepatic fibrosis after activation of the NF-\u03baB signaling pathway was presented ",
   "entities": [
    [
     "T1",
     57,
     62,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     80,
     96,
     "phenotype",
     "hepatic fibrosis"
    ]
   ]
  },
  "Sentences17": {
   "text": "However the relationship between NLRC5 and the NF-kB signaling pathway and its roles in many types of diseases have yet to be determined ",
   "entities": [
    [
     "T1",
     33,
     38,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     102,
     110,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences18": {
   "text": "The interaction of NLRC5 and NF-\u03baB accelerates the development of liver fibrosis ",
   "entities": [
    [
     "T1",
     19,
     24,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     66,
     80,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences19": {
   "text": "It has been found that NLRC5 is involved in the development of liver fibrosis by regulating the NF-\u03baB signaling pathway and some studies suggest that NLRC5 is a key regulator of liver fibrosis and its reversal but the role of NLRC5 in liver fibrosis remains unclear ",
   "entities": [
    [
     "T1",
     23,
     28,
     "gene",
     "NLRC5"
    ],
    [
     "T1",
     150,
     155,
     "gene",
     "NLRC5"
    ],
    [
     "T1",
     226,
     231,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     63,
     77,
     "phenotype",
     "liver fibrosis"
    ],
    [
     "T2",
     178,
     192,
     "phenotype",
     "liver fibrosis"
    ],
    [
     "T2",
     235,
     249,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences20": {
   "text": "Our study aimed to investigate the role and mechanism of NLRC5 in liver fibrosis to evaluate its clinical application value ",
   "entities": [
    [
     "T1",
     57,
     62,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     66,
     80,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences21": {
   "text": "Research objectives In this study we analyzed the expression levels of NLRC5 in liver tissue and LX-2 cells and the activity of NF-\u03baB in hepatic fibrosis after treatment with NLRC5-siRNA ",
   "entities": [
    [
     "T1",
     71,
     76,
     "gene",
     "NLRC5"
    ],
    [
     "T1",
     175,
     180,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     137,
     153,
     "phenotype",
     "hepatic fibrosis"
    ]
   ]
  },
  "Sentences22": {
   "text": "The purpose of this study was to explore the relationship between NLRC5 and the NF-\u03baB signaling pathways during the development and reversal of hepatic fibrosis ",
   "entities": [
    [
     "T1",
     66,
     71,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     144,
     160,
     "phenotype",
     "hepatic fibrosis"
    ]
   ]
  },
  "Sentences23": {
   "text": "The degree of liver fibrosis and the expression of NLRC5 in mouse tissues and LX-2 cells were detected by qPCR and Western blot ",
   "entities": [
    [
     "T1",
     51,
     56,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     14,
     28,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences24": {
   "text": "After interfering with NLRC5 by siRNA the activity of NF-\u03baB in liver fibrosis was detected ",
   "entities": [
    [
     "T1",
     23,
     28,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     63,
     77,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences25": {
   "text": "Research results The expression level of NLRC5 was higher in liver tissue of fibrosis mice and activated HSCs but decreased in mice with hepatic fibrosis with spontaneous reversion and inactivated HSC cells P lt 0 01 ",
   "entities": [
    [
     "T1",
     41,
     46,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     137,
     153,
     "phenotype",
     "hepatic fibrosis"
    ]
   ]
  },
  "Sentences26": {
   "text": "Research conclusions NLRC5 may play a key role in regulating the progression and reversal of liver fibrosis by negatively regulating the NF-\u03baB signaling pathway and it is expected to be one of the clinical therapeutic targets ",
   "entities": [
    [
     "T1",
     21,
     26,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     93,
     107,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  },
  "Sentences27": {
   "text": "Exploring the role and mechanism of NLRC5 and NF-\u03baB in liver fibrosis can provide an important reference for the treatment of liver fibrosis ",
   "entities": [
    [
     "T1",
     36,
     41,
     "gene",
     "NLRC5"
    ],
    [
     "T2",
     55,
     69,
     "phenotype",
     "liver fibrosis"
    ],
    [
     "T2",
     126,
     140,
     "phenotype",
     "liver fibrosis"
    ]
   ]
  }
 },
 "PMC6604591": {
  "Sentences0": {
   "text": "Background  The BRAFV600E mutation BRAF  is the most common genetic cause of papillary thyroid carcinoma PTC and is considered a specific diagnostic marker ",
   "entities": [
    [
     "T1",
     35,
     39,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     95,
     104,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences1": {
   "text": "Significant differences BRAF vs BRAF- exist in age at the time of primary treatment 49 5yrs vs 43 9yrs p 0 011  malignancy detection in fine needle puncture classified as Bethesda 6 18 9 vs 1 8  p 0 040  tumor size 14 4mm vs 18 3mm p 0 018  multifocal growth 30 6 vs 17 0  p 0 031 and extrathyroid extension 22 4 vs 10 2  p 0 026 Fig 1 ",
   "entities": [
    [
     "T1",
     24,
     28,
     "gene",
     "BRAF"
    ],
    [
     "T1",
     32,
     36,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     204,
     209,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences2": {
   "text": "The results suggest a connection of the BRAF mutation with more aggressive tumor characteristics as evidenced for instance by extrathyroid extension and multifocal growth and simultaneously smaller tumor size but a sole influence of BRAF on recurrence rate could not be proven ",
   "entities": [
    [
     "T1",
     40,
     44,
     "gene",
     "BRAF"
    ],
    [
     "T1",
     233,
     237,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     75,
     80,
     "phenotype",
     "tumor"
    ],
    [
     "T2",
     198,
     203,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences3": {
   "text": "However if a BRAF patient is treated surgically one should take into account the seemingly more aggressive tumor behavior ",
   "entities": [
    [
     "T1",
     13,
     17,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     107,
     112,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences4": {
   "text": "Histological analysis diagnosed the rare finding of an inflammatory myofibroblastic tumor of the liver and revealed cytoplasmic anaplastic lymphoma kinase ALK expression by immunohistochemistry Figure ",
   "entities": [
    [
     "T1",
     155,
     158,
     "gene",
     "ALK"
    ],
    [
     "T2",
     84,
     89,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     139,
     147,
     "phenotype",
     "lymphoma"
    ]
   ]
  },
  "Sentences5": {
   "text": "Background  Distal cholangiocarcinoma DCC is a rare but over the last decade increasing malignancy and is associated with poor prognosis ",
   "entities": [
    [
     "T1",
     38,
     41,
     "gene",
     "DCC"
    ],
    [
     "T2",
     19,
     37,
     "phenotype",
     "cholangiocarcinoma"
    ]
   ]
  },
  "Sentences6": {
   "text": "Background  Hilar en-bloc resection with portal vein resection PVR has emerged as the mainstay of treatment for patients with perihilar cholangiocarcinoma PHCC ",
   "entities": [
    [
     "T1",
     63,
     66,
     "gene",
     "PVR"
    ],
    [
     "T2",
     136,
     154,
     "phenotype",
     "cholangiocarcinoma"
    ]
   ]
  },
  "Sentences7": {
   "text": "Lysosome-associated protein transmembrane-4-beta LAPTM4B is up-regulated in a wide range of cancers associated with poor prognosis ",
   "entities": [
    [
     "T1",
     49,
     56,
     "gene",
     "LAPTM4B"
    ],
    [
     "T2",
     92,
     99,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences8": {
   "text": "Results  Expression of LAPTM4B was significantly increased in tumor tissue and in blood serum samples of patients with PDAC versus healthy controls p 0 002 p lt 0 001 and versus chronic pancreatitis p 0 02 p 0 031 ",
   "entities": [
    [
     "T1",
     23,
     30,
     "gene",
     "LAPTM4B"
    ],
    [
     "T2",
     186,
     198,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     62,
     67,
     "phenotype",
     "tumor"
    ],
    [
     "T4",
     178,
     198,
     "phenotype",
     "chronic pancreatitis"
    ]
   ]
  },
  "Sentences9": {
   "text": "Background  With increasing numbers of patients treated for locally advanced and borderline resectable pancreatic cancer the number of portal vein resections PVR is increasing ",
   "entities": [
    [
     "T1",
     158,
     161,
     "gene",
     "PVR"
    ],
    [
     "T2",
     114,
     120,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     103,
     120,
     "phenotype",
     "pancreatic cancer"
    ]
   ]
  },
  "Sentences10": {
   "text": "HGF signaling plays a vital role in the early stage of liver regeneration after PHx in mice Abstract ID 836 X -J ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "HGF"
    ],
    [
     "T2",
     55,
     73,
     "phenotype",
     "liver regeneration"
    ]
   ]
  },
  "Sentences11": {
   "text": "Background  Hepatocyte growth factor HGF is a complete hepatic mitogen and is considered an important initiator of liver regeneration ",
   "entities": [
    [
     "T1",
     37,
     40,
     "gene",
     "HGF"
    ],
    [
     "T2",
     115,
     133,
     "phenotype",
     "liver regeneration"
    ]
   ]
  },
  "Sentences12": {
   "text": "LSECs are one of the most important liver cell types that produce HGF but the exact contribution of LSECs to liver regeneration remains to be defined ",
   "entities": [
    [
     "T1",
     66,
     69,
     "gene",
     "HGF"
    ],
    [
     "T2",
     109,
     127,
     "phenotype",
     "liver regeneration"
    ]
   ]
  },
  "Sentences13": {
   "text": "Materials and methods  In order to investigate the effects of HGF signaling on liver regeneration Stab2-Cretg/wt HGFfl/fl mice where HGF is specifically knocked out in LSEC were used ",
   "entities": [
    [
     "T1",
     62,
     65,
     "gene",
     "HGF"
    ],
    [
     "T1",
     133,
     136,
     "gene",
     "HGF"
    ],
    [
     "T2",
     79,
     97,
     "phenotype",
     "liver regeneration"
    ]
   ]
  },
  "Sentences14": {
   "text": "Conclusion  HGF signaling plays a vital role in the early stage of liver regeneration after PHx in mice ",
   "entities": [
    [
     "T1",
     12,
     15,
     "gene",
     "HGF"
    ],
    [
     "T2",
     67,
     85,
     "phenotype",
     "liver regeneration"
    ]
   ]
  },
  "Sentences15": {
   "text": "In 4-quadrant peritonitis a laparotomy lavage and intra-abdominal NPT with an open-pore drainage film Suprasorb\u00ae CNP drainage film Lohmann amp Rauscher Germany was performed ",
   "entities": [
    [
     "T1",
     113,
     116,
     "gene",
     "CNP"
    ],
    [
     "T2",
     14,
     25,
     "phenotype",
     "peritonitis"
    ]
   ]
  }
 },
 "PMC6604593": {
  "Sentences0": {
   "text": "Certain single nucleotide polymorphisms SNP within the Low Density Lipoprotein Receptor-related Protein 1 LRP1 and copy number variant CNV enrichment within specific cardiovascular genes were identified in type B aortic dissections and CeAD respectively ",
   "entities": [
    [
     "T1",
     106,
     110,
     "gene",
     "LRP1"
    ],
    [
     "T2",
     206,
     231,
     "phenotype",
     "type B aortic dissections"
    ]
   ]
  }
 },
 "PMC6604597": {
  "Sentences0": {
   "text": "In all children with suspected appendicitis we determined leucocytes CRP extracellular DNA cfDNA  neutrophile elastase NE  myeloperoxidase MPO and citrulinized histone H3 H3cit in blood samples taken at the time of first clinical presentation ",
   "entities": [
    [
     "T1",
     69,
     72,
     "gene",
     "CRP"
    ],
    [
     "T2",
     139,
     142,
     "gene",
     "MPO"
    ],
    [
     "T3",
     31,
     43,
     "phenotype",
     "appendicitis"
    ]
   ]
  }
 },
 "PMC6605495": {
  "Sentences0": {
   "text": "Additionally OGT can also non-specifically modify proteins which contain regions of intrinsic disorder e g ",
   "entities": [
    [
     "T1",
     13,
     16,
     "gene",
     "OGT"
    ],
    [
     "T2",
     94,
     102,
     "phenotype",
     "disorder"
    ]
   ]
  },
  "Sentences1": {
   "text": "Donovan et al 81 indicated that hyperglycemia significantly increases the binding of Sp1 to the vascular endothelial growth factor VEGF -A promoter while the downregulation of OGT or Sp1 by shRNA significantly abro gates glucose-induced changes in proangiogenic protein VEGF-A in ARPE-19 human retinal pigment epithelial cells and TR-iBRB rat retinal microendothelial cells ",
   "entities": [
    [
     "T1",
     176,
     179,
     "gene",
     "OGT"
    ]
   ]
  },
  "Sentences2": {
   "text": "Signal transducer and activator of transcription 3 STAT3 plays a key role in the cytokine-cytokine receptor signaling pathway in colitis 83 ",
   "entities": [
    [
     "T1",
     51,
     56,
     "gene",
     "STAT3"
    ],
    [
     "T2",
     129,
     136,
     "phenotype",
     "colitis"
    ]
   ]
  },
  "Sentences3": {
   "text": "Li et al 84 demonstrated that modification of STAT3 with O-GlcNAc at T717 suppresses its phosphorylation and the expression of the downstream anti-inflammatory gene IL-10 in bone marrow-derived macrophages BMMs isolated from cullin Cul 3-deficient mice led to increased disease severity in azoxymethane AOM induced colitis and a colitis-associated cancer model ",
   "entities": [
    [
     "T1",
     46,
     51,
     "gene",
     "STAT3"
    ],
    [
     "T2",
     348,
     354,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     270,
     277,
     "phenotype",
     "disease"
    ],
    [
     "T4",
     315,
     322,
     "phenotype",
     "colitis"
    ],
    [
     "T4",
     329,
     336,
     "phenotype",
     "colitis"
    ]
   ]
  },
  "Sentences4": {
   "text": "Meanwhile the expression of pro-inflammatory cytokines such as IL-12 CXCL1 and CXCL2 are upregulated by O-GlcNAcylated STAT3 in BMMs generated from Cul 3-deficient mice make them more susceptible to AOM-induced colitis and colitis-associated cancer ",
   "entities": [
    [
     "T1",
     79,
     84,
     "gene",
     "CXCL2"
    ],
    [
     "T2",
     119,
     124,
     "gene",
     "STAT3"
    ],
    [
     "T3",
     242,
     248,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     211,
     218,
     "phenotype",
     "colitis"
    ],
    [
     "T4",
     223,
     230,
     "phenotype",
     "colitis"
    ]
   ]
  },
  "Sentences5": {
   "text": "In addition to GlcN and OGT overexpression thiamet G an OGA inhibitor has been found to dramatically reduce the infarct volume and ameliorate the neurological deficits either before or after middle cerebral artery occlusion MCAO ",
   "entities": [
    [
     "T1",
     24,
     27,
     "gene",
     "OGT"
    ],
    [
     "T2",
     56,
     59,
     "gene",
     "OGA"
    ],
    [
     "T3",
     159,
     167,
     "phenotype",
     "deficits"
    ]
   ]
  },
  "Sentences6": {
   "text": "SLE presents a reactivation of the silenced X-chromosome due to CD4 T cell DNA demethylation and diet is thought to promote disease progression ",
   "entities": [
    [
     "T1",
     64,
     67,
     "gene",
     "CD4"
    ],
    [
     "T2",
     124,
     131,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences7": {
   "text": "Further characterization of the role of OGT and O-GlcNAc in autoimmunity may suggest new therapeutic targets for autoimmune diseases ",
   "entities": [
    [
     "T1",
     40,
     43,
     "gene",
     "OGT"
    ],
    [
     "T2",
     124,
     132,
     "phenotype",
     "diseases"
    ]
   ]
  }
 },
 "PMC6605625": {
  "Sentences0": {
   "text": "A meta-analysis of nine randomized trials showed that a daily dose of \u2265109 colony-forming units probiotics significantly decreased both systolic BP SBP and diastolic BP DBP in human patients with hypertension 15 ",
   "entities": [
    [
     "T1",
     169,
     172,
     "gene",
     "DBP"
    ],
    [
     "T2",
     196,
     208,
     "phenotype",
     "hypertension"
    ]
   ]
  },
  "Sentences1": {
   "text": "However the SBP and DBP were markedly higher in the patients with hypertension ",
   "entities": [
    [
     "T1",
     20,
     23,
     "gene",
     "DBP"
    ],
    [
     "T2",
     66,
     78,
     "phenotype",
     "hypertension"
    ]
   ]
  },
  "Sentences2": {
   "text": "The \u03b1-diversity determined using the nonparametric ACE and Chao1 algorithms was significantly higher in the hypertension group than in the healthy individuals P 0 02 and P 0 03 respectively ",
   "entities": [
    [
     "T1",
     51,
     54,
     "gene",
     "ACE"
    ],
    [
     "T2",
     108,
     120,
     "phenotype",
     "hypertension"
    ]
   ]
  },
  "Sentences3": {
   "text": "Hypertension is the most important modifiable and potentially reversible risk factor for stroke in all age groups and is closely associated with SBP and DBP particularly in patients who experience intracerebral hemorrhage 36 37 ",
   "entities": [
    [
     "T1",
     153,
     156,
     "gene",
     "DBP"
    ],
    [
     "T2",
     0,
     12,
     "phenotype",
     "Hypertension"
    ]
   ]
  },
  "Sentences4": {
   "text": "The \u03b1-diversity measured by the nonparametric ACE and Chao1 algorithms was significantly higher in the hypertension group while the Shannon and Simpson index did not indicate significant differences between the two groups ",
   "entities": [
    [
     "T1",
     46,
     49,
     "gene",
     "ACE"
    ],
    [
     "T2",
     103,
     115,
     "phenotype",
     "hypertension"
    ]
   ]
  }
 },
 "PMC6606664": {
  "Sentences0": {
   "text": "Another example is the homozygous Cxcr2 line with several phenotypes involving B cell and T cell disturbances and the corresponding human orthologue CXCR2 associated to Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency ORPHA 420699 ",
   "entities": [
    [
     "T1",
     34,
     39,
     "gene",
     "CXCR2"
    ],
    [
     "T1",
     149,
     154,
     "gene",
     "CXCR2"
    ],
    [
     "T1",
     226,
     231,
     "gene",
     "CXCR2"
    ],
    [
     "T2",
     207,
     218,
     "phenotype",
     "neutropenia"
    ],
    [
     "T3",
     232,
     242,
     "phenotype",
     "deficiency"
    ]
   ]
  },
  "Sentences1": {
   "text": "Examples of new IMPC disease models with respect to the previously published reportHom homozygote Hem hemizygote Het heterozygoteUpf3b skeleton phenotypes in bold Rab3gap2 eye cardiovascular and skeleton phenotypes in bold Hmcn1 eye phenotypes in bold Dsg2 cardiovascular phenotypes in bold Mtnr1b endocrine/metabolism phenotypes in bold Cpa1 hematopoietic/blood and blood-forming tissues phenotypes in bold UPF3B associated to an X-linked syndromic mental retardation OMIM 300676  illustrates the added value of the IMPC for these type of disorders ",
   "entities": [
    [
     "T1",
     408,
     413,
     "gene",
     "UPF3B"
    ],
    [
     "T2",
     540,
     549,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences2": {
   "text": "Similarly RAB3GAP2 associated to Martsolf Syndrome OMIM 212720  has no previous mouse mutant produced with the novel IMPC model reflecting the pleiotropy of the gene by mimicking cardiovascular facial/eye and skeletal phenotypes ",
   "entities": [
    [
     "T1",
     10,
     18,
     "gene",
     "RAB3GAP2"
    ],
    [
     "T2",
     42,
     50,
     "phenotype",
     "Syndrome"
    ]
   ]
  },
  "Sentences3": {
   "text": "HMCN1 linked to age-related Macular Degeneration OMIM 603075  and with several vision/eye phenotype associations found in the mouse mutant including cataract abnormal optic disk morphology as well as an abnormal behavioural response to light or DSG2 associated to Cardiomyopathy dilated 1BB OMIM 612877 for which the ortholog homozygous knockout mouse shows several cardiovascular phenotypes decreased cardiac muscle contractility dilated heart left ventricle and increased heart weight ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "HMCN1"
    ],
    [
     "T2",
     245,
     249,
     "gene",
     "DSG2"
    ],
    [
     "T3",
     264,
     290,
     "phenotype",
     "Cardiomyopathy dilated 1BB"
    ]
   ]
  },
  "Sentences4": {
   "text": "Another example is MTNR1B related to noninsulin-dependent Diabetes mellitus OMIM 125853  and the corresponding IMPC mouse line showing increased fasted circulating glucose levels ",
   "entities": [
    [
     "T1",
     19,
     25,
     "gene",
     "MTNR1B"
    ],
    [
     "T2",
     58,
     75,
     "phenotype",
     "Diabetes mellitus"
    ],
    [
     "T3",
     58,
     66,
     "phenotype",
     "Diabetes"
    ],
    [
     "T4",
     37,
     66,
     "phenotype",
     "noninsulin-dependent Diabetes"
    ]
   ]
  },
  "Sentences5": {
   "text": "Finally an inherited form of pancreatitis Hereditary Chronic Pancreatitis ORPHA 676  for which mutations in CPA1 have been found to be associated with provides another example of a prospective disease model with no previous knockout mouse able to capture the clinical phenotypes and the IMPC homozygous mice displaying several phenotypes related to pancreatic function e g ",
   "entities": [
    [
     "T1",
     108,
     112,
     "gene",
     "CPA1"
    ],
    [
     "T2",
     29,
     41,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T2",
     61,
     73,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     42,
     73,
     "phenotype",
     "Hereditary Chronic Pancreatitis"
    ],
    [
     "T4",
     53,
     73,
     "phenotype",
     "Chronic Pancreatitis"
    ],
    [
     "T5",
     29,
     52,
     "phenotype",
     "pancreatitis Hereditary"
    ]
   ]
  }
 },
 "PMC6606754": {
  "Sentences0": {
   "text": "Our study thus implicates Fas in CD4 T cells as a target for inflammatory bowel disease therapy ",
   "entities": [
    [
     "T1",
     33,
     36,
     "gene",
     "CD4"
    ],
    [
     "T2",
     61,
     87,
     "phenotype",
     "inflammatory bowel disease"
    ],
    [
     "T3",
     80,
     87,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences1": {
   "text": "CD4 T cells with interferon-regulatory factor 4 IRF4  GATA-3 or STAT6 deficiency fail to develop into TH9 cells5 8 14 indicating the essential roles of these transcription factors TFs in TH9 cell differentiation ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "CD4"
    ],
    [
     "T2",
     48,
     52,
     "gene",
     "IRF4"
    ],
    [
     "T3",
     64,
     69,
     "gene",
     "STAT6"
    ],
    [
     "T4",
     70,
     80,
     "phenotype",
     "deficiency"
    ]
   ]
  },
  "Sentences2": {
   "text": "c Flow cytometric analysis of the frequencies of IL-9  IFN-\u03b3  IL-17A  and Foxp3 cells among CD4 T cells in the tumor-infiltrating lymphocytes TILs of the mice described in a 20 days after tumor inoculation n\u2009 \u20093 ",
   "entities": [
    [
     "T1",
     92,
     95,
     "gene",
     "CD4"
    ],
    [
     "T2",
     111,
     116,
     "phenotype",
     "tumor"
    ],
    [
     "T2",
     188,
     193,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences3": {
   "text": "c Flow cytometric analysis of the frequencies of IL-9  interleukin-9  IFN-\u03b3  and IL-17A cells among CD4 T cells in the TILs of the mice described in a 20 days after tumor inoculation n\u2009 \u20092\u20133 ",
   "entities": [
    [
     "T1",
     100,
     103,
     "gene",
     "CD4"
    ],
    [
     "T2",
     165,
     170,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences4": {
   "text": "Then we detected Fas and IL-9 expression in CD4 T cells from tumor tissues in a cohort of 36 cancer patients with non-small-cell lung carcinoma NSCLC  Supplementary Table\u00a01 ",
   "entities": [
    [
     "T1",
     44,
     47,
     "gene",
     "CD4"
    ],
    [
     "T2",
     61,
     66,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     93,
     99,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     134,
     143,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences5": {
   "text": "Further analysis confirmed the positive correlation between the numbers of Fas CD4 T cells and IL-9 CD4 T cells in the tumor tissues Fig ",
   "entities": [
    [
     "T1",
     79,
     82,
     "gene",
     "CD4"
    ],
    [
     "T1",
     100,
     103,
     "gene",
     "CD4"
    ],
    [
     "T2",
     119,
     124,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences6": {
   "text": "d Representative immunofluorescence staining of Fas CD4 and IL-9 CD4 T cells in tumor tissues from non-small-cell lung carcinoma NSCLC patients ",
   "entities": [
    [
     "T1",
     52,
     55,
     "gene",
     "CD4"
    ],
    [
     "T1",
     65,
     68,
     "gene",
     "CD4"
    ],
    [
     "T2",
     80,
     85,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     119,
     128,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences7": {
   "text": "e Pearson s correlation between Fas CD4 T cells and IL-9 CD4 T cells in tumor tissues from NSCLC patients ",
   "entities": [
    [
     "T1",
     36,
     39,
     "gene",
     "CD4"
    ],
    [
     "T1",
     57,
     60,
     "gene",
     "CD4"
    ],
    [
     "T2",
     72,
     77,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences8": {
   "text": "f The relationship between the recurrence-free survival rate of NSCLC patients and the corresponding Fas CD4 or IL-9 CD4 T cell numbers in tumor tissues ",
   "entities": [
    [
     "T1",
     105,
     108,
     "gene",
     "CD4"
    ],
    [
     "T1",
     117,
     120,
     "gene",
     "CD4"
    ],
    [
     "T2",
     139,
     144,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences9": {
   "text": "However Fas-mediated non-apoptotic signaling was observable because the mice receiving the transfer of WT CD4 T cells differentiated under TH9-skewing conditions showed IBD symptoms with increased severity dependent on IL-9 ",
   "entities": [
    [
     "T1",
     106,
     109,
     "gene",
     "CD4"
    ],
    [
     "T2",
     173,
     181,
     "phenotype",
     "symptoms"
    ]
   ]
  },
  "Sentences10": {
   "text": "We also detected decreased TH17 cell differentiation and increased TH1 cell differentiation in CD4 T cells with Fas deficiency in vitro ",
   "entities": [
    [
     "T1",
     95,
     98,
     "gene",
     "CD4"
    ],
    [
     "T2",
     116,
     126,
     "phenotype",
     "deficiency"
    ]
   ]
  },
  "Sentences11": {
   "text": "The number of Fas CD4 T cells and IL-9 CD4 T cells in tumor tissues was positively correlated and higher TH9 cell numbers in patients with tumor indicated a better prognosis than lower TH9 cell numbers ",
   "entities": [
    [
     "T1",
     18,
     21,
     "gene",
     "CD4"
    ],
    [
     "T1",
     39,
     42,
     "gene",
     "CD4"
    ],
    [
     "T2",
     54,
     59,
     "phenotype",
     "tumor"
    ],
    [
     "T2",
     139,
     144,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences12": {
   "text": "Retroviral infection of CD4 T cells Retroviruses were produced by transfecting Plat-E cells with 7 5\u2009\u03bcg of pMX-IRES-GFP pMX-Fas-WT IRES-GFP pMX-Fas-T189A IRES-GFP pMX-Fas-T224A IRES-GFP pMX-Fas-T274A IRES-GFP or pMX-Fas-T283A IRES-GFP ",
   "entities": [
    [
     "T1",
     24,
     27,
     "gene",
     "CD4"
    ],
    [
     "T2",
     11,
     20,
     "phenotype",
     "infection"
    ]
   ]
  }
 },
 "PMC6606844": {
  "Sentences0": {
   "text": "Hypophosphatasia HPP is a genetic disease caused by one or several mutations in ALPL gene encoding the tissue-nonspecific alkaline phosphatase affecting the mineralization process ",
   "entities": [
    [
     "T1",
     80,
     84,
     "gene",
     "ALPL"
    ],
    [
     "T2",
     26,
     41,
     "phenotype",
     "genetic disease"
    ],
    [
     "T3",
     34,
     41,
     "phenotype",
     "disease"
    ]
   ]
  }
 },
 "PMC6607032": {
  "Sentences0": {
   "text": "Effects of L plantarum TW1-1 on Oxidative Stress in the Serum Testes and Colon and DEHP Concentration in the Serum and Testes For the detection of oxidative stress induced by DEPH exposure we focused on some popular and reliable oxidative stress markers including GSH CAT SOD LPO and MDA ",
   "entities": [
    [
     "T1",
     268,
     271,
     "gene",
     "CAT"
    ],
    [
     "T2",
     276,
     279,
     "gene",
     "LPO"
    ],
    [
     "T3",
     32,
     48,
     "phenotype",
     "Oxidative Stress"
    ],
    [
     "T3",
     147,
     163,
     "phenotype",
     "Oxidative Stress"
    ],
    [
     "T3",
     229,
     245,
     "phenotype",
     "Oxidative Stress"
    ]
   ]
  },
  "Sentences1": {
   "text": "As shown in Figures 2A\u2013E DEHP exposure significantly reduced GSH concentration CAT and SOD activities and increased concentrations of LPO and MDA both in the testes and colon which means that DEHP caused oxidative stress by reducing the antioxidant status and increasing oxidant status ",
   "entities": [
    [
     "T1",
     79,
     82,
     "gene",
     "CAT"
    ],
    [
     "T2",
     134,
     137,
     "gene",
     "LPO"
    ],
    [
     "T3",
     204,
     220,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences2": {
   "text": "The accumulation of LPO products decreases antioxidant activity and increases free radical production resulting in an oxidative stress ",
   "entities": [
    [
     "T1",
     20,
     23,
     "gene",
     "LPO"
    ],
    [
     "T2",
     118,
     134,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences3": {
   "text": "MDA as an end product of LPO is one of the most popular and reliable oxidative stress markers the accumulation of which decreases antioxidant activity and increases free radical production resulting in oxidative stress ",
   "entities": [
    [
     "T1",
     25,
     28,
     "gene",
     "LPO"
    ],
    [
     "T2",
     69,
     85,
     "phenotype",
     "oxidative stress"
    ],
    [
     "T2",
     202,
     218,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences4": {
   "text": "In accordance with previous studies Abd El-Fattah et al  2016  our results demonstrated that DEHP reduced GSH concentration SOD and CAT activities while increased LPO and MDA concentrations in the serum and testes of mice indicating that DEHP accelerated the oxidative stress ",
   "entities": [
    [
     "T1",
     132,
     135,
     "gene",
     "CAT"
    ],
    [
     "T2",
     163,
     166,
     "gene",
     "LPO"
    ],
    [
     "T3",
     259,
     275,
     "phenotype",
     "oxidative stress"
    ]
   ]
  }
 },
 "PMC6607946": {
  "Sentences0": {
   "text": "This group includes bullous pemphigoid BP  epidermolysis bullosa acquisita EBA  pemphigoid gestationis PG  mucous membrane pemphigoid MMPh  linear IgA bullous dermatosis also known as linear IgA disease LABD  anti-laminin \u03b31 pemphigoid lichen planus pemphigoid LPP  and other rare diseases ",
   "entities": [
    [
     "T1",
     261,
     264,
     "gene",
     "LPP"
    ],
    [
     "T2",
     20,
     38,
     "phenotype",
     "bullous pemphigoid"
    ],
    [
     "T3",
     276,
     289,
     "phenotype",
     "rare diseases"
    ],
    [
     "T4",
     140,
     169,
     "phenotype",
     "linear IgA bullous dermatosis"
    ],
    [
     "T5",
     107,
     133,
     "phenotype",
     "mucous membrane pemphigoid"
    ],
    [
     "T6",
     28,
     38,
     "phenotype",
     "pemphigoid"
    ],
    [
     "T6",
     80,
     90,
     "phenotype",
     "pemphigoid"
    ],
    [
     "T6",
     123,
     133,
     "phenotype",
     "pemphigoid"
    ],
    [
     "T6",
     225,
     235,
     "phenotype",
     "pemphigoid"
    ],
    [
     "T6",
     250,
     260,
     "phenotype",
     "pemphigoid"
    ]
   ]
  },
  "Sentences1": {
   "text": "Since this salt-split treatment separates the skin at the level of lamina lucida and the localizations of target autoantigens in each disease are characteristic detailed in the Pathomechanism s of Pemphigoid Diseases section  salt-split skins of BP PG LPP LABD and most of MMPh show the immunoglobulin deposition in the epidermal side or in both the epidermal and dermal sides ",
   "entities": [
    [
     "T1",
     252,
     255,
     "gene",
     "LPP"
    ],
    [
     "T2",
     197,
     207,
     "phenotype",
     "Pemphigoid"
    ],
    [
     "T3",
     134,
     141,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences2": {
   "text": "The mean age of onset in LPP is between 40 and 50 years of age 1  whilst in PG as the disease develops during pregnancy the median age of the onset is 30 years of age 22 ",
   "entities": [
    [
     "T1",
     25,
     28,
     "gene",
     "LPP"
    ],
    [
     "T2",
     86,
     93,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences3": {
   "text": "The protein or combination of proteins recognized by the autoantibodies vary for each specific pemphigoid disease collagen XVII BP180 bullous pemphigoid antigen 2 BPAG2  and/or BPAG1e BP230 dystonin for BP PG and LPP collagen VII for EBA collagen XVII BPAG1e laminin-332 laminin-5  laminin-311 laminin-6  collagen VII or \u03b24 integrin for MMPh truncated collagen XVII fragments linear IgA disease antigen-1 LAD-1  linear IgA bullous disease antigen of 97 kDa LABD97  and/or BPAG1e for LABD and laminin \u03b31 for anti-laminin \u03b31 pemphigoid 56\u201374 ",
   "entities": [
    [
     "T1",
     213,
     216,
     "gene",
     "LPP"
    ],
    [
     "T2",
     134,
     152,
     "phenotype",
     "bullous pemphigoid"
    ],
    [
     "T3",
     95,
     105,
     "phenotype",
     "pemphigoid"
    ],
    [
     "T3",
     142,
     152,
     "phenotype",
     "pemphigoid"
    ],
    [
     "T3",
     523,
     533,
     "phenotype",
     "pemphigoid"
    ],
    [
     "T4",
     106,
     113,
     "phenotype",
     "disease"
    ],
    [
     "T4",
     387,
     394,
     "phenotype",
     "disease"
    ],
    [
     "T4",
     431,
     438,
     "phenotype",
     "disease"
    ]
   ]
  }
 },
 "PMC6609784": {
  "Sentences0": {
   "text": "The marked reduction of GST SOD and CAT levels of AFs-rats associated with lipid peroxides accumulation that increase during hepatotoxicity ",
   "entities": [
    [
     "T1",
     36,
     39,
     "gene",
     "CAT"
    ],
    [
     "T2",
     125,
     139,
     "phenotype",
     "hepatotoxicity"
    ]
   ]
  }
 },
 "PMC6609813": {
  "Sentences0": {
   "text": "Meth A a 3\u2032\u2010methylcholanthrene\u2010induced sarcoma \u2010bearing mice harbor immune suppressive CD4 T cells which are peripherally induced Treg cells 7 There are also thymus\u2010derived immune suppressive lymphocytes which appear in autoimmune diseases caused by neonatal thymectomy 8 These lymphocytes were identified by Sakaguchi et\u00a0al2 as CD25 CD4 T cells and are currently known as thymus\u2010derived natural Treg cells ",
   "entities": [
    [
     "T1",
     87,
     90,
     "gene",
     "CD4"
    ],
    [
     "T1",
     334,
     337,
     "gene",
     "CD4"
    ],
    [
     "T2",
     39,
     46,
     "phenotype",
     "sarcoma"
    ],
    [
     "T3",
     231,
     239,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences1": {
   "text": "CD4 CD25\u2212 naive T cells that are transfected with Foxp3 can convert to CD4 CD25 Treg\u2010like cells that produce inhibitory cytokines and express typical Treg\u2010cell molecules such as CD25 cytotoxic T\u2010lymphocyte antigen\u20104 CTLA\u20104  and glucocorticoid\u2010induced tumor necrosis factor TNF receptor\u2010related protein GITR 13 Thus FoxP3 is a lineage\u2010specific marker and a master regulatory gene in the generation maintenance and immune suppressive functions of Treg cells ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "CD4"
    ],
    [
     "T1",
     71,
     74,
     "gene",
     "CD4"
    ],
    [
     "T2",
     251,
     256,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences2": {
   "text": "CCR4 CC chemokine receptor 4 CCR8 chemokine receptor 8 CTLA\u20104 cytotoxic T\u2010lymphocyte antigen\u20104 eTreg effector/activated Treg GITR glucocorticoid\u2010induced tumor necrosis factor receptor\u2010related protein ICOS inducible T\u2010cell costimulator IFN\u2010\u03b3 \u03b3\u2010interferon IL interleukin PD\u20101 programmed cell death 1 rTreg resting/na\u00efve Treg TCR T\u2010cell receptor TGF\u2010\u03b2 transforming growth factor\u2010\u03b2 Treg regulatory T cell ",
   "entities": [
    [
     "T1",
     0,
     4,
     "gene",
     "CCR4"
    ],
    [
     "T2",
     200,
     204,
     "gene",
     "ICOS"
    ],
    [
     "T3",
     153,
     158,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences3": {
   "text": "Typical staining pattern of CD4 T cells in peripheral blood and lung cancer tissue ",
   "entities": [
    [
     "T1",
     28,
     31,
     "gene",
     "CD4"
    ],
    [
     "T2",
     69,
     75,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     64,
     75,
     "phenotype",
     "lung cancer"
    ]
   ]
  },
  "Sentences4": {
   "text": "eTreg cells predominantly express various activation cell surface markers including cytotoxic T\u2010lymphocyte antigen\u20104 CTLA \u20104 programmed cell death PD \u20101 inducible T\u2010cell costimulator ICOS  glucocorticoid\u2010induced tumor necrosis factor receptor\u2010related protein GITR  OX40 CD15s CCR4 and CCR8 ",
   "entities": [
    [
     "T1",
     183,
     187,
     "gene",
     "ICOS"
    ],
    [
     "T2",
     276,
     280,
     "gene",
     "CCR4"
    ],
    [
     "T3",
     212,
     217,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences5": {
   "text": "Regulatory T cells in the TME possessed a unique TCR repertoire distinct from other conventional CD4 T cells and the TCRs were specific for tumor\u2010specific antigens meaning that Treg cells in the TME recognize tumor\u2010specific antigens ",
   "entities": [
    [
     "T1",
     97,
     100,
     "gene",
     "CD4"
    ],
    [
     "T2",
     140,
     145,
     "phenotype",
     "tumor"
    ],
    [
     "T2",
     209,
     214,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences6": {
   "text": "4 1 Involvement of DCs through CTLA\u20104 Cytotoxic T\u2010lymphocyte antigen\u20104 expressed by Treg cells impairs maturation of APCs such as DCs by binding to CD80/86 36 Antigen stimulation by immature DCs or DCs with a low expression of CD80/86 induces T cells with relatively low\u2010affinity TCRs for tumor\u2010antigens derived from self\u2010components to enter an anergic state characterized by hypoproliferation and hypoproduction of cytokines following antigen restimulation 37 The CTLA\u20104 binds to CD80/86 on APCs with a higher affinity than CD28 thereby inhibiting costimulatory signals ",
   "entities": [
    [
     "T1",
     148,
     152,
     "gene",
     "CD80"
    ],
    [
     "T1",
     227,
     231,
     "gene",
     "CD80"
    ],
    [
     "T1",
     481,
     485,
     "gene",
     "CD80"
    ],
    [
     "T2",
     525,
     529,
     "gene",
     "CD28"
    ],
    [
     "T3",
     289,
     294,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences7": {
   "text": "4 4 Involvement of immune suppressive metabolites Indoleamine 2 3\u2010dioxygenase IDO  an essential enzyme in the kynurenine pathway of tryptophan metabolism and tryptophan 2 3\u2010dioxygenase TDO deplete tryptophan in the TME and cause T cell dysfunction 46 The interaction between CTLA\u20104 expressed by Treg cells and CD80/86 on APCs promotes IDO secretion 47 Additionally Treg cells are more sensitive to oxidative stress than effector T cells because Treg cells have a lower expression of NRF2 which is a key transcription factor for antioxidant responses ",
   "entities": [
    [
     "T1",
     310,
     314,
     "gene",
     "CD80"
    ],
    [
     "T2",
     398,
     414,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences8": {
   "text": "Indeed a phase I clinical trial of Treg cell depletion by the administration of anti\u2010CCR4 mAb in patients with solid tumors resulted in increased antitumor immune responses in several patients but clinical responses were not observed in most patients 49 Another concern is that systemic Treg cell depletion might increase the risk of immune\u2010related adverse events irAE  such as autoimmunity\u2010related toxicities ",
   "entities": [
    [
     "T1",
     85,
     89,
     "gene",
     "CCR4"
    ],
    [
     "T2",
     117,
     123,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences9": {
   "text": "5 1 1 CD25 Because Treg cells were originally identified as CD25 CD4 T cells several studies explored the effects of targeting CD25 with Abs or a recombinant protein composed of IL\u20102 and the active domain of the diphtheria toxin to deplete Treg cells 53 Treg cell depletion by anti\u2010CD25 mAb was evaluated in clinical trials vaccination with multiple tumor\u2010associated peptides resulted in stable disease in 6 of 10 patients with a median progression\u2010free survival of 4 8\u00a0months when followed by Treg cell depletion with an anti\u2010CD25\u2010depleting mAb daclizumab in breast cancer patients 54 In contrast another study showed that daclizumab depleted both effector T cells and Treg cells but neither an antitumor immune response nor Ab production was observed ",
   "entities": [
    [
     "T1",
     65,
     68,
     "gene",
     "CD4"
    ],
    [
     "T2",
     350,
     355,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     212,
     222,
     "phenotype",
     "diphtheria"
    ],
    [
     "T4",
     567,
     573,
     "phenotype",
     "cancer"
    ],
    [
     "T5",
     395,
     402,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences10": {
   "text": "Intratumoral administration of anti\u2010CCR10 immunotoxin which blocks the interaction of CCL28 and CCR10 reduces Treg cell accumulation in the TME and increases the antitumor immune response in a mouse model 62 CCR4 is highly expressed by eTreg cells but not by naive Treg cells or most effector T cells except for some Th2 and Th17 cells in peripheral blood 28 Using PBMCs from melanoma patients increased tumor antigen NY\u2010ESO\u20101 \u2010specific CD4 and CD8 T cell responses are observed after depletion of CCR4 eTreg cells 63 Anti\u2010CCR4 mAb is therefore instrumental in evoking and augmenting antitumor immunity in cancer patients by selectively depleting eTreg cells and a phase Ia/Ib multicenter clinical trial has been carried out 49 Administration of anti\u2010CCR4 mAb mogamulizumab for advanced or recurrent solid tumor patients significantly reduces eTreg cells in peripheral blood ",
   "entities": [
    [
     "T1",
     208,
     212,
     "gene",
     "CCR4"
    ],
    [
     "T1",
     498,
     502,
     "gene",
     "CCR4"
    ],
    [
     "T1",
     523,
     527,
     "gene",
     "CCR4"
    ],
    [
     "T1",
     751,
     755,
     "gene",
     "CCR4"
    ],
    [
     "T2",
     437,
     440,
     "gene",
     "CD4"
    ],
    [
     "T3",
     404,
     409,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     806,
     811,
     "phenotype",
     "tumor"
    ],
    [
     "T4",
     606,
     612,
     "phenotype",
     "cancer"
    ],
    [
     "T5",
     376,
     384,
     "phenotype",
     "melanoma"
    ]
   ]
  },
  "Sentences11": {
   "text": "The secretion of CCL1 by CD11b CD14 myeloid cells is involved in Treg cell infiltration 64 Increased expression of CCR8 a receptor for CCL1 is observed in Treg cells and NKT cells particularly in cancer patients and faint expression is observed in CD8 T cells or Th1 cells ",
   "entities": [
    [
     "T1",
     17,
     21,
     "gene",
     "CCL1"
    ],
    [
     "T1",
     135,
     139,
     "gene",
     "CCL1"
    ],
    [
     "T2",
     196,
     202,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences12": {
   "text": "Interactions between CCL1 and CCR8 enhance the expression of FoxP3 through the STAT3 pathway and activated CCR8 Treg cells strongly suppress antitumor immunity by promoting ATP\u2010adenosine metabolism by CD39 and secretion of IL\u201010 and granzyme B 29 The overall survival of breast cancer patients with a high infiltration of CCR8 FoxP3 Treg cells is significantly shorter than that of patients with low infiltration 64 Therefore therapies that target CCL1\u2010CCR8 molecules warrant testing in the clinic ",
   "entities": [
    [
     "T1",
     21,
     25,
     "gene",
     "CCL1"
    ],
    [
     "T1",
     448,
     452,
     "gene",
     "CCL1"
    ],
    [
     "T2",
     79,
     84,
     "gene",
     "STAT3"
    ],
    [
     "T3",
     278,
     284,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences13": {
   "text": "Regulatory T cell\u2010specific ablation of PTEN the primary negative regulator of PI3K impairs mitochondrial fitness upregulates glycolysis causes loss of FoxP3 expression in Treg cells and induces effector T cells 77 78 Furthermore a cancer vaccine co\u2010administered with a PI3K\u03b4 inhibitor reduces Treg cells and increases effector T cells efficiently inhibiting tumor growth 79 In addition Treg cell\u2010specific deletion of Atg7 or Atg5 two essential genes involved in autophagy breaks self\u2010tolerance and facilitates tumor eradication because of increased MTOR complex 1 activity c\u2010Myc expression and glycolytic metabolism characteristic of anabolic upregulation 80 Heat shock protein HSP inhibitor induces PI3K/AKT phosphorylation and increases suppressive activity in Treg cells 81 Regulatory T cells treated with HSP70 significantly inhibit the proliferation and production of CD25\u2212CD4 T cells which produce effector cytokines such as \u03b3\u2010interferon and TNF\u2010\u03b1 ",
   "entities": [
    [
     "T1",
     39,
     43,
     "gene",
     "PTEN"
    ],
    [
     "T2",
     549,
     553,
     "gene",
     "MTOR"
    ],
    [
     "T3",
     878,
     881,
     "gene",
     "CD4"
    ],
    [
     "T4",
     358,
     363,
     "phenotype",
     "tumor"
    ],
    [
     "T4",
     510,
     515,
     "phenotype",
     "tumor"
    ],
    [
     "T5",
     231,
     237,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences14": {
   "text": "Furthermore VEGFA promotes VEGFR2 eTreg cell proliferation and this effect is inhibited by Ramucirumab 23 Thus targeting VEGFR2 molecules expressed by activated Treg cells or blocking the VEGF\u2010VEGFR2 axis might contribute to tumor\u2010shrinking through Treg cell inhibition ",
   "entities": [
    [
     "T1",
     12,
     17,
     "gene",
     "VEGFA"
    ],
    [
     "T2",
     225,
     230,
     "phenotype",
     "tumor"
    ],
    [
     "T3",
     175,
     183,
     "phenotype",
     "blocking"
    ]
   ]
  }
 },
 "PMC6609814": {
  "Sentences0": {
   "text": "by regulating gene expression at epigenetic transcriptional and post\u2010transcriptional levels 5 Meanwhile differentially expressed lncRNAs have been found to play an important role in cancer by taking part in generation proliferation apoptosis and other biological processes of cancer cells 6 For example investigation has shown that B3GALT5\u2010AS1 repressed miR\u2010203 expression thereby upregulating ZEB2 and SNAI2 and inducing epithelial\u2010to\u2010mesenchymal transition in colon cancer 7 However there is still little knowledge about lncRNAs in CCA as a result of unavailability of CCA tissues ",
   "entities": [
    [
     "T1",
     332,
     339,
     "gene",
     "B3GALT5"
    ],
    [
     "T2",
     394,
     398,
     "gene",
     "ZEB2"
    ],
    [
     "T3",
     403,
     408,
     "gene",
     "SNAI2"
    ],
    [
     "T4",
     462,
     474,
     "phenotype",
     "colon cancer"
    ],
    [
     "T5",
     182,
     188,
     "phenotype",
     "cancer"
    ],
    [
     "T5",
     276,
     282,
     "phenotype",
     "cancer"
    ],
    [
     "T5",
     468,
     474,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences1": {
   "text": "For example lncRNA APF regulates miR\u2010188\u20103p and thus affects ATG7 expression autophagic cell death and myocardial infarction in the heart 9 Hence we determined the effect of dysregulated RMRP on the downstream miRNA expression profile using second\u2010generation sequencing technology ",
   "entities": [
    [
     "T1",
     61,
     65,
     "gene",
     "ATG7"
    ],
    [
     "T2",
     103,
     124,
     "phenotype",
     "myocardial infarction"
    ]
   ]
  },
  "Sentences2": {
   "text": "In both cholangiocarcinoma cell lines  B CCK\u20108 assay was used to determine the cell viability of si\u2010RMRP si\u201003 si\u201007 group and si\u2010control group ",
   "entities": [
    [
     "T1",
     41,
     44,
     "gene",
     "CCK"
    ],
    [
     "T2",
     8,
     26,
     "phenotype",
     "cholangiocarcinoma"
    ]
   ]
  },
  "Sentences3": {
   "text": "Because GO and KEGG analysis based on downstream miRNA expression profiles of RMRP focused the function of RMRP on stem cell\u2010related characteristics and previous studies of Jiang et\u00a0al and Dai et\u00a0al showed that miR\u2010217 can participate in tumor progression partially by regulating DKK1 15 16 we also detected expression of DKK1 Bmi1 CD44 and CD24 in HCCC\u20109810 cells after RMRP knockdown ",
   "entities": [
    [
     "T1",
     332,
     336,
     "gene",
     "CD44"
    ],
    [
     "T2",
     238,
     243,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences4": {
   "text": "Among the three pathways one referred to metabolism of stem cells which corresponds to the previous study that found that RMRP allows cancer cells to infinitely proliferate through interaction with TERT 27 Moreover cancer stem cell\u2010related markers such as Bmi1 and CD24 were found to be subsequently decreased after RMRP knockdown but CD44 expression remained the same ",
   "entities": [
    [
     "T1",
     335,
     339,
     "gene",
     "CD44"
    ],
    [
     "T2",
     134,
     140,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     215,
     221,
     "phenotype",
     "cancer"
    ]
   ]
  }
 },
 "PMC6610190": {
  "Sentences0": {
   "text": "The incidence of coronary artery disease CAD is rising in South Korea and although cerebral hemorrhage has declined since 2002 cerebral infarction is on the rise 3 ",
   "entities": [
    [
     "T1",
     41,
     44,
     "gene",
     "CAD"
    ],
    [
     "T2",
     33,
     40,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences1": {
   "text": "Thus aggressive diagnosis and treatment of dyslipidemia the most important risk factor for atherosclerosis are critical for lowering the incidence and mortality of CAD and cerebral infarction ",
   "entities": [
    [
     "T1",
     164,
     167,
     "gene",
     "CAD"
    ],
    [
     "T2",
     43,
     55,
     "phenotype",
     "dyslipidemia"
    ]
   ]
  },
  "Sentences2": {
   "text": "Since the development of the Framingham risk score by the Framingham Heart Study to compute the 10-year risk of CAD using seven items of information age sex total cholesterol high density lipoprotein cholesterol HDL-C  blood pressure diabetes and smoking  various CVD prediction models have been developed and a CVD prediction recommendation guideline has been formulated ",
   "entities": [
    [
     "T1",
     112,
     115,
     "gene",
     "CAD"
    ],
    [
     "T2",
     234,
     242,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences3": {
   "text": "In South Korea there are studies available that developed a stroke risk model a CAD risk model and a CVD risk assessment model using data from health check-up recipients 13 15-19 ",
   "entities": [
    [
     "T1",
     80,
     83,
     "gene",
     "CAD"
    ]
   ]
  },
  "Sentences4": {
   "text": "Very high-risk group Patients with CVD CAD peripheral artery disease ischemic stroke transient ischemic attack are classified as the very high-risk group ",
   "entities": [
    [
     "T1",
     39,
     42,
     "gene",
     "CAD"
    ],
    [
     "T2",
     43,
     68,
     "phenotype",
     "peripheral artery disease"
    ],
    [
     "T3",
     61,
     68,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences5": {
   "text": "The 2018 AACE/ACE guidelines recommend that patients with atherosclerotic CVD and 1 atherosclerotic CVD continuing to progress even after lowering LDL-C to lt 70 mg/dL  2 diabetes  3 stage 3 or 4 chronic kidney disease  4 heterozygous familial hypercholesterolemia heFH  or 5 history of premature atherosclerotic CVD men lt 55 years women lt 65 years should be classified into the extreme risk group and that the target for LDL-C should be set to lt 55 mg/dL 28 ",
   "entities": [
    [
     "T1",
     14,
     17,
     "gene",
     "ACE"
    ],
    [
     "T2",
     196,
     218,
     "phenotype",
     "chronic kidney disease"
    ],
    [
     "T3",
     171,
     179,
     "phenotype",
     "diabetes"
    ],
    [
     "T4",
     211,
     218,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences6": {
   "text": "This recommendation stems from the Improved Reduction of Outcomes Vytorin Efficacy International Trial IMPROVE-IT  which proved the superiority of combined statin and ezetimibe therapy for patients with acute coronary artery syndrome and the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk FOURIER study and the ODYSSEY OUTCOMES trial which confirmed the effects of PCSK9 inhibitors 29-31 ",
   "entities": [
    [
     "T1",
     288,
     293,
     "gene",
     "PCSK9"
    ],
    [
     "T1",
     412,
     417,
     "gene",
     "PCSK9"
    ],
    [
     "T2",
     225,
     233,
     "phenotype",
     "syndrome"
    ]
   ]
  },
  "Sentences7": {
   "text": "Hypertriglyceridemia due to alcohol consumption is associated with suppression of chylomicron degradation as a result of reduced lipoprotein lipase LPL activity ",
   "entities": [
    [
     "T1",
     148,
     151,
     "gene",
     "LPL"
    ],
    [
     "T2",
     0,
     20,
     "phenotype",
     "Hypertriglyceridemia"
    ]
   ]
  },
  "Sentences8": {
   "text": "Pharmacological therapy can be initiated according to established history of CAD peripheral artery disease and ischemic stroke and patients with atherosclerotic artery disease aortic aneurysm transient ischemic attack carotid artery disease with significant stenosis or diabetes as well as to the number of CAD risk factors smoking hypertension low HDL cholesterolemia family history of premature CAD age ",
   "entities": [
    [
     "T1",
     77,
     80,
     "gene",
     "CAD"
    ],
    [
     "T1",
     307,
     310,
     "gene",
     "CAD"
    ],
    [
     "T1",
     397,
     400,
     "gene",
     "CAD"
    ],
    [
     "T2",
     81,
     106,
     "phenotype",
     "peripheral artery disease"
    ],
    [
     "T3",
     218,
     240,
     "phenotype",
     "carotid artery disease"
    ],
    [
     "T4",
     270,
     278,
     "phenotype",
     "diabetes"
    ],
    [
     "T5",
     332,
     344,
     "phenotype",
     "hypertension"
    ],
    [
     "T6",
     99,
     106,
     "phenotype",
     "disease"
    ],
    [
     "T6",
     168,
     175,
     "phenotype",
     "disease"
    ],
    [
     "T6",
     233,
     240,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences9": {
   "text": "Very high-risk group are the patients with atherosclerotic CVD CAD peripheral artery disease ischemic stroke transient ischemic attack are classified as the very high-risk group ",
   "entities": [
    [
     "T1",
     63,
     66,
     "gene",
     "CAD"
    ],
    [
     "T2",
     67,
     92,
     "phenotype",
     "peripheral artery disease"
    ],
    [
     "T3",
     85,
     92,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences10": {
   "text": "Monoclonal antibody type PCSK9 inhibitors Indications For patients with familial hypercholesterolemia and the very high-risk group whose LDL-C levels do not reached to target LDL-C level despite statin monotherapy with maximum tolerable dose or statin and ezetimibe combination therapy PCSK9 inhibitors may be combined with statin with or without ezetimibe IIb A ",
   "entities": [
    [
     "T1",
     25,
     30,
     "gene",
     "PCSK9"
    ],
    [
     "T1",
     286,
     291,
     "gene",
     "PCSK9"
    ]
   ]
  },
  "Sentences11": {
   "text": "Two types of PCSK9 inhibitors currently available evolocumab and alirocumab lower LDL-C by 50 to 70 regardless of statin/ezetimibe therapy for hyperlipidemia 30 137 138 ",
   "entities": [
    [
     "T1",
     13,
     18,
     "gene",
     "PCSK9"
    ]
   ]
  },
  "Sentences12": {
   "text": "Cholesterol-lowering drug therapy in adult patients with chronic kidney disease Regarding cholesterol-lowering therapy for patients with chronic kidney disease the 2011 guidelines by ESC/EAS stresses that chronic kidney disease is considered a CAD risk equivalent and lowering LDL-C is the primary treatment goal for these patients 151 ",
   "entities": [
    [
     "T1",
     244,
     247,
     "gene",
     "CAD"
    ],
    [
     "T2",
     57,
     79,
     "phenotype",
     "chronic kidney disease"
    ],
    [
     "T2",
     137,
     159,
     "phenotype",
     "chronic kidney disease"
    ],
    [
     "T2",
     205,
     227,
     "phenotype",
     "chronic kidney disease"
    ],
    [
     "T3",
     72,
     79,
     "phenotype",
     "disease"
    ],
    [
     "T3",
     152,
     159,
     "phenotype",
     "disease"
    ],
    [
     "T3",
     220,
     227,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences13": {
   "text": "For patients under the age of 50 years statin or statin/ezetimibe is recommended if the patient has a history of CAD diabetes or ischemic stroke or if the 10-year risk for CAD mortality or non-fatal MI exceeds 10 ",
   "entities": [
    [
     "T1",
     113,
     116,
     "gene",
     "CAD"
    ],
    [
     "T1",
     172,
     175,
     "gene",
     "CAD"
    ],
    [
     "T2",
     117,
     125,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences14": {
   "text": "Among patients with chronic kidney disease who had a kidney transplantation the incidence of CAD is very high compared to that of the normal population at about 21 5 events/1 000 patient-year 148 ",
   "entities": [
    [
     "T1",
     93,
     96,
     "gene",
     "CAD"
    ],
    [
     "T2",
     20,
     42,
     "phenotype",
     "chronic kidney disease"
    ],
    [
     "T3",
     35,
     42,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences15": {
   "text": "Based on these studies adding ezetimibe or PCSK9 inhibitor may be considered for patients with diabetes and CVD if the target LDL-C goal is not met with maximum tolerable dose of statin ",
   "entities": [
    [
     "T1",
     43,
     48,
     "gene",
     "PCSK9"
    ],
    [
     "T2",
     95,
     103,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences16": {
   "text": "Screening of complications For examination of CAD or aortic disease it is desirable to consult to cardiologist ",
   "entities": [
    [
     "T1",
     46,
     49,
     "gene",
     "CAD"
    ],
    [
     "T2",
     60,
     67,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences17": {
   "text": "Further a systematic literature review reported that vascular calcification increases the risk for mortality CAD and cerebrovascular disease by two to four times 197 ",
   "entities": [
    [
     "T1",
     109,
     112,
     "gene",
     "CAD"
    ],
    [
     "T2",
     53,
     75,
     "phenotype",
     "vascular calcification"
    ],
    [
     "T3",
     133,
     140,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences18": {
   "text": "In a study that investigated the incidence of CVD in four racial groups the risk for CAD was about 10 times higher in the group with a calcium score of 300 or higher compared to the group without coronary artery calcification 205 ",
   "entities": [
    [
     "T1",
     85,
     88,
     "gene",
     "CAD"
    ]
   ]
  },
  "Sentences19": {
   "text": "This tool is characterized by the use of five community cohort data to increase the representativeness of the data and that the scope of target diseases was expanded to include acute MI stroke CAD mortality and stroke mortality 208 ",
   "entities": [
    [
     "T1",
     193,
     196,
     "gene",
     "CAD"
    ],
    [
     "T2",
     144,
     152,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences20": {
   "text": "There have been studies in Korea aiming to develop risk assessment models to predict stroke CAD and overall CVD and the Globorisk score also provides a risk assessment chart for Koreans 13 18 19 210 ",
   "entities": [
    [
     "T1",
     92,
     95,
     "gene",
     "CAD"
    ]
   ]
  }
 },
 "PMC6610220": {
  "Sentences0": {
   "text": "N3 Prevalence phenotype and clinical consequences of mosaicism in APC and other colorectal cancer and polyposis associated genes M Suerink1 S Aretz2 3 A Wagner4 M Nielsen1 T van Wezel5 H Morreau5 1Department of clinical genetics LUMC Leiden The Netherlands 2Institute of Human Genetics University of Bonn 53127 Bonn Germany 3Center for Hereditary Tumor Syndromes University of Bonn 53127 Bonn Germany 4Department of clinical genetics Erasmuc Medical Centre Rotterdam The Netherlands 5Department of pathology LUMC Leiden The Netherlands Correspondence M Suerink Aim APC mosaicism is identified in 25 of previously unexplained polyposis patients with gt 20 adenomas ",
   "entities": [
    [
     "T1",
     66,
     69,
     "gene",
     "APC"
    ],
    [
     "T1",
     565,
     568,
     "gene",
     "APC"
    ],
    [
     "T2",
     353,
     362,
     "phenotype",
     "Syndromes"
    ],
    [
     "T3",
     347,
     352,
     "phenotype",
     "Tumor"
    ],
    [
     "T4",
     91,
     97,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences1": {
   "text": "DNA will be isolated from the neoplasms n\u22652 and a gene panel including the following genes APC POLE/D1 MUTYH NTHL1 MSH3 MLH1 MSH2 MSH6 PMS2 SMAD4 BMPR1A ENG RNF43 STK11 TP53 BRCA1 BRCA2 PALB2 and PTEN will be run to identify APC mosaic cases as well as other mosaic causes of polyposis/colorectal cancer ",
   "entities": [
    [
     "T1",
     91,
     94,
     "gene",
     "APC"
    ],
    [
     "T1",
     225,
     228,
     "gene",
     "APC"
    ],
    [
     "T2",
     95,
     99,
     "gene",
     "POLE"
    ],
    [
     "T3",
     103,
     108,
     "gene",
     "MUTYH"
    ],
    [
     "T4",
     109,
     114,
     "gene",
     "NTHL1"
    ],
    [
     "T5",
     115,
     119,
     "gene",
     "MSH3"
    ],
    [
     "T6",
     120,
     124,
     "gene",
     "MLH1"
    ],
    [
     "T7",
     125,
     129,
     "gene",
     "MSH2"
    ],
    [
     "T8",
     130,
     134,
     "gene",
     "MSH6"
    ],
    [
     "T9",
     135,
     139,
     "gene",
     "PMS2"
    ],
    [
     "T10",
     140,
     145,
     "gene",
     "SMAD4"
    ],
    [
     "T11",
     146,
     152,
     "gene",
     "BMPR1A"
    ],
    [
     "T12",
     153,
     156,
     "gene",
     "ENG"
    ],
    [
     "T13",
     157,
     162,
     "gene",
     "RNF43"
    ],
    [
     "T14",
     163,
     168,
     "gene",
     "STK11"
    ],
    [
     "T15",
     169,
     173,
     "gene",
     "TP53"
    ],
    [
     "T16",
     180,
     185,
     "gene",
     "BRCA2"
    ],
    [
     "T17",
     186,
     191,
     "gene",
     "PALB2"
    ],
    [
     "T18",
     196,
     200,
     "gene",
     "PTEN"
    ],
    [
     "T19",
     297,
     303,
     "phenotype",
     "cancer"
    ],
    [
     "T20",
     30,
     39,
     "phenotype",
     "neoplasms"
    ]
   ]
  },
  "Sentences2": {
   "text": "N4 Breast cancer pathology and stage are better predicted by risk stratification models including mammographic density and common genetic variants D G Evans1 2 6 7 8 E Harkness2 3 4 A Brentnall5 E van Veen1 S Astley2 3 4 8 H Byers1 S Sampson2 J Southworth2 P Stavrinos2 S Howell2 6 8 A Maxwell2 3 4 8 A Howell2 6 8 W Newman1 7 8 J Cuzick5 1Division of Evolution and Genomic Sciences Faculty of Biology Medicine and Health University of Manchester Manchester UK 2Prevention Breast Cancer Unit and Nightingale Breast Screening Centre Manchester University NHS Foundation Trust South  Manchester UK 3Division of Informatics Imaging and Data Sciences School of Health Sciences Faculty of Biology Medicine and Health University of Manchester Manchester UK 4Manchester Academic Health Science Centre University of Manchester Manchester UK 5Centre for Cancer Prevention Wolfson Institute of Preventive Medicine Charterhouse Square Barts and The London Queen Mary University of London London UK 6The Christie NHS Foundation Trust Manchester UK 7Manchester Centre for Genomic Medicine Manchester University NHS Foundation Trust Central  Manchester UK 8Manchester Breast Centre Manchester Cancer Research Centre University of Manchester Manchester UK Correspondence D G Evans Aim To better stratify breast cancer risks to enable more targeted early detection/prevention strategies particularly to balance the risks/benefits of population ",
   "entities": [
    [
     "T1",
     554,
     557,
     "gene",
     "NHS"
    ],
    [
     "T1",
     1001,
     1004,
     "gene",
     "NHS"
    ],
    [
     "T1",
     1098,
     1101,
     "gene",
     "NHS"
    ],
    [
     "T2",
     10,
     16,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     480,
     486,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     845,
     851,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     1179,
     1185,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     1296,
     1302,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences3": {
   "text": "N7 Cancer risks by age and gender and survival after cancer in Path_MSH6 carriers a Prospective Lynch Syndrome Database PLSD report J Sampson1 J P Plazzer2 M Dominguez-Valentin3 4 S Nakken4 T Sepp\u00e4l\u00e45 C Engel6 S Aretz6 H K Schackert6 W Schmiegel6 N Rahner6 M von Knebel Doeberitz6 M Loffler6 E Holinski-Feder6 I Bernstein7 L Sunde7 M Jenkins8 D G Evans9 J Burn9 L Bertario10 G M Cavestro10 A Lindblom11 A Della Valle12 R H Sijmons13 W H de Vos tot Nederveen Cappel13 L Katz14 N Gluck14 K Heinimann15 C A Vaccaro16 F Lopez-Koestner17 F Balaguer18 E Hovig4 F Macrae19 G M\u00f6slein6 J P Mecklin5 G Capella18 Members of the PLSD project20 P\u00e5l M\u00f8ller4 21 1Cardiff University Cardiff UK 2Australia amp InSiGHT database 3PLSD curator  4Norwaycarriers a Prospective Lynch Syndrome 5Finlandcarriers a Prospective Lynch Syndrome 6Germany 7Denmark 8Australia 9UK 10Italy 11Sweden 12Uruguaycarriers a Prospective Lynch Syndrome 13The Netherlands 14Israel 15Switzerland 16Argentina 17Chile 18Spain 19Australia 20Interational 21PLSD PI Correspondence J Sampson Aim To determine cancer risks by age and gender and cancer survival in carriers of path_MSH6 variants ",
   "entities": [
    [
     "T1",
     68,
     72,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     102,
     110,
     "phenotype",
     "Syndrome"
    ],
    [
     "T2",
     761,
     769,
     "phenotype",
     "Syndrome"
    ],
    [
     "T2",
     807,
     815,
     "phenotype",
     "Syndrome"
    ],
    [
     "T2",
     904,
     912,
     "phenotype",
     "Syndrome"
    ],
    [
     "T3",
     3,
     9,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     53,
     59,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     1061,
     1067,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     1096,
     1102,
     "phenotype",
     "Cancer"
    ]
   ]
  },
  "Sentences4": {
   "text": "Results Preliminary analysis suggest that for MLH1 mutations the risk of colorectal cancer to age 70 is highest for carriers in Australasia 68 males 55 females and North America 61 males 48 females and lowest for carriers in South America 12 males 10 females and East Asia 20 males 14 females ",
   "entities": [
    [
     "T1",
     46,
     50,
     "gene",
     "MLH1"
    ],
    [
     "T2",
     84,
     90,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences5": {
   "text": "N10 Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation a new genotype-phenotype correlation I Frayling1 V F Mautner2 R van Minkelen3 R A Kallionp\u00e4\u00e44 S Akta\u015f5 D Baralle6 S Ben-Shachar7 A Callaway8 H Cox1 D M Eccles6 S Ferkal9 H LaDuca10 C L\u00e1zaro11 M T Rogers1 A J Stuenkel10 P Summerour10 A Varan12 Y S Yap13 J Peltonen4 D G Evans14 15 P Wolkenstein16 M Upadhyaya1 1Institute of Cancer amp Genetics Cardiff University Cardiff UK 2Neurofibromatose\u2013Ambulanz\u2013Hamburg Geb\u00e4ude O 54 im UKE Martinistra\u00dfe 52 20246 Hamburg Germany 3Klinische Genetica Erasmus MC Rotterdam Netherlands 4Department of Cell Biology and Anatomy University of Turku Turku Finland 5Dokuz Eyl\u00fcl \u00dcniversitesi Izmir Turkey 6Faculty of Medicine Southampton University Southampton UK 7The Genetic Institute Tel-Aviv Sourasky Medical Center Tel-Aviv Israel 8Wessex Regional Genetics Laboratory Salisbury NHS Foundation Trust Salisbury UK 9Service de Sant\u00e9 Publique H\u00f4pital Henri Mondor Cr\u00e9teil France\u00a0 10Ambry Genetics Aliso Viejo California USA 11Institut Catal\u00e0 d Oncologia L Hospitalet Spain 12Hacettepe \u00dcniversitesi Kanser Enstit\u00fcs\u00fc Turkey 13Department of Medical Oncology National Cancer Centre Singapore 14Manchester Centre for Genomic Medicine Central Manchester University Hospitals NHS Foundation Trust Manchester UK 15Manchester Centre for Genomic Medicine University of Manchester Manchester UK 16Immunity Transplantation Infections H\u00f4pital Henri Mondor APHP University Paris Est Cr\u00e9teil Cr\u00e9teil France Correspondence I Frayling Aim NF1 predisposes to breast cancer BC  but no genotype-phenotype correlations have been described ",
   "entities": [
    [
     "T1",
     80,
     83,
     "gene",
     "NF1"
    ],
    [
     "T1",
     1549,
     1552,
     "gene",
     "NF1"
    ],
    [
     "T2",
     909,
     912,
     "gene",
     "NHS"
    ],
    [
     "T2",
     1296,
     1299,
     "gene",
     "NHS"
    ],
    [
     "T3",
     1438,
     1448,
     "phenotype",
     "Infections"
    ],
    [
     "T4",
     11,
     17,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     421,
     427,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     1191,
     1197,
     "phenotype",
     "cancer"
    ],
    [
     "T4",
     1575,
     1581,
     "phenotype",
     "cancer"
    ],
    [
     "T5",
     1173,
     1181,
     "phenotype",
     "Oncology"
    ]
   ]
  },
  "Sentences6": {
   "text": "N11 A dominantly inherited 5 UTR variant causing methylation associated silencing of BRCA1 as a novel cause of breast and ovarian cancer D G Evans1 2 3 4 8 E M van Veen1 5 8 H J Byers1 5 A J Wallace5 J M Ellingford1 5 G Beaman1 5 J Santoyo-Lopez6 T J Aitman6 D M Eccles7 F I Lalloo5 M J Smith1 5 8 W G Newman1 4 5 8 1Division of Evolution and Genomic Sciences School of Biological Sciences Faculty of Biology Medicine and Health University of Manchester Manchester Academic Health Science Centre Manchester UK 2Prevention Breast Cancer Centre and Nightingale Breast Screening Centre University Hospital of South Manchester Manchester UK 3The Christie NHS Foundation Trust Manchester UK 4Manchester Breast Centre Manchester Cancer Research Centre University of Manchester Manchester UK 5Manchester Centre for Genomic Medicine St Mary s Hospital Manchester University NHS Foundation Trust Manchester Academic Health Science Centre Manchester UK 6Centre for Genomic and Experimental Medicine and Edinburgh Genomics University of Edinburgh Edinburgh UK 7Cancer Sciences Academic Unit and Southampton Clinical Trials Unit Faculty of Medicine University of Southampton and University Hospital Southampton Foundation Trust Southampton UK 8Department of Genomic Medicine St Mary s Hospital Manchester Universities NHS Foundation Trust Manchester UK Correspondence D G Evans Aim Pathogenic variants in BRCA1/BRCA2 are identified in 20 of families with multiple individuals with early-onset breast/ovarian cancer ",
   "entities": [
    [
     "T1",
     651,
     654,
     "gene",
     "NHS"
    ],
    [
     "T1",
     866,
     869,
     "gene",
     "NHS"
    ],
    [
     "T1",
     1306,
     1309,
     "gene",
     "NHS"
    ],
    [
     "T2",
     1399,
     1404,
     "gene",
     "BRCA2"
    ],
    [
     "T3",
     130,
     136,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     529,
     535,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     723,
     729,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     1496,
     1502,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences7": {
   "text": "1 Munich Germany 4MGZ\u2014Medizinisch Genetisches Zentrum Munich Germany 5Department of Pathology Oslo University Hospital Norwegian Radium Hospital Oslo Norway 6University of Oslo Faculty of Medicine Institute of Clinical Medicine N-0316 Oslo Norway 7Department of Human Medicine Universit\u00e4t Witten/Herdecke Germany 8Department of Medical Genetics and Tumor Biology Oslo University Hospital Norway Correspondence M Dominguez-Valentin Aim To study the potential contribution of genes other than BRCA1/2 PTEN TP53 and MMR to the biological and clinical characteristics of early-onset and familial cancers in Norwegian families ",
   "entities": [
    [
     "T1",
     499,
     503,
     "gene",
     "PTEN"
    ],
    [
     "T2",
     504,
     508,
     "gene",
     "TP53"
    ],
    [
     "T3",
     349,
     354,
     "phenotype",
     "Tumor"
    ],
    [
     "T4",
     592,
     599,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences8": {
   "text": "N14 Identification and characterization of an alu element insertion in BRCA2 in a Spanish family associated to prostate cancer V Barca-Tierno1 M Mor\u00edn1 L Santos1 C Garc\u00eda-Hoz3 L Fuente-Garc\u00eda1 P Marcos-Cava1 M Salazar2 C Guill\u00e9n-Ponce2 M A Moreno-Pelayo1 1Genetics Service Ramon and Cajal Hospital-IRYCIS-CIBERER Raregenomics 2Oncology Service Ramon and Cajal Hospital 3Immunology Service Ramon and Cajal Hospital Correspondence V Barca-Tierno Aim Pathogenic Alu element insertions are rarely reported because this type of insertions are undetectable with the classical screening methods ",
   "entities": [
    [
     "T1",
     71,
     76,
     "gene",
     "BRCA2"
    ],
    [
     "T2",
     120,
     126,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     111,
     126,
     "phenotype",
     "prostate cancer"
    ]
   ]
  },
  "Sentences9": {
   "text": "Results We have identified and characterized a heterozygous pathogenic variant c 5007_5008ins174 located at the exon 11 of the BRCA2 gene in a patient with prostate cancer ",
   "entities": [
    [
     "T1",
     127,
     132,
     "gene",
     "BRCA2"
    ],
    [
     "T2",
     165,
     171,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     156,
     171,
     "phenotype",
     "prostate cancer"
    ]
   ]
  },
  "Sentences10": {
   "text": "This insertion could generate a framesift resulting in the abrogation of BRCA2 protein function that has been associated with oxidative stress involved in carcinogenesis ",
   "entities": [
    [
     "T1",
     73,
     78,
     "gene",
     "BRCA2"
    ],
    [
     "T2",
     126,
     142,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences11": {
   "text": "N19 Colorectal cancer risk is not increased in NTHL1 heterozygous mutation carriers A Ragunathan1 3 M Clendenning1 K Mahmood1 B J Pope1 D J Park1 H Jayasekara1 J E Joo1 C Rosty2 T Green1 S Preston1 N O Callaghan1 F A Macrae3 I M Winship3 A K Win1 J L Hopper1 P Newcomb4 S Gallinger5 M A Jenkins1 D D Buchanan1 1University of Melbourne Melbourne Australia 2University of Queensland Queensland Australia 3The Royal Melbourne Hospital Melbourne Australia 4Fred Hutchinson Cancer Research Center Washington USA 5Lunenfeld Tanenbaum Research Institute Mount Sinai Hospital New York USA Correspondence A Ragunathan Aim Bilallelic loss-of-function germline mutations in the base excision repair gene NTHL1 result in an increased risk of colorectal polyps and different cancer types resulting in the inclusion of this gene on many multi-gene cancer predisposition panels ",
   "entities": [
    [
     "T1",
     47,
     52,
     "gene",
     "NTHL1"
    ],
    [
     "T1",
     693,
     698,
     "gene",
     "NTHL1"
    ],
    [
     "T2",
     15,
     21,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     469,
     475,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     762,
     768,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     834,
     840,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences12": {
   "text": "However the impact of heterozygous germline NTHL1 mutations on colorectal cancer CRC risk is unclear ",
   "entities": [
    [
     "T1",
     44,
     49,
     "gene",
     "NTHL1"
    ],
    [
     "T2",
     74,
     80,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences13": {
   "text": "Method 1953 CRC-affected individuals and 1207 controls from the Colon Cancer Family Registry Cohort were screened for coding single nucleotide and short indels variants in NTHL1 using a targeted multiplex PCR-based sequencing approach Hi-PLEX ",
   "entities": [
    [
     "T1",
     172,
     177,
     "gene",
     "NTHL1"
    ],
    [
     "T2",
     64,
     76,
     "phenotype",
     "Colon Cancer"
    ],
    [
     "T3",
     70,
     76,
     "phenotype",
     "Cancer"
    ]
   ]
  },
  "Sentences14": {
   "text": "A suspected case of metastatic breast cancer in the family was confirmed in 65yo female bearing the in 12/2017 and a suspected case od CRC was identified in 67yo male bearing the MSH6 variant ",
   "entities": [
    [
     "T1",
     179,
     183,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     38,
     44,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences15": {
   "text": "Results Pilot work has focused upon BRCA1 and BRCA2 genes we are now commencing collection of colorectal cancer predisposition gene data ",
   "entities": [
    [
     "T1",
     46,
     51,
     "gene",
     "BRCA2"
    ],
    [
     "T2",
     105,
     111,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences16": {
   "text": "N28 Awareness of Lynch like syndrome within clinical genetics \u2013 results from a UK survey D Georgiou1 V Kiesel1 A F Brady1 K Monahan2 1North West Thames Regional Genetics Service UK 2Chelsea and Westminster Hospitals NHS Foundation Trust UK Correspondence D Georgiou Aim UK NICE guidelines 2017 recommend screening of all new colorectal cancers with either immunohistochemistry IHC or Microsatellite instability MSI testing ",
   "entities": [
    [
     "T1",
     216,
     219,
     "gene",
     "NHS"
    ],
    [
     "T2",
     28,
     36,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     336,
     343,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences17": {
   "text": "B2M mutations were related to a higher density of activated T cells infiltrating the tumor and to a lower frequency of regulatory T cells in the tumor environment ",
   "entities": [
    [
     "T1",
     0,
     3,
     "gene",
     "B2M"
    ],
    [
     "T2",
     85,
     90,
     "phenotype",
     "tumor"
    ],
    [
     "T2",
     145,
     150,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences18": {
   "text": "N33 Validation and updating of Path_MLH1 in cases with class 4 And 5 genetic variants a Prospective Lynch Syndrome Database PLSD Report T Sepp\u00e4l\u00e41 J P Plazzer2 M Dominguez-Valentin3 S Nakken4 C Engel5 S Aretz5 M A Jenkins6 L Sunde7 I Bernstein7 F Balaguer8 A Lindblom9 D G Evans10 L Bertario11 J Burn12 E Holinski-Feder13 F Lopez-Koestner14 A Della Valle15 K Heinimann16 C A Vaccaro17 W H de Vos tot Nederveen Cappel18 R H Sijmons19 N Gluck20 L Katz20 G M Cavestro11 E Hovig4 F Macrae21 G M\u00f6slein22 J Sampson23 G Capella8 J P Mecklin1 P M\u00f8ller24 1Finland 2InSiGHT database Australia 3PLSD curator Norway 4Norway 5German HNPCC consortium 6Colon Cancer Family Registry Australia USA Canada 7Denmark 8Spain 9Sweden 10Manchester United Kingdom 11Italy 12Newcastle United Kingdom 13M\u00fcnich Germany 14Chile 15Uruguay 16Switzerland 17Argentina 18Leiden Holland 19Groningen Holland 20Israel 21Melbourne Australia 22Germany 23Cardiff United Kingdom 24PLSD PI OUS Norway Witten-Herdecke Germany Correspondence T Sepp\u00e4l\u00e4 Aim Determine average risks for and survival after cancer in path_MLH1 carriers ",
   "entities": [
    [
     "T1",
     36,
     40,
     "gene",
     "MLH1"
    ],
    [
     "T2",
     106,
     114,
     "phenotype",
     "Syndrome"
    ],
    [
     "T3",
     644,
     650,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     1060,
     1066,
     "phenotype",
     "Cancer"
    ]
   ]
  },
  "Sentences19": {
   "text": "Conclusion PLSD reports average risks for and survival after cancer in path_MLH1 carriers of variants classified as clinically actionable in the InSiGHT database ",
   "entities": [
    [
     "T1",
     76,
     80,
     "gene",
     "MLH1"
    ],
    [
     "T2",
     61,
     67,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences20": {
   "text": "N37 Cancer incidences by age in Path_PMS2 carriers a report from the Prospective Lynch Syndrome Database PLSD  M Dominguez-Valentin1 S W Ten Broeke2 J P Plazzer3 T Sepp\u00e4l\u00e44 S Nakken1 M A Jenkins5 R H Sijmons6 G Capella7 C Engel8 S Aretz9 L Sunde10 I Bernstein11 D G Evans12 J Burn13 M Greenblatt14 F Balaguer15 M Grazia Tibiletti16 E Holinski-Feder17 H K Schackert18 W Schmiegel19 N Rahner20 M L\u00f6ffler8 F Macrae3 J Sampson21 H Thomas22 A Lindblom23 W H de Vos tot Nederveen Cappel24 F Lopez-Koestner25 A Della Valle26 E Hovig1 G M\u00f6slein27 J P Mecklin28 M Nielsen2 P M\u00f8ller1 29 30 1Oslo University Hospital Oslo Norway 2Leiden University Medical Center The Netherlands 3Melbourne University Melbourne Australia 4University of Helsinki Helsinki Finland 5Colon Cancer Family Registry Australia 6University Medical Center Groningen Groningen The Netherlands 7L Hospitalet de Llobregat Barcelona Spain 8University of Leipzig Leipzig Germany 9University of Bonn Bonn Germany 10Aarhus University Hospital Denmark 11Aalborg University Hospital Aalborg Denmark 12University of Manchester London UK 13Newcastle University Newcastle upon Tyne UK 14University of Vermont College of Medicine USA 15Universitat de Barcelona Barcelona Spain 16Universit\u00e0 dell Insubria Varese Italy 17Center of Medical Genetics Munich Germany 18University of Dresden Germany 19University of Bochum Germany 20University of D\u00fcsseldorf Germany 21Cardiff University School of Medicine Heath Park UK 22Imperial College London London UK 23Karolinska Institutet Stockholm Sweden 24Isala Clinics Zwolle The Netherlands 25Clinica Las Condes Chile 26Hospital de las Fuerzas Armadas Uruguay 27University Witten-Herdecke Wuppertal Germany 28University of Jyv\u00e4skyl\u00e4 Jyv\u00e4skyl\u00e4 Finland 29PLSD PI 30Witten-Herdecke Germany Correspondence M Dominguez-Valentin Aim Determine average risks for cancer in path_PMS2 carriers ",
   "entities": [
    [
     "T1",
     37,
     41,
     "gene",
     "PMS2"
    ],
    [
     "T2",
     87,
     95,
     "phenotype",
     "Syndrome"
    ],
    [
     "T3",
     4,
     10,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     758,
     764,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     1842,
     1848,
     "phenotype",
     "Cancer"
    ]
   ]
  },
  "Sentences21": {
   "text": "Method Prospectively observed cancers in carriers of PMS2 variants classified as pathogenic class 4/5 in the InSiGHT database ",
   "entities": [
    [
     "T1",
     53,
     57,
     "gene",
     "PMS2"
    ],
    [
     "T2",
     30,
     37,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences22": {
   "text": "The patients examined were mostly selected from cancer kindreds and the late onset cancers might not necessarily have been caused by the path_PMS2 variants ",
   "entities": [
    [
     "T1",
     142,
     146,
     "gene",
     "PMS2"
    ],
    [
     "T2",
     48,
     54,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences23": {
   "text": "Erasmus MC University Medical Center Rotterdam The Netherlands 2Department of Gastroenterology and Hepatology Erasmus MC University Medical Center Rotterdam The Netherlands Correspondence A Wagner Aim To assess the yield of Lynch syndrome LS surveillance for MLH1 MSH2 MSH6 and PMS2 mutation carriers ",
   "entities": [
    [
     "T1",
     259,
     263,
     "gene",
     "MLH1"
    ],
    [
     "T2",
     264,
     268,
     "gene",
     "MSH2"
    ],
    [
     "T3",
     269,
     273,
     "gene",
     "MSH6"
    ],
    [
     "T4",
     278,
     282,
     "gene",
     "PMS2"
    ],
    [
     "T5",
     230,
     238,
     "phenotype",
     "syndrome"
    ]
   ]
  },
  "Sentences24": {
   "text": "In MSH6 mutation carriers advanced neoplasia advanced adenoma or colorectal carcinoma was found after a longer follow-up time than in the other mutation carrier groups ",
   "entities": [
    [
     "T1",
     3,
     7,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     35,
     44,
     "phenotype",
     "neoplasia"
    ],
    [
     "T3",
     76,
     85,
     "phenotype",
     "carcinoma"
    ]
   ]
  },
  "Sentences25": {
   "text": "Conclusion Since no CRC was found during follow-up in MSH6 mutation carriers and advanced neoplasia was found in shorter follow-up time in MLH1 and MSH2 mutation carriers the colonoscopy interval in MSH6 mutation carriers might be less stringent than for MLH1 and MSH2 mutation carriers ",
   "entities": [
    [
     "T1",
     54,
     58,
     "gene",
     "MSH6"
    ],
    [
     "T1",
     199,
     203,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     139,
     143,
     "gene",
     "MLH1"
    ],
    [
     "T2",
     255,
     259,
     "gene",
     "MLH1"
    ],
    [
     "T3",
     148,
     152,
     "gene",
     "MSH2"
    ],
    [
     "T3",
     264,
     268,
     "gene",
     "MSH2"
    ],
    [
     "T4",
     90,
     99,
     "phenotype",
     "neoplasia"
    ]
   ]
  },
  "Sentences26": {
   "text": "N40 Validated and updated risks for and survival after cancer by age and gender in Path_MSH2 carriers a Prospective Lynch Syndrome Database PLSD Report P M\u00f8ller1 J P Plazzer2 T Sepp\u00e4l\u00e43 M Dominguez-Valentin4 S Nakken5 C Engel6 S Aretz7 H K Schackert8 W Schmiegel9 N Rahner10 M von Knebel Doeberitz11 M L\u00f6ffler12 I Bernstein13 L Sunde13 M Jenkins14 D G Evans15 F Balaguer16 E Holinski-Feder17 J Burn18 L Bertario19 A Lindblom20 A Della Valle21 R H Sijmons22 L Katz23 W H de Vos tot Nederveen Cappel24 K Heinimann25 N Gluck23 C A Vaccaro26 F Lopez-Koestner27 G Martina Cavestro19 E Hovig5 F Macrae28 G M\u00f6slein29 J P Mecklin3 J Sampson30 G Capella16 1PI to the PLSD Oslo University Hospital Norway and University of Witten-Herdecke Germany 2InSiGHT database 3Finland 4PLSD curator Norway 5Norway 6German HNPCC consortium 7University of Bonn 8University of Dresden 9University of Bochum 10University of D\u00fcsseldorf 11University of Heidelberg 12University of Leipzig 13Danish HNPCC Registry 14Colon Cancer Family Registry Australia USA Canada 15Manchester UK 16Spain 17M\u00fcnich Germany 18Newcastle UK 19Italy 20Sweden 21Uruguay 22Groningen Holland 23Israel 24Leiden Holland 25Switzerland 26Argentina 27Chile 28Melbourne Australia 29Germany 30Cardiff UK Correspondence P M\u00f8ller Aim Determine average risks for and survival after cancer in path_MSH2 carriers ",
   "entities": [
    [
     "T1",
     88,
     92,
     "gene",
     "MSH2"
    ],
    [
     "T2",
     122,
     130,
     "phenotype",
     "Syndrome"
    ],
    [
     "T3",
     55,
     61,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     993,
     999,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     1320,
     1326,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences27": {
   "text": "N48 Molecular tumor testing in Lynch-like patients reveals de novo mosaic DNA mismatch repair gene pathogenic variants transmitted to offspring E Guillerm1 H Delhomelle2 M Warcoin1 A Palmyre1 M Svrcek2 A Bardier Dupas1 I Sourrouille2 N Janin3 M Eyries1 V Cusin1 F Soubrier1 F Coulet1 C Colas4 1H\u00f4pital Universitaire Piti\u00e9 Salp\u00eatri\u00e8re Assistance Publique-H\u00f4pitaux de Paris  Sorbone University Paris France 2H\u00f4pital Universitaire Saint Antoine Assistance Publique-H\u00f4pitaux de Paris  Sorbone University Paris France\u00a0 3Cliniques Universitaires Saint-Luc Brussels Belgium\u00a0 4Curie Institute Paris France Correspondence C Colas Aim Lynch-like syndrome LLS patients have tumors with Microsatellite Instability but no germline variant in Mismatch Repair genes MMR or somatic methylation of the MLH1 promoter ",
   "entities": [
    [
     "T1",
     785,
     789,
     "gene",
     "MLH1"
    ],
    [
     "T2",
     636,
     644,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     14,
     19,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences28": {
   "text": "N50 Age-related efficiency of BRAF V600E mutational testing for the exclusion of Lynch syndrome in MSI colorectal cancers H Bl\u00e4ker1 A Ahadova2 J Chang-Claude3 A Arnold4 M von Knebel Doeberitz2 H Brenner3 M Hoffmeister3 M Kloor2 1Institute of Pathology Charite Berlin Germany 2University Hospital Heidelberg Germany 3German Cancer Research Center Germany 4Charite Berlin Germany Correspondence A Ahadova Aim For distinguishing Lynch syndrome patients from sporadic microsatellite unstable MSI patients BRAF V600E testing has become one of the most important tools ",
   "entities": [
    [
     "T1",
     30,
     34,
     "gene",
     "BRAF"
    ],
    [
     "T1",
     501,
     505,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     87,
     95,
     "phenotype",
     "syndrome"
    ],
    [
     "T2",
     432,
     440,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     114,
     121,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences29": {
   "text": "In order to analyze the discriminatory power of BRAF mutations in different age groups we looked at the age distribution of BRAF mutations in MSI colorectal cancers ",
   "entities": [
    [
     "T1",
     48,
     52,
     "gene",
     "BRAF"
    ],
    [
     "T1",
     124,
     128,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     157,
     164,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences30": {
   "text": "Method Age at diagnosis and BRAF mutation status were retrieved for unselected series of MSI colorectal cancers n 151 from publicly available databases DFCI and the DACHS cohort ",
   "entities": [
    [
     "T1",
     28,
     32,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     104,
     111,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences31": {
   "text": "Results The prevalence of BRAF V600E mutations in MSI cancers strongly increased with age at diagnosis with 87 of BRAF mutations occurring after the age of 65 ",
   "entities": [
    [
     "T1",
     26,
     30,
     "gene",
     "BRAF"
    ],
    [
     "T1",
     114,
     118,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     54,
     61,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences32": {
   "text": "Conclusion Our data demonstrate that BRAF mutation testing to exclude Lynch syndrome has very limited value in patients younger than 50 as the likelihood of detecting BRAF mutation in a patient under 50 is close to 0 ",
   "entities": [
    [
     "T1",
     37,
     41,
     "gene",
     "BRAF"
    ],
    [
     "T1",
     167,
     171,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     76,
     84,
     "phenotype",
     "syndrome"
    ]
   ]
  },
  "Sentences33": {
   "text": "Reports of BRAF mutations in 1-2 of cancers from proven Lynch syndrome mutation carriers call into question the role of BRAF mutations as a bona-fide exclusion marker for Lynch syndrome ",
   "entities": [
    [
     "T1",
     11,
     15,
     "gene",
     "BRAF"
    ],
    [
     "T1",
     120,
     124,
     "gene",
     "BRAF"
    ],
    [
     "T2",
     62,
     70,
     "phenotype",
     "syndrome"
    ],
    [
     "T2",
     177,
     185,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     36,
     43,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences34": {
   "text": "Mutational signatures of MMR deficiency were reflected in canonical CRC gene mutations demonstrating that 100 of KRAS and more than 60 of APC mutations likely occurred after the onset of MMR deficiency ",
   "entities": [
    [
     "T1",
     113,
     117,
     "gene",
     "KRAS"
    ],
    [
     "T2",
     138,
     141,
     "gene",
     "APC"
    ],
    [
     "T3",
     25,
     39,
     "phenotype",
     "MMR deficiency"
    ],
    [
     "T3",
     187,
     201,
     "phenotype",
     "MMR deficiency"
    ],
    [
     "T4",
     29,
     39,
     "phenotype",
     "deficiency"
    ],
    [
     "T4",
     191,
     201,
     "phenotype",
     "deficiency"
    ]
   ]
  },
  "Sentences35": {
   "text": "These tumors showed a distinct molecular pattern enriched for TP53 and CTNNB1 mutations ",
   "entities": [
    [
     "T1",
     62,
     66,
     "gene",
     "TP53"
    ],
    [
     "T2",
     71,
     77,
     "gene",
     "CTNNB1"
    ],
    [
     "T3",
     6,
     12,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences36": {
   "text": "N53 Discordant IHC MMR staining and MSI results in tumors of MSH6 mutation carriers A S van der Werf \u2013 t Lam1 M S Kan1 M Suerink1 L P van Hest2 H J P Gille2 A Wagner3 C Tops1 T van Wezel4 H Morreau4 S ten Broeke1 M Nielsen1 1Department of Clinical Genetics Leiden University Medical Centre The Netherlands 2Department of Clinical Genetics VU Medical Center Amsterdam The Netherlands 3Department of Clinical Genetics Erasmus Medical Centre Rotterdam The Netherlands 4Department of Pathology Leiden University Medical Centre The Netherland Correspondence M Suerink Aim Diagnosing Lynch Syndrome caused by a MSH6 mutation can be challenging due to the relatively frequent occurrence of discordant immunohistochemistry staining i e MSH6 positive staining and microsatellite stable phenotype ",
   "entities": [
    [
     "T1",
     61,
     65,
     "gene",
     "MSH6"
    ],
    [
     "T1",
     605,
     609,
     "gene",
     "MSH6"
    ],
    [
     "T1",
     728,
     732,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     584,
     592,
     "phenotype",
     "Syndrome"
    ],
    [
     "T3",
     51,
     57,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences37": {
   "text": "The aim of this study is to describe to what extent discordant phenotypes occur in colorectal and endometrial carcinomas CRC/EC in MSH6 families ",
   "entities": [
    [
     "T1",
     131,
     135,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     110,
     120,
     "phenotype",
     "carcinomas"
    ]
   ]
  },
  "Sentences38": {
   "text": "Method Data were collected from 192 MSH6 families with a confirmed segregating pathogenic germline variant ascertained from Dutch family cancer clinics ",
   "entities": [
    [
     "T1",
     36,
     40,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     137,
     143,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences39": {
   "text": "Of the tested tumors discordant staining for MSH6 was reported in 10 out of 68 CRCs 14 7  and 3 out of 26 ECs 11 5  ",
   "entities": [
    [
     "T1",
     45,
     49,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     14,
     20,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences40": {
   "text": "MSH6 germline or tumor DNA analysis - preferably as part of a larger gene panel - should therefore be considered especially in patients fulfilling the Bethesda criteria ",
   "entities": [
    [
     "T1",
     0,
     4,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     17,
     22,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences41": {
   "text": "Patients were included when CRC tumors showed immunochemical loss of MSH2 MSH6 PMS2 or loss of MLH1 with BRAF-WT and/or no MLH1 methylation and absence of pathogenic mutation in these genes ",
   "entities": [
    [
     "T1",
     69,
     73,
     "gene",
     "MSH2"
    ],
    [
     "T2",
     74,
     78,
     "gene",
     "MSH6"
    ],
    [
     "T3",
     79,
     83,
     "gene",
     "PMS2"
    ],
    [
     "T4",
     95,
     99,
     "gene",
     "MLH1"
    ],
    [
     "T4",
     123,
     127,
     "gene",
     "MLH1"
    ],
    [
     "T5",
     32,
     38,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences42": {
   "text": "Conclusion Histopathologic features including loss of MSH 2 / MSH6 protein expression on immunohistochemistry in both the primary tumor as well as the metastatic lesions confirms the presence of metastatic seeding ",
   "entities": [
    [
     "T1",
     62,
     66,
     "gene",
     "MSH6"
    ],
    [
     "T2",
     130,
     135,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences43": {
   "text": "Method We estimated colorectal cancer risk for MSH2 c 942 3A gt T variant using 234 families from the International Mismatch Repair Consortium ",
   "entities": [
    [
     "T1",
     47,
     51,
     "gene",
     "MSH2"
    ],
    [
     "T2",
     31,
     37,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences44": {
   "text": "M Daly1 J P Plazzer2 3 F Macrae2 3 1Melbourne Medical School University of Melbourne Melbourne Victoria Australia 2Familial Cancer Centre Royal Melbourne Hospital Melbourne Victoria Australia 3Department of Colorectal Medicine and Genetics The Royal Melbourne Hospital Melbourne Victoria Australia Correspondence F Macrae Aim We aimed to evaluate the frequency of conflicts in interpretation of pathogenicity for gene variants in the mismatch repair genes MLH1 MSH2 MSH6 and PMS2 between InSiGHT s Variant Interpretation Committee VIC and those provided by submissions from primary sources to ClinVar ",
   "entities": [
    [
     "T1",
     456,
     460,
     "gene",
     "MLH1"
    ],
    [
     "T2",
     461,
     465,
     "gene",
     "MSH2"
    ],
    [
     "T3",
     466,
     470,
     "gene",
     "MSH6"
    ],
    [
     "T4",
     475,
     479,
     "gene",
     "PMS2"
    ],
    [
     "T5",
     124,
     130,
     "phenotype",
     "Cancer"
    ]
   ]
  },
  "Sentences45": {
   "text": "N72 CSTF2T and ACTB discern sporadic from FAP-associated colon carcinomas at various stages of carcinogenesis on the proteomic level T Gemoll1 A Masche1 U J Roblick1 F Bader1 A Unger1 S Becker2 G M\u00f6slein3 U Hellmann4 H J\u00f6rnvall5 H P Bruch1 G Auer2 J K Habermann1 1Department of Surgery University Hospital Schleswig-Holstein Campus L\u00fcbeck Germany 2Karolinska Biomic Center Karolinska Institutet Stockholm Sweden 3Department of Surgery St Josefs-Hospital Bochum Linden Bochum Germany 4Ludwig Institute of Cancer Research Uppsala Sweden 5Department of Medical Biochemistry and Biophysics Karolinska Institutet Stockholm Sweden Correspondence T Gemoll Aim Familial adenomatous polyposis FAP is an autosomal dominant inherited disease with a germline mutation of the APC gene ",
   "entities": [
    [
     "T1",
     4,
     10,
     "gene",
     "CSTF2T"
    ],
    [
     "T2",
     15,
     19,
     "gene",
     "ACTB"
    ],
    [
     "T3",
     42,
     45,
     "gene",
     "FAP"
    ],
    [
     "T3",
     684,
     687,
     "gene",
     "FAP"
    ],
    [
     "T4",
     763,
     766,
     "gene",
     "APC"
    ],
    [
     "T5",
     504,
     510,
     "phenotype",
     "Cancer"
    ],
    [
     "T6",
     63,
     73,
     "phenotype",
     "carcinomas"
    ],
    [
     "T7",
     723,
     730,
     "phenotype",
     "disease"
    ],
    [
     "T8",
     713,
     730,
     "phenotype",
     "inherited disease"
    ]
   ]
  },
  "Sentences46": {
   "text": "Method Protein profiling by 2-D gel electrophoresis was performed on samples obtained from 15 different patients FAP n 8 sporadic colorectal cancer n 7 ",
   "entities": [
    [
     "T1",
     113,
     116,
     "gene",
     "FAP"
    ],
    [
     "T2",
     141,
     147,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences47": {
   "text": "Comparing three FAP carcinomas with seven sporadic colorectal carcinomas yielded 66 proteins with absence/ presence expression pattern ",
   "entities": [
    [
     "T1",
     16,
     19,
     "gene",
     "FAP"
    ],
    [
     "T2",
     20,
     30,
     "phenotype",
     "carcinomas"
    ],
    [
     "T2",
     62,
     72,
     "phenotype",
     "carcinomas"
    ]
   ]
  },
  "Sentences48": {
   "text": "Conclusion The data obtained demonstrate specific differences of FAP and sporadic colorectal disease on the protein expression level and could help to identify patients with FAP disease already in macroscopically normal colorectal mucosa ",
   "entities": [
    [
     "T1",
     65,
     68,
     "gene",
     "FAP"
    ],
    [
     "T1",
     174,
     177,
     "gene",
     "FAP"
    ],
    [
     "T2",
     93,
     100,
     "phenotype",
     "disease"
    ],
    [
     "T2",
     178,
     185,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences49": {
   "text": "Sporadic MSI-high cancers were defined as tumors with loss of MLH1/PMS2 amp BRAF V600E mutated ",
   "entities": [
    [
     "T1",
     62,
     66,
     "gene",
     "MLH1"
    ],
    [
     "T2",
     67,
     71,
     "gene",
     "PMS2"
    ],
    [
     "T3",
     76,
     80,
     "gene",
     "BRAF"
    ],
    [
     "T4",
     42,
     48,
     "phenotype",
     "tumors"
    ],
    [
     "T5",
     18,
     25,
     "phenotype",
     "cancers"
    ]
   ]
  },
  "Sentences50": {
   "text": "With the increasing grade there was significant decrease of CD4 and CD68 cells and a clear decrease of CD8 cells at the edge of significance of infiltration of the tumor tissue ",
   "entities": [
    [
     "T1",
     60,
     63,
     "gene",
     "CD4"
    ],
    [
     "T2",
     68,
     72,
     "gene",
     "CD68"
    ],
    [
     "T3",
     164,
     169,
     "phenotype",
     "tumor"
    ]
   ]
  },
  "Sentences51": {
   "text": "of Gastroenterology Prince Charles Hospital Merthyr Tydfil UK 14Clinical Cancer Genetics Program UT MD Anderson Cancer Center USA 15Hopital Saint-Antoine AP-HP Universit\u00e9 Pierre et Marie Curie Paris France\u00a0 16Unit of Hereditary Digestive Tract Tumors Department of Surgery Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy 17Digestive Department Edouard Herriot Hospital Lyon France 18Department of Clinical Cancer Prevention UT MD Anderson Cancer Center USA Correspondence L E Thomas Aim Duodenal polyposis and cancer represent significant disease manifestations in patients with FAP and MAP ",
   "entities": [
    [
     "T1",
     590,
     593,
     "gene",
     "FAP"
    ],
    [
     "T2",
     244,
     250,
     "phenotype",
     "Tumors"
    ],
    [
     "T3",
     73,
     79,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     112,
     118,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     417,
     423,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     450,
     456,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     521,
     527,
     "phenotype",
     "Cancer"
    ],
    [
     "T4",
     498,
     516,
     "phenotype",
     "Duodenal polyposis"
    ],
    [
     "T5",
     550,
     557,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences52": {
   "text": "This study aims to determine the extent and incidence of duodenal disease in patients with MAP to establish whether upper GI surveillance recommendations developed for patients with FAP are also appropriate for MAP ",
   "entities": [
    [
     "T1",
     182,
     185,
     "gene",
     "FAP"
    ],
    [
     "T2",
     66,
     73,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences53": {
   "text": "N81 Genomic and transcriptomic profiling of duodenal adenomas in Familial Adenomatous FAP and MUTYH-Associated Polyposis MAP  E Meuser1 K Chang2 M Mort1 J J Hurley3 K Ashelford1 M Naven1 N Hawkes3 E Short1 4 5 H Jundi1 P Georgiades1 M W Taggart6 L Reyes-Uribe2 P M Lynch7 F Neumann8 S J Walton9 10 S K Clark9 10 J Sampson1 E Vilar2 11 L E Thomas1 1Division of Cancer and Genetics School of Medicine Cardiff University UK 2Department of Clinical Cancer Prevention UT MD Anderson Cancer Center Houston USA 3Department of Gastroenterology Cwm Taf University Health Board Merthyr Tydfil UK 4Department of Histopathology Cardiff UK 5Vale University Health Board Cardiff UK 6Department of Pathology and Laboratory Medicine UT MD Anderson Cancer Center Houston USA 7Department of Gastroenterology Hepatology and Nutrition UT MD Anderson Cancer Center Houston USA 8Science for Life Laboratory Stockholm University Sweden 9The Polyposis Registry St Marks Hospital London UK 10Department of Surgery and Cancer Faculty of Medicine Imperial College London UK 11Clinical Cancer Genetics Program UT MD Anderson Cancer Center Houston USA Correspondence E Meuser Aim Duodenal polyposis and cancer are important yet poorly understood causes of morbidity and mortality in FAP and MAP patients ",
   "entities": [
    [
     "T1",
     86,
     89,
     "gene",
     "FAP"
    ],
    [
     "T1",
     1254,
     1257,
     "gene",
     "FAP"
    ],
    [
     "T2",
     360,
     366,
     "phenotype",
     "Cancer"
    ],
    [
     "T2",
     445,
     451,
     "phenotype",
     "Cancer"
    ],
    [
     "T2",
     478,
     484,
     "phenotype",
     "Cancer"
    ],
    [
     "T2",
     732,
     738,
     "phenotype",
     "Cancer"
    ],
    [
     "T2",
     830,
     836,
     "phenotype",
     "Cancer"
    ],
    [
     "T2",
     993,
     999,
     "phenotype",
     "Cancer"
    ],
    [
     "T2",
     1058,
     1064,
     "phenotype",
     "Cancer"
    ],
    [
     "T2",
     1097,
     1103,
     "phenotype",
     "Cancer"
    ],
    [
     "T2",
     1174,
     1180,
     "phenotype",
     "Cancer"
    ],
    [
     "T3",
     1151,
     1169,
     "phenotype",
     "Duodenal polyposis"
    ]
   ]
  },
  "Sentences54": {
   "text": "We aimed to characterise the genomic and transcriptomic signatures associated with duodenal adenomas from patients with FAP and MAP to better understand duodenal tumourigenesis in these hereditary disorders ",
   "entities": [
    [
     "T1",
     120,
     123,
     "gene",
     "FAP"
    ],
    [
     "T2",
     197,
     206,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences55": {
   "text": "Recurrently mutated genes in duodenal adenomas included known drivers APC KRAS and additional potential duodenal-specific tumour initiators ",
   "entities": [
    [
     "T1",
     70,
     73,
     "gene",
     "APC"
    ],
    [
     "T2",
     74,
     78,
     "gene",
     "KRAS"
    ],
    [
     "T3",
     122,
     128,
     "phenotype",
     "tumour"
    ]
   ]
  },
  "Sentences56": {
   "text": "During 2004-2006 this support enabled us to implement the MSI and IHC analyses in tumors as well as the detection of point mutations in APC MLH1 and MSH2 genes ",
   "entities": [
    [
     "T1",
     136,
     139,
     "gene",
     "APC"
    ],
    [
     "T2",
     140,
     144,
     "gene",
     "MLH1"
    ],
    [
     "T3",
     149,
     153,
     "gene",
     "MSH2"
    ],
    [
     "T4",
     82,
     88,
     "phenotype",
     "tumors"
    ]
   ]
  },
  "Sentences57": {
   "text": "In nine probands with a characteristic hereditary colon cancer phenotype only MUTYH monoallelic mutations were found ",
   "entities": [
    [
     "T1",
     78,
     83,
     "gene",
     "MUTYH"
    ],
    [
     "T2",
     50,
     62,
     "phenotype",
     "colon cancer"
    ],
    [
     "T3",
     56,
     62,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences58": {
   "text": "N94 Uruguayan hereditary breast and ovarian cancer syndrome registry BRCA and non-BRCA pathogenic variants P Esperon1 2 F Neffa1 C Acevedo1 G Santander1 M Sapone1 C Vergara1 F Carusso1 A Della Valle1 1Grupo Colaborativo Uruguayo 2Facultad de Qu\u00edmica UDELAR Montevideo Uruguay Introduction Mutations in BRCA1 or BRCA2 genes are considered the most prevalent cause of hereditary breast and ovarian cancer syndrome HBOC  although other genes also explain this kind of affection ",
   "entities": [
    [
     "T1",
     311,
     316,
     "gene",
     "BRCA2"
    ],
    [
     "T2",
     51,
     59,
     "phenotype",
     "syndrome"
    ],
    [
     "T2",
     403,
     411,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     44,
     50,
     "phenotype",
     "cancer"
    ],
    [
     "T3",
     396,
     402,
     "phenotype",
     "cancer"
    ]
   ]
  }
 },
 "PMC6610427": {
  "Sentences0": {
   "text": "The cytokine CCL2 previously known as MCP-1 is a chemokine that is primarily responsible for inducing and regulating the migration and infiltration of macrophages to the sites of inflammation produced by either tissue injury or infection ",
   "entities": [
    [
     "T1",
     13,
     17,
     "gene",
     "CCL2"
    ],
    [
     "T2",
     228,
     237,
     "phenotype",
     "infection"
    ]
   ]
  },
  "Sentences1": {
   "text": "In mouse peritonitis models CCL2 is the most important mediator of monocyte migration into the abdomen 37 ",
   "entities": [
    [
     "T1",
     28,
     32,
     "gene",
     "CCL2"
    ],
    [
     "T2",
     9,
     20,
     "phenotype",
     "peritonitis"
    ]
   ]
  },
  "Sentences2": {
   "text": "In dogs with SP the concentrations of glucose cfDNA nucleosomes PCT CCL2 IL-6 IL-10 and KC-like were significantly different between blood and peritoneal effusion ",
   "entities": [
    [
     "T1",
     68,
     72,
     "gene",
     "CCL2"
    ]
   ]
  },
  "Sentences3": {
   "text": "These findings suggest effusion concentrations of CCL2 IL-6 and IL-10 may be more specific to bacterial infection rather than reflecting only the presence of an inflammatory process ",
   "entities": [
    [
     "T1",
     50,
     54,
     "gene",
     "CCL2"
    ],
    [
     "T2",
     104,
     113,
     "phenotype",
     "infection"
    ]
   ]
  },
  "Sentences4": {
   "text": "Other studies have demonstrated that CCL2 may be prognostic in dogs with IMHA 71  lymphoma 80  and babesiosis 81 ",
   "entities": [
    [
     "T1",
     37,
     41,
     "gene",
     "CCL2"
    ],
    [
     "T2",
     82,
     90,
     "phenotype",
     "lymphoma"
    ]
   ]
  }
 },
 "PMC6610778": {
  "Sentences0": {
   "text": "Evidence is emerging that not all T-cell responses are protective and mainly only those targeting conserved regions of HIV-1 proteins are effective but typically immunologically subdominant while those recognizing hypervariable easy-to-escape immunodominant decoys do not control viremia and do not protect from a loss of CD4 T cells ",
   "entities": [
    [
     "T1",
     322,
     325,
     "gene",
     "CD4"
    ],
    [
     "T2",
     280,
     287,
     "phenotype",
     "viremia"
    ]
   ]
  },
  "Sentences1": {
   "text": "Cells were stained first with Aqua Live/Dead and fixed with 1 paraformaldehyde/20\u202f\u03bcg/mL lysolecithin at room temperature permeabilized with cold 50 methanol followed by 0 1 Nonidet P-40 and finally stained with anti-Gag p24 KC-57-FITC Beckman Coulter  anti-CD3 APC-Cy7 BD Biosciences  anti-CD4 PerCP BD Biosciences  and anti-CD8 APC BD Biosciences mAbs ",
   "entities": [
    [
     "T1",
     261,
     264,
     "gene",
     "APC"
    ],
    [
     "T1",
     329,
     332,
     "gene",
     "APC"
    ],
    [
     "T2",
     140,
     144,
     "phenotype",
     "cold"
    ]
   ]
  },
  "Sentences2": {
   "text": "3 6 Early cART preserves antiviral function of CD8 T cells and might contribute to an efficacious vaccine response To determine CD8 T-cell mediated viral inhibitory capacity against HIV-1 BaL and IIIB isolates at different CD8 CD4 ratios E T\u202f \u202f1 1 1 2 and 1 10  longitudinal cryopreserved-and-thawed samples obtained at 6\u202fmonths on stable cART and just before vaccination C0  at the peak of vaccine-induced immunogenicity M1 or M4 collectively Mpeak and at the end of trial in all individuals from the Long and Short arms M24 were used in in vitro viral replication inhibition assays ",
   "entities": [
    [
     "T1",
     227,
     230,
     "gene",
     "CD4"
    ],
    [
     "T2",
     511,
     521,
     "phenotype",
     "Short arms"
    ]
   ]
  },
  "Sentences3": {
   "text": "These levels of proviral DNA were 3-fold lower than values in virally suppressed individuals who started cART during chronic HIV-1 infection median of 1065 copies/106 CD4 T cells  49 ",
   "entities": [
    [
     "T1",
     167,
     170,
     "gene",
     "CD4"
    ],
    [
     "T2",
     131,
     140,
     "phenotype",
     "infection"
    ]
   ]
  },
  "Sentences4": {
   "text": "Overall the frequency of CD4 T cells harboring HIV-1 DNA correlated well with pre-cART viremia in acute/recent infection Spearman r\u202f \u202f0 54 p\u202f lt \u202f0 0001 at C0 and Spearman r\u202f \u202f0 59 p\u202f lt \u202f0 0001 at M24 see Appendix Fig 3 ",
   "entities": [
    [
     "T1",
     25,
     28,
     "gene",
     "CD4"
    ],
    [
     "T2",
     111,
     120,
     "phenotype",
     "infection"
    ],
    [
     "T3",
     87,
     94,
     "phenotype",
     "viremia"
    ]
   ]
  },
  "Sentences5": {
   "text": "In line with this hypothesis we observed also in our cohort a more marked immune restoration normal CD4/CD8 T-cell ratios  56  a reduced expression of immune exhaustion markers and stronger CD8 T-cell viral inhibitory capacity than those reported for individuals who started treatment in the chronic phase of HIV-1 infection 49 ",
   "entities": [
    [
     "T1",
     100,
     103,
     "gene",
     "CD4"
    ],
    [
     "T2",
     315,
     324,
     "phenotype",
     "infection"
    ],
    [
     "T3",
     158,
     168,
     "phenotype",
     "exhaustion"
    ]
   ]
  }
 },
 "PMC6611217": {
  "Sentences0": {
   "text": "Vitamin D receptor VDR gene polymorphism has been found to be associated with different kinds of diseases ",
   "entities": [
    [
     "T1",
     19,
     22,
     "gene",
     "VDR"
    ],
    [
     "T2",
     97,
     105,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences1": {
   "text": "There are different SNP locations in the VDR gene and an association between VDR SNPs and risk of different diseases ",
   "entities": [
    [
     "T1",
     41,
     44,
     "gene",
     "VDR"
    ],
    [
     "T1",
     77,
     80,
     "gene",
     "VDR"
    ],
    [
     "T2",
     108,
     116,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences2": {
   "text": "There have also been reports on SNP in VDR gene associated with the incidence of different disorders ",
   "entities": [
    [
     "T1",
     39,
     42,
     "gene",
     "VDR"
    ],
    [
     "T2",
     91,
     100,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences3": {
   "text": "In a case-control study with acute pancreatitis patients n 129 and an alcohol-abuse control group n 110  it was found that polymorphism Taq-1 occurred in the vitamin D receptor 23 and had an impact on the development of acute pancreatitis due to the lack of the protective role of vitamin D There was also a synonymous SNP rs731236 in the VDR gene that has been reported in another study to be associated with a higher risk of Crohn s disease 24 ",
   "entities": [
    [
     "T1",
     339,
     342,
     "gene",
     "VDR"
    ],
    [
     "T2",
     35,
     47,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T2",
     226,
     238,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     29,
     47,
     "phenotype",
     "acute pancreatitis"
    ],
    [
     "T3",
     220,
     238,
     "phenotype",
     "acute pancreatitis"
    ],
    [
     "T4",
     435,
     442,
     "phenotype",
     "disease"
    ]
   ]
  }
 },
 "PMC6611219": {
  "Sentences0": {
   "text": "Procalcitonin and C-reactive protein CRP are two acute-phase serum proteins that are commonly used as early markers of infection 65 ",
   "entities": [
    [
     "T1",
     37,
     40,
     "gene",
     "CRP"
    ],
    [
     "T2",
     119,
     128,
     "phenotype",
     "infection"
    ]
   ]
  },
  "Sentences1": {
   "text": " 67 reported that a CRP gt 12 15 mg/L was a reliable indicator of bacterial infection in patients with ACLF ",
   "entities": [
    [
     "T1",
     20,
     23,
     "gene",
     "CRP"
    ],
    [
     "T2",
     76,
     85,
     "phenotype",
     "infection"
    ]
   ]
  }
 },
 "PMC6611749": {
  "Sentences0": {
   "text": "Many animal studies have confirmed the therapeutic potential of FGF19 in the treatment of metabolic disorders such as obesity or diabetes ",
   "entities": [
    [
     "T1",
     64,
     69,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     118,
     125,
     "phenotype",
     "obesity"
    ],
    [
     "T3",
     129,
     137,
     "phenotype",
     "diabetes"
    ],
    [
     "T4",
     100,
     109,
     "phenotype",
     "disorders"
    ],
    [
     "T5",
     90,
     109,
     "phenotype",
     "metabolic disorders"
    ]
   ]
  },
  "Sentences1": {
   "text": "The formation of HNF-\u03b1 and SHP complex prevents the interaction of HNF-\u03b1 with co-activators and their dissociation causes repression of the CYP7A1 gene ",
   "entities": [
    [
     "T1",
     140,
     146,
     "gene",
     "CYP7A1"
    ],
    [
     "T2",
     102,
     114,
     "phenotype",
     "dissociation"
    ]
   ]
  },
  "Sentences2": {
   "text": "FGF19 also stimulates glycogen synthesis in mice with streptozotocin-induced diabetes with very low insulin levels ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     77,
     85,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences3": {
   "text": " 66 showed that treatment with FGF19 increases triglycerides and cholesterol blood levels in mice with obesity resulting from diet ",
   "entities": [
    [
     "T1",
     31,
     36,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     103,
     110,
     "phenotype",
     "obesity"
    ]
   ]
  },
  "Sentences4": {
   "text": "Obesity FGF19 and FGF21 play an important role in the regulation of glucose and lipid metabolism ",
   "entities": [
    [
     "T1",
     8,
     13,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     18,
     23,
     "gene",
     "FGF21"
    ],
    [
     "T3",
     0,
     7,
     "phenotype",
     "Obesity"
    ]
   ]
  },
  "Sentences5": {
   "text": "Clinical studies show that FGF19 concentration in the blood of obese patients is lower than in healthy subjects 21 75 ",
   "entities": [
    [
     "T1",
     27,
     32,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     63,
     68,
     "phenotype",
     "obese"
    ]
   ]
  },
  "Sentences6": {
   "text": "FGF19 concentration is also reduced in obese adolescents with non-alcoholic fatty liver disease NAFLD  when compared to healthy subjects ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     39,
     44,
     "phenotype",
     "obese"
    ],
    [
     "T3",
     82,
     95,
     "phenotype",
     "liver disease"
    ],
    [
     "T4",
     62,
     87,
     "phenotype",
     "non-alcoholic fatty liver"
    ],
    [
     "T5",
     88,
     95,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences7": {
   "text": "Interestingly there is a correlation between low FGF19 levels during fasting and the likelihood of NAFLD occurrence in obese children 65 ",
   "entities": [
    [
     "T1",
     49,
     54,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     119,
     124,
     "phenotype",
     "obese"
    ]
   ]
  },
  "Sentences8": {
   "text": "showed that in patients with NAFLD and insulin resistance FGF19 synthesis is preserved while liver response to FGF19 is impaired 54 ",
   "entities": [
    [
     "T1",
     58,
     63,
     "gene",
     "FGF19"
    ],
    [
     "T1",
     111,
     116,
     "gene",
     "FGF19"
    ]
   ]
  },
  "Sentences9": {
   "text": "The negative correlation between FGF19 and obesity has also been confirmed in animal studies ",
   "entities": [
    [
     "T1",
     33,
     38,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     43,
     50,
     "phenotype",
     "obesity"
    ]
   ]
  },
  "Sentences10": {
   "text": "Administration of human recombinant FGF19 to mice in which obesity was induced by high-fat diet resulted in a dose-dependent significant decrease in body weight and blood glucose concentration ",
   "entities": [
    [
     "T1",
     36,
     41,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     59,
     66,
     "phenotype",
     "obesity"
    ]
   ]
  },
  "Sentences11": {
   "text": "Diabetes Transgenic mice bearing the FGF19 gene show an increased sensitivity to insulin compared to the wild type 59 ",
   "entities": [
    [
     "T1",
     37,
     42,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     0,
     8,
     "phenotype",
     "Diabetes"
    ]
   ]
  },
  "Sentences12": {
   "text": "Similarly the administration of exogenous FGF19 prevents the development of glucose metabolism disorders ",
   "entities": [
    [
     "T1",
     42,
     47,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     76,
     104,
     "phenotype",
     "glucose metabolism disorders"
    ],
    [
     "T3",
     95,
     104,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences13": {
   "text": "In mice with obesity genetically induced by ablation of brown adipose tissue or lack of leptin FGF19 prevented or reversed diabetes 12 ",
   "entities": [
    [
     "T1",
     95,
     100,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     13,
     20,
     "phenotype",
     "obesity"
    ],
    [
     "T3",
     123,
     131,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences14": {
   "text": "Recent studies have demonstrated that FGF19 administered to cerebral ventricles results in insulin-independent decreasing glucose levels in obese mice and increasing insulin sensitivity in mice on a high-fat diet ",
   "entities": [
    [
     "T1",
     38,
     43,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     140,
     145,
     "phenotype",
     "obese"
    ]
   ]
  },
  "Sentences15": {
   "text": "This is consistent with the results obtained in people with diabetes and metabolic syndrome in whom FGF19 concentration negatively correlated with BMI triglycerides HDL cholesterol CRP and glycated hemoglobin levels 5 ",
   "entities": [
    [
     "T1",
     100,
     105,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     181,
     184,
     "gene",
     "CRP"
    ],
    [
     "T3",
     83,
     91,
     "phenotype",
     "syndrome"
    ],
    [
     "T4",
     73,
     91,
     "phenotype",
     "metabolic syndrome"
    ],
    [
     "T5",
     60,
     68,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences16": {
   "text": "Before the surgery lower concentrations of FGF19 and fatty acids were observed in people with diabetes compared to nondiabetic patients regardless of BMI ",
   "entities": [
    [
     "T1",
     43,
     48,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     94,
     102,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences17": {
   "text": "After the surgery a gradual increase in FGF19 and fatty acids concentrations was observed in all patients however it was greater in people with diabetes 5 ",
   "entities": [
    [
     "T1",
     40,
     45,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     144,
     152,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences18": {
   "text": "In the end stage of chronic kidney disease an impaired post-meal FGF19 response was observed which was partially normalized by therapy with antioxidants 34 ",
   "entities": [
    [
     "T1",
     65,
     70,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     20,
     42,
     "phenotype",
     "chronic kidney disease"
    ],
    [
     "T3",
     35,
     42,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences19": {
   "text": "An overdose of FGF21 does not lead to hypoglycemia as with insulin ",
   "entities": [
    [
     "T1",
     15,
     20,
     "gene",
     "FGF21"
    ]
   ]
  },
  "Sentences20": {
   "text": "Peroxisome proliferator-activated receptors \u03b1 PPAR\u03b1 is a transcription factor that controls hepatic FGF21 expression in hunger as well as lipid metabolism and energy homeostasis ",
   "entities": [
    [
     "T1",
     100,
     105,
     "gene",
     "FGF21"
    ]
   ]
  },
  "Sentences21": {
   "text": "Fenofibrate a PPAR\u03b1 agonist is a potent inducer of FGF21 expression in hunger both in the mouse liver and in human primary hepatocytes ",
   "entities": [
    [
     "T1",
     51,
     56,
     "gene",
     "FGF21"
    ]
   ]
  },
  "Sentences22": {
   "text": "In case of FGF21 deficiency in mice the biological activity of PPAR\u03b1 is reduced ",
   "entities": [
    [
     "T1",
     11,
     16,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     17,
     27,
     "phenotype",
     "deficiency"
    ]
   ]
  },
  "Sentences23": {
   "text": "It is possible that PPAR\u03b1 mainly with help of FGF21 mediates in adaptation of metabolism during hunger or after a meal including ketogenesis fatty acid oxidation or gluconeogenesis 10 17 37 47 75 ",
   "entities": [
    [
     "T1",
     46,
     51,
     "gene",
     "FGF21"
    ]
   ]
  },
  "Sentences24": {
   "text": "In mice with diet-induced obesity and missing \u03b2-Klotho co-receptor in the central nervous system the beneficial effects of FGF21 on the body weight or insulin resistance were not observed 15 44 ",
   "entities": [
    [
     "T1",
     123,
     128,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     26,
     33,
     "phenotype",
     "obesity"
    ]
   ]
  },
  "Sentences25": {
   "text": "The administration of FGF21 directly into the cerebrospinal fluid increases energy expenditure and reduces insulin resistance in obese rats 10 70 ",
   "entities": [
    [
     "T1",
     22,
     27,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     129,
     134,
     "phenotype",
     "obese"
    ]
   ]
  },
  "Sentences26": {
   "text": "Both transgenic expression and administration of FGF21 induce mice into a lethargic state ",
   "entities": [
    [
     "T1",
     49,
     54,
     "gene",
     "FGF21"
    ]
   ]
  },
  "Sentences27": {
   "text": "FGF21 KO mice are more susceptible to cerulein-induced pancreatitis CIP  while FGF21 transgenic mice are resistant to acute pancreatitis ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "FGF21"
    ],
    [
     "T1",
     79,
     84,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     55,
     67,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T2",
     124,
     136,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T3",
     118,
     136,
     "phenotype",
     "acute pancreatitis"
    ]
   ]
  },
  "Sentences28": {
   "text": "Short-term administration of FGF21 reduces insulin levels in both healthy and db/db mice diabetes mice ",
   "entities": [
    [
     "T1",
     29,
     34,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     89,
     97,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences29": {
   "text": "In contrast to the peroxisome proliferator-activated receptor PPAR\u03b3 agonist and metformin FGF21 leads to a rapid insulin sensitization within 1\u00a0h Such fast action may indicate post-translational mechanisms without the need for new protein synthesis ",
   "entities": [
    [
     "T1",
     90,
     95,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     121,
     134,
     "phenotype",
     "sensitization"
    ]
   ]
  },
  "Sentences30": {
   "text": "Studies have shown that FGF21 levels are positively correlated with obesity and hepatic steatosis degree ",
   "entities": [
    [
     "T1",
     24,
     29,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     68,
     75,
     "phenotype",
     "obesity"
    ]
   ]
  },
  "Sentences31": {
   "text": "Reduction of FGF21 level in mice on a ketogenic diet leads to hepatic steatosis lipemia and a decrease of serum ketone concentration 4 75 ",
   "entities": [
    [
     "T1",
     13,
     18,
     "gene",
     "FGF21"
    ]
   ]
  },
  "Sentences32": {
   "text": "Another study has shown that FGF21 induces adipocyte differentiation and lipogenesis in obese mice ",
   "entities": [
    [
     "T1",
     29,
     34,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     88,
     93,
     "phenotype",
     "obese"
    ]
   ]
  },
  "Sentences33": {
   "text": "Administration of exogenous FGF21 increases the body ability to defend against chronic cold by increasing the expression of UCP1 and other thermogenic genes in adipose tissue ",
   "entities": [
    [
     "T1",
     28,
     33,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     87,
     91,
     "phenotype",
     "cold"
    ]
   ]
  },
  "Sentences34": {
   "text": "Studies on the relationship between WAT and an FGF21 pharmacological action in metabolism regulation concluded that the therapeutic effect of FGF21 on carbohydrate and lipid metabolism disorders is independent of the transformation of white into brown adipose tissue ",
   "entities": [
    [
     "T1",
     47,
     52,
     "gene",
     "FGF21"
    ],
    [
     "T1",
     142,
     147,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     168,
     194,
     "phenotype",
     "lipid metabolism disorders"
    ],
    [
     "T3",
     185,
     194,
     "phenotype",
     "disorders"
    ]
   ]
  },
  "Sentences35": {
   "text": "However exogenous FGF21 or mimetic FGF21 induce similar effects such as increased energy expenditure without altering the food intake weight loss and regulation of glucose and lipid levels ",
   "entities": [
    [
     "T1",
     18,
     23,
     "gene",
     "FGF21"
    ],
    [
     "T1",
     35,
     40,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     134,
     145,
     "phenotype",
     "weight loss"
    ]
   ]
  },
  "Sentences36": {
   "text": "Diabetes The FGF21 levels increased in type 2 diabetes and is positively correlated with hypertension hyperglycemia glycated hemoglobin level insulin resistance and hsCRP level 10 ",
   "entities": [
    [
     "T1",
     13,
     18,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     0,
     8,
     "phenotype",
     "Diabetes"
    ],
    [
     "T2",
     46,
     54,
     "phenotype",
     "Diabetes"
    ],
    [
     "T3",
     89,
     101,
     "phenotype",
     "hypertension"
    ],
    [
     "T4",
     39,
     54,
     "phenotype",
     "type 2 diabetes"
    ]
   ]
  },
  "Sentences37": {
   "text": "Multiple studies have been done to determine the relationship between FGF21 and type 2 diabetes mellitus 10 53 75 ",
   "entities": [
    [
     "T1",
     70,
     75,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     87,
     104,
     "phenotype",
     "diabetes mellitus"
    ],
    [
     "T3",
     80,
     104,
     "phenotype",
     "type 2 diabetes mellitus"
    ],
    [
     "T4",
     87,
     95,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences38": {
   "text": "A large Chinese prospective study has found that increase of FGF21 levels positively correlated with hyperglycemia and dyslipidemia in pre-diabetic subjects of normal phenotype 8 ",
   "entities": [
    [
     "T1",
     61,
     66,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     119,
     131,
     "phenotype",
     "dyslipidemia"
    ]
   ]
  },
  "Sentences39": {
   "text": "However FGF21 level in the case of type 1 diabetes and latent autoimmune diabetes of adults LADA was significantly lower than in a healthy control group 61 67 ",
   "entities": [
    [
     "T1",
     8,
     13,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     35,
     50,
     "phenotype",
     "type 1 diabetes"
    ],
    [
     "T3",
     62,
     81,
     "phenotype",
     "autoimmune diabetes"
    ],
    [
     "T4",
     42,
     50,
     "phenotype",
     "diabetes"
    ],
    [
     "T4",
     73,
     81,
     "phenotype",
     "diabetes"
    ],
    [
     "T5",
     55,
     91,
     "phenotype",
     "latent autoimmune diabetes of adults"
    ]
   ]
  },
  "Sentences40": {
   "text": "The diminishing effect on FGF21 level in type 1 and LADA diabetes is probably caused by insulin deficiency which acts as an inducer of hepatic FGF21 53 75 ",
   "entities": [
    [
     "T1",
     26,
     31,
     "gene",
     "FGF21"
    ],
    [
     "T1",
     143,
     148,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     57,
     65,
     "phenotype",
     "diabetes"
    ],
    [
     "T3",
     96,
     106,
     "phenotype",
     "deficiency"
    ]
   ]
  },
  "Sentences41": {
   "text": "A functional study has shown that an administration of exogenous FGF21 to diabetic mice resulted in decreased blood glucose and lipids improved insulin sensitivity weight loss increased fat consumption and energy expenditure 75 ",
   "entities": [
    [
     "T1",
     65,
     70,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     164,
     175,
     "phenotype",
     "weight loss"
    ]
   ]
  },
  "Sentences42": {
   "text": "As FGF21 has been shown to reduce glucose and lipid levels it has been suggested as a potential therapeutic agent for the treatment of diabetes obesity and dyslipidemia 3 ",
   "entities": [
    [
     "T1",
     3,
     8,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     144,
     151,
     "phenotype",
     "obesity"
    ],
    [
     "T3",
     135,
     143,
     "phenotype",
     "diabetes"
    ],
    [
     "T4",
     156,
     168,
     "phenotype",
     "dyslipidemia"
    ]
   ]
  },
  "Sentences43": {
   "text": "Administration of the FGF21 analogue to people suffering from obesity and type 2 diabetes caused beneficial effects on some disorders associated with diabetes however further studies with the analogue are needed 3 13 ",
   "entities": [
    [
     "T1",
     22,
     27,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     62,
     69,
     "phenotype",
     "obesity"
    ],
    [
     "T3",
     81,
     89,
     "phenotype",
     "diabetes"
    ],
    [
     "T3",
     150,
     158,
     "phenotype",
     "diabetes"
    ],
    [
     "T4",
     124,
     133,
     "phenotype",
     "disorders"
    ],
    [
     "T5",
     47,
     56,
     "phenotype",
     "suffering"
    ],
    [
     "T6",
     74,
     89,
     "phenotype",
     "type 2 diabetes"
    ]
   ]
  },
  "Sentences44": {
   "text": "Therefore FGF21 is currently considered as a therapeutic option but also as a predictive marker for the development of type 2 diabetes ",
   "entities": [
    [
     "T1",
     10,
     15,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     126,
     134,
     "phenotype",
     "diabetes"
    ],
    [
     "T3",
     119,
     134,
     "phenotype",
     "type 2 diabetes"
    ]
   ]
  },
  "Sentences45": {
   "text": "Since reduced FGF19 level is a contributing factor in the development of gestational diabetes it created much interest in understanding the role of FGF21 61 62 ",
   "entities": [
    [
     "T1",
     14,
     19,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     148,
     153,
     "gene",
     "FGF21"
    ],
    [
     "T3",
     73,
     93,
     "phenotype",
     "gestational diabetes"
    ],
    [
     "T4",
     85,
     93,
     "phenotype",
     "diabetes"
    ]
   ]
  },
  "Sentences46": {
   "text": " 58 observed similar blood level of FGF21 in women who are healthy and those suffering from gestational diabetes however it was positively correlated with markers of insulin resistance and dyslipidemia including triglycerides leptin adiponectin and HDL ",
   "entities": [
    [
     "T1",
     36,
     41,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     92,
     112,
     "phenotype",
     "gestational diabetes"
    ],
    [
     "T3",
     104,
     112,
     "phenotype",
     "diabetes"
    ],
    [
     "T4",
     77,
     86,
     "phenotype",
     "suffering"
    ],
    [
     "T5",
     189,
     201,
     "phenotype",
     "dyslipidemia"
    ]
   ]
  },
  "Sentences47": {
   "text": "Although studies suggest that reduced FGF19 level may play a role in the pathophysiology of gestational diabetes the increased FGF21 level may be a response to the disease 58 61 62 ",
   "entities": [
    [
     "T1",
     38,
     43,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     127,
     132,
     "gene",
     "FGF21"
    ],
    [
     "T3",
     92,
     112,
     "phenotype",
     "gestational diabetes"
    ],
    [
     "T4",
     104,
     112,
     "phenotype",
     "diabetes"
    ],
    [
     "T5",
     164,
     171,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences48": {
   "text": "Obesity Obese diabetic mice as well as people suffering from obesity show elevated FGF21 levels 3 ",
   "entities": [
    [
     "T1",
     83,
     88,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     8,
     13,
     "phenotype",
     "Obese"
    ],
    [
     "T3",
     0,
     7,
     "phenotype",
     "Obesity"
    ],
    [
     "T3",
     61,
     68,
     "phenotype",
     "Obesity"
    ]
   ]
  },
  "Sentences49": {
   "text": "Mouse studies have shown that high-fat diet-induced obesity leads to FGF21 blood level increase ",
   "entities": [
    [
     "T1",
     69,
     74,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     52,
     59,
     "phenotype",
     "obesity"
    ]
   ]
  },
  "Sentences50": {
   "text": "Whereas sensitivity to FGF21 can be restored by weight loss or by a therapeutic glucose level reduction 33 75 ",
   "entities": [
    [
     "T1",
     23,
     28,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     48,
     59,
     "phenotype",
     "weight loss"
    ]
   ]
  },
  "Sentences51": {
   "text": "Interestingly the studies in obese diabetic volunteers demonstrate the FGF21 analog LY2405319 causes body weight loss 15 40 ",
   "entities": [
    [
     "T1",
     71,
     76,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     29,
     34,
     "phenotype",
     "obese"
    ],
    [
     "T3",
     106,
     117,
     "phenotype",
     "weight loss"
    ]
   ]
  },
  "Sentences52": {
   "text": "It has been observed that FGF21 level increases during hunger and in overfeeding in adults as well as in children ",
   "entities": [
    [
     "T1",
     26,
     31,
     "gene",
     "FGF21"
    ]
   ]
  },
  "Sentences53": {
   "text": "Obese children show an elevated blood concentration of free fatty acids that stimulate FGF21 secretion ",
   "entities": [
    [
     "T1",
     87,
     92,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     0,
     5,
     "phenotype",
     "Obese"
    ]
   ]
  },
  "Sentences54": {
   "text": "FGF21 may be considered an independent marker of metabolic syndrome and obesity 10 48 ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     59,
     67,
     "phenotype",
     "syndrome"
    ],
    [
     "T3",
     49,
     67,
     "phenotype",
     "metabolic syndrome"
    ],
    [
     "T4",
     72,
     79,
     "phenotype",
     "obesity"
    ]
   ]
  },
  "Sentences55": {
   "text": "Vascular diseases FGF21 is also produced and secreted by cardiomyocytes and acts as a cardiomyokine 10 ",
   "entities": [
    [
     "T1",
     18,
     23,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     0,
     17,
     "phenotype",
     "Vascular diseases"
    ],
    [
     "T3",
     9,
     17,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences56": {
   "text": "Patients with atherosclerotic carotid arteries disease have been shown to have elevated FGF21 levels that are positively correlated to risk factors such as adverse lipid profile and CRP ",
   "entities": [
    [
     "T1",
     88,
     93,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     182,
     185,
     "gene",
     "CRP"
    ],
    [
     "T3",
     30,
     54,
     "phenotype",
     "carotid arteries disease"
    ],
    [
     "T4",
     47,
     54,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences57": {
   "text": "High FGF21 levels predicted the incidence coronary artery disease 32 ",
   "entities": [
    [
     "T1",
     5,
     10,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     58,
     65,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences58": {
   "text": "Moreover FGF21 deletion increases myocardial fatty tissue likely via positive regulation of NF-E2 an Nrf2 transcription factor and CD36 which causes increased myocardial oxidative stress and changes in the heart muscle structure and possible development of diabetic cardiomyopathy ",
   "entities": [
    [
     "T1",
     9,
     14,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     131,
     135,
     "gene",
     "CD36"
    ],
    [
     "T3",
     257,
     280,
     "phenotype",
     "diabetic cardiomyopathy"
    ],
    [
     "T4",
     170,
     186,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences59": {
   "text": "FGF21 also protects H9C2 cells embryonic rat cardiomyocytes from oxidative stress and apoptosis caused by ischemia-reperfusion injury 71 75 ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     65,
     81,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences60": {
   "text": "Kidney diseases Animal studies have shown that FGF21 prevents diabetic nephropathy by improving metabolic systems and anti-fibrotic effect ",
   "entities": [
    [
     "T1",
     47,
     52,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     62,
     82,
     "phenotype",
     "diabetic nephropathy"
    ],
    [
     "T3",
     7,
     15,
     "phenotype",
     "diseases"
    ]
   ]
  },
  "Sentences61": {
   "text": "It has been observed that FGF21 has a beneficial effect on the kidneys of mice with type 1 diabetes because it prevents oxidative stress inflammation apoptosis and fibrosis 73 75 ",
   "entities": [
    [
     "T1",
     26,
     31,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     84,
     99,
     "phenotype",
     "type 1 diabetes"
    ],
    [
     "T3",
     91,
     99,
     "phenotype",
     "diabetes"
    ],
    [
     "T4",
     120,
     136,
     "phenotype",
     "oxidative stress"
    ]
   ]
  },
  "Sentences62": {
   "text": "In patients with chronic and acute kidney disease FGF21 levels increase as the disease progresses 35 75 ",
   "entities": [
    [
     "T1",
     50,
     55,
     "gene",
     "FGF21"
    ],
    [
     "T2",
     42,
     49,
     "phenotype",
     "disease"
    ],
    [
     "T2",
     79,
     86,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences63": {
   "text": "FGF19 and FGF21 are also considered as predictors of development of some diseases for example type 2 diabetes non-alkoholic fatty liver disease atherosclerosis coronary artery disease and chronic kidney disease ",
   "entities": [
    [
     "T1",
     0,
     5,
     "gene",
     "FGF19"
    ],
    [
     "T2",
     10,
     15,
     "gene",
     "FGF21"
    ],
    [
     "T3",
     130,
     143,
     "phenotype",
     "liver disease"
    ],
    [
     "T4",
     188,
     210,
     "phenotype",
     "chronic kidney disease"
    ],
    [
     "T5",
     101,
     109,
     "phenotype",
     "diabetes"
    ],
    [
     "T6",
     73,
     81,
     "phenotype",
     "diseases"
    ],
    [
     "T7",
     94,
     109,
     "phenotype",
     "type 2 diabetes"
    ]
   ]
  }
 },
 "PMC6612011": {
  "Sentences0": {
   "text": "Cytosolic Trx1 prevents dissociation of I\u03baB from NF\u03baB 31 and also directly interacts with the Nrf-2 interacting protein Kelch-like ECH-associated protein-1 Keap-1  maintaining KEAP1 in a reduced state 32 and thus blocking NF\u03baB and Nrf-2 nuclear translocation respectively ",
   "entities": [
    [
     "T1",
     176,
     181,
     "gene",
     "KEAP1"
    ],
    [
     "T2",
     24,
     36,
     "phenotype",
     "dissociation"
    ],
    [
     "T3",
     213,
     221,
     "phenotype",
     "blocking"
    ]
   ]
  }
 },
 "PMC6612288": {
  "Sentences0": {
   "text": "Genetically the majority of genomic alterations in breast cancer are sporadic and just 5\u201310 are germline mutations are classified as hereditary 3 The most common germline mutations related to breast cancer are in the breast and ovarian cancer susceptibility gene 1 BRCA1 or BRCA2 ",
   "entities": [
    [
     "T1",
     274,
     279,
     "gene",
     "BRCA2"
    ],
    [
     "T2",
     58,
     64,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     199,
     205,
     "phenotype",
     "cancer"
    ],
    [
     "T2",
     236,
     242,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences1": {
   "text": "Mutations in these genes located on chromosome 17 and 13 respectively are highly penetrant classically more frequent in Ashkenazi Jews and increase the lifetime risk of breast cancer up to 70 in patients with BRCA1 mutations and between 40 and 70 in patients with BRCA2 mutations 3 BRCA1 and BRCA2 proteins which are at maximal expression during the DNA replication phases S and G2 phases  present an essential role for cellular survival by integrating a complex mechanism of DNA double-strand damage restoration called homologous recombination repair 4 BRCA1 interacts with the MRE1/RAD50/Nbs1 protein complex and identifies through histone phosphorylation sites of DNA damage and subsequently resets and recreates the double-stranded DNA ",
   "entities": [
    [
     "T1",
     264,
     269,
     "gene",
     "BRCA2"
    ],
    [
     "T1",
     292,
     297,
     "gene",
     "BRCA2"
    ],
    [
     "T2",
     176,
     182,
     "phenotype",
     "cancer"
    ]
   ]
  },
  "Sentences2": {
   "text": "Alternatively the majority of BRCA2 cancers are estrogen receptor-positive and have a lower mitotic index 10 Considering this specific disease biology studies have investigated tailoring treatment for patients with BRCA1/2 mutations ",
   "entities": [
    [
     "T1",
     30,
     35,
     "gene",
     "BRCA2"
    ],
    [
     "T2",
     36,
     43,
     "phenotype",
     "cancers"
    ],
    [
     "T3",
     135,
     142,
     "phenotype",
     "disease"
    ]
   ]
  },
  "Sentences3": {
   "text": "High proliferation rates as seen in tumors and the absence of competent homologous recombination make cells more susceptible to these drugs 11 In addition poly ADP-ribose polymerase-1/2 PARP1/2 inhibitors have emerged as novel agents that act as a personalized targeted treatment in patients with BRCA1/2 mutations by inhibiting the single-strand DNA repair mechanism ",
   "entities": [
    [
     "T1",
     186,
     191,
     "gene",
     "PARP1"
    ],
    [
     "T2",
     36,
     42,
     "phenotype",
     "tumors"
    ]
   ]
  }
 },
 "PMC6612359": {
  "Sentences0": {
   "text": "These studies reported EAIRs for pancreatitis that were not statistically significantly different between exenatide BID and comparator 0 27 vs 0 18 events per 100 patient-years risk difference 0 09 or were comparable between exenatide QW and comparator 0 5 vs 0 5 events per 100 patient-years  however these studies did not examine individual cases of pancreatitis ",
   "entities": [
    [
     "T1",
     116,
     119,
     "gene",
     "BID"
    ],
    [
     "T2",
     33,
     45,
     "phenotype",
     "pancreatitis"
    ],
    [
     "T2",
     352,
     364,
     "phenotype",
     "pancreatitis"
    ]
   ]
  }
 }
}